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Abstract 
The Sigma1 receptor (σ1R) is an endoplasmic reticulum (ER) chaperone 
targeted to mitochondrion associated ER membranes (MAMs). The upregulation of 
σ1R is associated with various cancers, whereas the decreased expression and 
mutant forms of σ1R are associated with neurodegenerative disorders. The 
underlying cellular mechanism by which σ1R exerts such a versatile impact remains 
elusive. At MAMs, σ1R is reported to regulate inter-organelle Ca2+ levels. Following 
translocation to ER-plasma membrane junctions, σ1R is reported to interact with 
various ion channels, including the key regulators of store-operated Ca2+ entry 
(SOCE).  
I have investigated the role of σ1R in the regulation of SOCE within a 
population of cells and within the SOCE microdomains of single cells. In a population 
of cells, overexpression of σ1R profoundly inhibited both Ca2+ store content and 
SOCE. Although these measurements of global [Ca2+]cyt provide essential 
information about the functional role of σ1R in the regulation of SOCE, they do not 
provide detailed information about the effects of σ1R on temporal and spatial aspects 
of SOCE within the microdomain of the ER-plasma membrane junction. Recently 
developed, the G-GECO1.2-Orai1 construct encodes for a fully functional Orai1 
protein with a genetically encoded fluorescent Ca2+ reporter protein. The Orai1 
channel is a key regulator of SOCE. GECO1.2-Orai1 allows for the monitoring of 
Orai1 channel activity in SOCE microdomains. Within the SOCE microdomains, 
overexpression of σ1R reduced the frequency of highly-activated G-GECO1.2-Orai1 
clusters, which resulted in cumulatively low SOCE. Overexpression of σ1RE102Q, an 
ALS-causing mutant, failed to inhibit SOCE. In situ, σ1R was shown to interact with 
another key regulator of SOCE, STIM1 and its less-studied homolog STIM2. 
Overexpression of σ1R resulted in the inhibition of STIM2.2-mediated SOCE 
triggered by the ER Ca2+ store depletion. σ1R failed to inhibit STIM2.2-mediated 
SOCE during basal conditions, suggesting that regulation of SOCE by σ1R requires 
a greater drop in ER [Ca2+] than occurs under basal conditions.  
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1 Chapter I: Introduction 
1.1 Sigma1 receptor (σ1R) 
1.1.1 Historical overview of Sigma (σ)-receptors 
σ-receptors are pharmacologically well-defined, transmembrane proteins that are 
targeted by compounds from the variety of structural classes. The existence of “sigma” (σ) 
site was first proposed by Martin et al. (1976) during pharmacological studies using SKF-
10,047 and related benzomorphans1. This historical, ground-breaking study was performed 
in morphine-dependent and non-dependent chronic spinal dogs. Based on the behavioural 
effects that occurred following the application of benzomorphans, several types of novel 
opioid receptors were proposed: µ (Mu), κ (Kappa) and σ (Sigma).  
Further pharmacological and photo-labelling studies demonstrated that SKF-10,047 
interacted with several distinct sites, resulting in opioid and non-opioid related effects2–5. 
Separate evaluation of SKF-10,047 (+)- and (-)-isomers explained these observations. It 
was demonstrated that (-)-isomers of benzomorphans account for the opioid-mediated 
effects, including the effects reported by Martin et al. study which used a racemic mixture of 
benzomorphans. Today, it is considered that observed opioid-effects during Martin et al. 
study were the result of benzomorphans binding to µ- and κ- sites as opioid antagonists 
failed to modulate the effects of σ-ligands. Hence,  σ-receptors were eventually reclassified 
as non-opioid receptors with high affinity for (+)-isomers of benzomorphans.  
In addition to pharmacological and photo-labelling studies, development of molecular 
and cell biology techniques has provided new insights into σ-site, demonstrating that σ-
receptors have different architecture, as well as pharmacology when compared to opioid 
receptors6. Based on the different tissue distribution, protein size and drug selectivity, two 
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subtypes of σ-receptors were proposed; σ1R - with a molecular mass of 25.3 kDa, and σ2R 
– with a molecular mass of 18-21.5 kDa 6–8.  
As most of the pharmacologically described receptors during the 20th century, σ1R 
was cloned by the end of the 1990s. The original σ1R clone was from guinea pig, but it has 
also been cloned from numerous other species, including humans, rats, and mice7,9,10. 
Contrary, the identification of σ2R sequence took forty years of scientific wandering until 
σ2R was finally purified from calf liver by Alon et al. in 2017– two years after the beginning 
of this doctoral work -  and identified as previously known human transmembrane protein 97 
(TMEM97)11.  
Two σ-subtypes appear to be distinct physical entities. Following sequence 
identification, σ1R has shown no homology to other mammalian proteins. It shares 
approximately 30.3% sequence identity with ERG2, a fungal gene encoding for a C8-C7 
sterol isomerase.  However, σ1R itself is not found in yeast, and it also lacks sterol 
isomerase activity7. As such, and in the absence of σ2R identity sequence, σ1R has been 
used as a starting point in the characterization of both σ-receptors, placing them into distinct 
protein family. However, recent sequence identity of σ2R/TMEM97 has shown that σ2R has 
EXPERA domain which makes it a distant homolog of human TM6SF1, TM6SF2, EBP, and 
EBPL proteins – proteins implicated in cholesterol biology11.  
Currently, there is a growing scientific interest in functional and molecular 
mechanisms of both σ-subtypes as promising therapeutic targets in various cancers and 
neurodegenerative diseases12. However, while recent cloning of σ2R/TMEM97 has merely 
just opened doors for mechanistic studies of this subtype, the σ1R subtype has been made 
the focus of this doctoral work.  
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1.1.2 Anatomical and subcellular distribution of σ-receptors 
σ-receptors are widely expressed within various peripheral tissues, including heart, 
kidney, pancreas, liver, lung, spleen, and adrenal glands, as well as the central nervous 
system (CNS) where they exhibit neuroprotective properties12. The expression of both σ-
subtypes is also upregulated in the various cancers with functional implications in cell 
proliferation and migration13–16.  
Within CNS, particularly within the brain, σ1Rs have been associated with the areas 
involved in the regulation of memory (memory deficit), pain, sensory and motor functions, 
such as the hippocampus, the dentate gyrus, cortical layers, pons, the central grey, locus 
ceruleus, the substantia nigra pars compacta, hypothalamus, dorsal raphe, olfactory bulb 
the red nucleus, and motor cranial nerve nuclei17. The expression of σ2Rs is also detected 
within the brain, including the cerebellum, motor cortex, hippocampus, and the substantia 
nigra18. The current body of research suggests that within these areas σ-receptors are 
involved in various neural mechanisms, including calcium (Ca2+) signalling, cell survival and 
function, , neurotransmitter release, and synaptogenesis, but their precise mode of action 
remains elusive19.  
At the subcellular level, the σ1R is detected in the membrane of the endoplasmic 
reticulum (ER), microsome, mitochondrion, nucleus, and the plasma membrane (PM)17. In 
the rat hypothalamic and hippocampal neurons, electron microscopy studies showed the 
association of σ1Rs with neuronal perikarya, the membranes of mitochondria, cisternae of 
the ER, and dendrites20,21. However, σ-receptors are predominately ER transmembrane 
proteins which accumulate at the ER-mitochondrion contact sites known as the MAM 
(mitochondrion associated ER membranes; Figure 1.11)22. The formation of MAM junctions 
occurs in the area where membranes of two organelles are estimated to be within 25nm of 
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each other, enabling their protein complexes to interact and regulate inter-organelle 
signalling pathways, which are crucial for cellular “housekeeping” functions such as the non-
vesicular movement of phospholipids, proteins, and ions23,24. The functional role of σ1R at 
the MAM is described in the latter part of this chapter (Section 1.15).  
In a series of studies22,23,25, Hayashi and Su demonstrated that σ1Rs accumulate in 
the lipid domains of the ER. These domains, also known as lipid microdomains, lipid rafts or 
lipid droplets, are cholesterol- and sphingolipid-enriched areas present in the external leaflet 
of the membranes. Upregulation of σ1Rs in human neuroblastoma cells reduced free 
cholesterol and glycosphingolipids in the ER and mitochondrion membranes, indicating that 
at the MAM, σ1Rs participate in the lipid-based signalling pathways17.  
σ2Rs have also been detected in the lipid microdomains of rat liver membranes26. 
Contrary to σ1Rs that possess the ability to translocate from MAM to either nuclear envelope 
or ER-PM junctions, σ2Rs seem to be exclusively lipid raft proteins with the ability to affect 
Ca2+ signalling via sphingolipid products.  
1.1.3 Molecular and structural features of σ1R 
σ1Rs are 223 amino acids long transmembrane proteins. Early hydrophobicity study 
of the σ1R sequence detected a high hydrophobicity of its segment close to its N-terminus, 
and correctly predicted single transmembrane helix between ~9–30 residues of the 
receptor7. However, in the absence of the σ1R crystal structure, another model of σ1R was 
proposed and became widely embraced within the scientific community. This latter model 
predicted two-transmembrane domains of  σ1R based on the homology of the receptor with 
a database of known TM segments, as well as immunostaining experiments with antibodies 
targeting green fluorescent protein (GFP) fused to either N- or C-terminus of σ1R. During 
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these immunostaining experiments, the N and C termini of σ1R have been observed to be 
on the same side of the PM of Xenopus oocytes or of the ER membrane of CHO cells27. 
Contrary, the first crystal structure of σ1R published in 2016 revealed single transmembrane 
pass, and thus, confirmed the initial predictions28.  
The crystal structure of human σ1R was published forty years after the original 
proposal of σ-site. In their first publication, the crystal structures of the human σ1R were 
reported in the complex with two chemically divergent, but experimentally uncommon σ1R 
ligands, PD144418 and 4-IBP28. However, in the following publication, σ1R was crystallized 
bound to its classical antagonists – haloperidol (Figure 1.11) and NE-100, as well as 
thoroughly-studied agonist - (+)-pentazocine29. Using lipid cubic phase crystallization 
method, σ1R was crystallized as a trimer where each protomer was binding a single ligand 
at the centre of its C-terminal domain while showing unusual fold28. Each protomer included 
a single transmembrane domain (6-31 aa) flanked by α cytosolic domain made of a β-barrel 
(81–176 aa) and flanking α-helices28,29. 
The existence of σ1R as homotrimer was not predicted by previous studies. Before 
publication of σ1R’s crystal structure, numerous binding and fluorescent studies indicated 
an even-number of σ1R subunits during oligomerization2,30–33. As similar studies also 
suggested that σ1R oligomerization states may regulate its function(s), the full significance 
of σ1R as homotrimer has yet to be determined 32,33.  
σ1Rs are regulated by a structurally diverse array of compounds that are used for 
different therapeutic applications, including benzomorphans, neuroleptics, antitussives, 
antidepressants, drugs of abuse, and drugs used to treat pain, psychosis, anxiety , and 
neurodegenerative diseases33,34. Thus, another unexpected insight into the novel σ1R 
structure was the discovery that the site for ligand-binding is sterically occluded29. Kinetic 
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analysis of ligands association and dissociation to σ1Rs revealed that the ligand-binding to 
σ1R occurs very slowly and in multiple steps, requiring a conformational change of the 
protein and dynamic exposure of its binding pocket29.  
A unique domain within σ1R named the Sterol Binding Domain Like region (SDBL) 
plays an important role in the protein- and ligand-binding to σ1R35. Photo-affinity 
experiments identified two SBDL domains spanning between 91-109 (SBDL1) and 176-194 
(SBDL2) residues of σ1R2. A considerable number of mutational studies demonstrated that 
SBDL1 and SBDL2 of σ1R form at least a portion of the ligand- or specialized lipid-binding 
site35. Residues spanning between amino acid 119-149 and 208-223 of σ1R have been 
established as crucial for ligand-binding and functional interaction with partner proteins33. 
These results are firmly in agreement with the novel σ1R structure;  the most mutations with 
significant impact on ligand-binding affinity, such as juvenile amyotrophic lateral sclerosis 
(ALS)-causing mutation E102Q, are found to be in the proximity of structurally demonstrated 
ligand-binding site.  
The cytosolic portion of σ1R also contains two cholesterol-binding domains located 
between residues 161-180 and 191-210. These domains contain two unique motifs, 
VEYGER and LFYTLRSYAR, which have been identified as essential for the functional role 
of σ1R in lipid trafficking and lipid-based signalling pathways27. Additionally, removal of 
residues 2-8 from the N-terminus results in the impairment of σ1R interaction with ER lipids 
and cholesterol, leading towards an increase in the lipid and cholesterol content of the ER 
and decreased cholesterol content in the PM23.  
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Figure 1 Features of σ1R 
Fig1.11 Features of σ1R. A) Cartoon of σ1R trimer from cytosolic perspective created using Swiss PDB 
viewer. σ1R monomers are bound to their classical antagonist haloperidol. B) Cartoon of σ1R trimer from 
side perspective. σ1R monomer has a single transmembrane domain with the largest portion of the 
protein being located in the cytosol, including protein’s ligand binding and cholesterol binding domains. 
C) At subcellular level, σ1Rs are predominately found at MAMs regions, but can also translocate to the 
regions known as ER-PM junctions.  
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1.1.4 Therapeutic potential of σ1Rs  
A rich history of scientific inquiry into σ1R established its therapeutic potential in two 
major pathological areas: (1) neurodegenerative diseases and (2) cancers.  
1.1.4.1 The implication of σ1Rs in neurodegenerative diseases  
Neurodegenerative disease is a term for a range of pathological conditions that 
damage the neuronal integrity within CNS, including Huntington's disease Alzheimer's 
disease, amyotrophic lateral sclerosis (ALS), Parkinson's diseases, and multiple sclerosis. 
ALS is a motor neuron disease that manifests as the death of neurons required for 
controlling voluntary muscles. One of identified, underlying causes of diagnosed ALS are 
mutations in the gene for the copper-zinc superoxide dismutase (SOD1).  A treatment of 
ALS mouse-model, SOD1-G93A, with the PRE084 - selective σ1R agonist - improved 
survival and function of spinal motor neurons and the locomotor performance, as well as the 
maintenance of muscle action potential amplitudes, and motor neuron number of the spinal 
cord33. In contrast, a global knockout of σ1R in the same mouse model resulted in the 
acceleration of motor deficiency and the decreased longevity of the mouse model33.  
Genotyping studies that used a single nucleotide polymorphism (SNP) approach 
identified E102Q-mutant of σ1R in the genomic DNA of patients diagnosed with juvenile-
onset of ALS36. Overexpression of σ1RE102Q in motor neuron-like cell line NSC34 resulted in 
a shift of the σ1RE102Q to membranes of  lower density during sucrose gradient 
fractionation36. Interestingly, during the Western blot analysis, σ1RE102Q was detected as a 
complex  at ~ 50kDa (instead of ~25kDa) even in the buffers containing 150mM DTT and 
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2% Triton‐X. This result indicates that σ1RE102Q forms dimers with the strong hydrophobic 
interaction between the monomers. Additionally, the overexpression of σ1RE102Q reduced 
viability of NSC34 cell line. Further investigations of σ1RE102Q have shown that it also 
aggregates at the subcellular level, leading to mislocalisation of the major pathological 
protein in sporadic ALS known as TDP43, and thus, an increase in cytoxicity37.  
Alzheimer's disease is a neurological disorder characterised by a slow, increasing 
decline in cognitive functions as well as the pathological self-assembly of amyloid-beta (Aβ) 
plaques and tangles. The predominant hypothesis about development and advancement of 
Alzheimer’s disease, so-called  “amyloid hypothesis”, proposes that alteration in cleavage, 
processing, and clearance of the amyloid precursor protein (APP) causes the disease. The 
Aβ plaques form during proteolysis of APP33.  
A memory deficit is one of the symptoms of Alzheimer's disease38. The role of σ1Rs 
in the memory deficits was investigated using an Aβ25-35-infusion mouse. In a dose-
dependent manner, the selective σ1R agonist (+)-pentazocine attenuated memory deficits 
that were caused by amyloid β25–35 injection33.  
Current therapy of Alzheimer’s disease uses acetylcholinesterase inhibitor 
donepezil. Donepezil enhances the cognitive functions disturbed during the disease. In the 
brain, donepezil binds to σ1Rs39. Activation of σ1Rs has been reported as a by-product of 
donepezil-treatment, contributing to overall neuroprotective and anti-amnesic effects of 
donepezil. Donepezil also significantly improves neurite outgrowth in PC12 cells, which can 
be countered by the treatment with NE-100, the σ1R antagonist40.  
Overall, these results demonstrate that expression and activation of σ1R confer a 
neuroprotective role in pre-clinical models of neurodegenerative disorders. However,  the 
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mechanisms by which σ1R exhibits its neuroprotective role yet remain to be fully 
understood.  
1.1.4.2 The implication of σ1Rs in cancers  
 Although there are currently no clinically approved σ1R ligands in cancer treatment, 
the study of σ1Rs’ involvement in cancers represents a growing and exciting area of 
research.  
Enhanced expression of both σ-subtypes has been reported in a variety of cancer 
tissues, including small- and non-small-cell lung carcinoma, colon carcinoma, sarcoma, 
renal carcinoma, breast cancer, prostate cancer, melanoma and neuroblastoma.13,41–46. In 
neoplastic breast cancer cells, treatment with σ1R antagonists, haloperidol and 
progesterone, inhibited cell viability in dose-dependent manner13. Additionally, Aydar et al.47  
demonstrated that overexpression of σ1R-targeted siRNA reduced breast cancer 
proliferation and cell adhesion.  
In breast cancer and colorectal cancer cells, downregulation of σ1R as well as the 
treatment with its antagonist, igmesine, resulted in reduced cell migration14. This result is of 
particular interest for this doctoral work as Gueguinou et al.14 proposed the regulatory 
mechanism of cell migration in which expression of σ1R promotes SK3-dependent Ca2+ 
influx through Orai1 channel – the main channel of store-operated Ca2+ entry (SOCE). 
Therefore, the mechanism that proposes interplay of SK3, σ1R and Orai1 is discussed in 
the latter part of this thesis (Section 1.2.11).  
To summarise, current inquiries in the role of σ1Rs in cancers suggest their “cancer-
protective” role. Enhanced levels of σ1Rs promote proliferation, cell adhesion, and 
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migration, whereas the downregulation of σ1Rs and the treatment with σ1R antagonist 
reduces cancer cell viability.  
  
27 
 
 
Figure 2 Mechanism of σ1R 
Fig1.12 Mechanism of σ1R. A schematic illustrating the effects exerted by σ1R agonists and antagonists 
that were mentioned in literature review. σ1R are found predominantly within MAMs and associated 
with binding immunoglobulin protein (BiP). Treatment with σ1R agonists disrupts σ1R/BiP interaction, 
freeing σ1R to interact with other proteins. The antagonist deters the dissociation of σ1R/BiP interactive 
complex resulting in inactive σ1R. 
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1.1.5 The functional roles of σ1R  
1.1.5.1 The functional roles of σ1R at the MAMs  
σ1R was initially identified as a receptor1,3,7. However, an increasing body of 
evidence suggests it primarily acts as an intracellular ER chaperone aiding in the proper 
folding and stabilisation of proteins22,48,49.  
Co-immunoprecipitation and co-localisation studies in CHO cells identified σ1R in a 
complex with binding immunoglobulin protein or BiP (Fig1.12)22. BiP is a well-characterized 
intraluminal chaperone that binds newly stabilised proteins upon their translocation into the 
ER and facilitates their maintenance in a state of competence for post-translational 
modification and oligomerization50. BiP is also Ca2+ buffering chaperone as it binds luminal 
Ca2+ and contributes to the storage of Ca2+ within the ER51. Dissociation of the σ1R-BiP 
complex occurs during stress, such as serum starvation, a significant decline in ER Ca2+ 
levels or treatment with σ1R agonists, and results in active σ1R allowing its interaction with 
other ER proteins or proteins at the ER contact sites. Hence, σ1R-BiP interaction is 
considered inhibitory for σ1R and its functional roles, and it is stabilized by intraluminal 
Ca2+22.  
ER is a dynamic organelle that forms contact sites with mitochondria, at MAM, and 
with PM, at ER-PM junctions. Following dissociation from BiP, σ1R was reported to interact 
with ion channels at MAM and ER-PM junctions22,34. At MAMs, σ1R was shown to stabilize 
the subtype 3 of inositol 1,4,5-trisphosphate receptors (IP3R). By chaperoning IP3Rs, σ1Rs 
promote the Ca2+ flux from the ER to the mitochondria by increasing the sensitivity of IP3Rs 
for their endogenous ligand, IP3 22,48. This movement of Ca2+ from ER to mitochondria is 
essential for the regulation of bioenergetics, as well as the free radical formation in 
mitochondria48. A downregulation of σ1R protein levels was shown to enhance the 
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proteasomal degradation of IP3R, type 3, at the MAMs, resulting in dysregulation of Ca2+ 
homeostasis between the ER and mitochondria22.  
More recently, Brailoiu et al.52 have demonstrated that the functional interaction 
between σ1Rs and IP3Rs is potentiated by binding of choline to σ1Rs in an agonist-like 
manner. The activation of G-protein-coupled receptors (GPCRs) at the PM stimulates 
phospholipase C (PLC) and the downstream production of IP3. IP3 binds to IP3Rs and 
activates the release of Ca2+ from the ER through IP3Rs. Additionally, the activation of 
GPCRs stimulates phospholipase D (PLD), leading to the formation of choline which as 
endogenous ligand binds σ1Rs, and thus, potentiates Ca2+ signals evoked by IP3-activated 
IP3Rs. This proposed mechanism combines the initially proposed role of σ1Rs as a receptor 
with its widely demonstrated role as a chaperone.  
As a chaperone, σ1Rs has also been reported to regulate cytoskeletal adaptor 
protein ankyrin-B, which is localized in the ER lumen. In several cell types, including 
cardiomyocytes ad striated muscle cells, ankyrin-B has been shown to regulate the 
localization and membrane stabilization of ion transporters and ion channels, including 
Na+/Ca2+ exchanger, Na+/K+ ATPases ATP1A1 and ATP1A2 and IP3R3.  The regulation of 
ankyrin-B by σ1Rs is demonstrated to be coupled with σ1R’s regulatory role of IP3Rs. At 
MAMs, ankyrin-B interacts with subtype 3 of IP3Rs. This interaction can be modulated by 
treatment with σ1R ligands where the application of agonists reduces ankyrin-B/IP3R 
interaction whilst the application of σ1R antagonists has the opposite effect. The cellular 
expression of ankyrin-B is reduced by downregulation of σ1Rs which results in the prolonged 
activation of IP3R3 at MAMs, triggering apoptosis53. 
At MAMs, σ1Rs also regulate the inositol requiring enzyme-1 (IRE1)48. IRE1 is a 
serine/threonine-protein kinase, and endoribonuclease that acts as a sensor for the ER 
30 
 
unfolded protein response (UPR), and thus, assumes the role of the ER stress response 
protein51,54,55. Similar to σ1R, the luminal domain of IRE1 interacts with BiP during 
unstressed conditions54. Increase in misfolded protein content within the ER promotes BiP 
and IRE1 dissociation and leads to subsequent activation of IRE1 endonuclease activity. 
Mori et al. have demonstrated that under ER stress conditions IRE1 accumulates at the 
MAMs to respond to reactive oxygen species (ROS) released from the mitochondria56. 
Following σ1R and IRE1 dissociation from BiP, σ1R stabilises IRE-1 at the MAM, enhancing 
the stress response and promoting cell survival which seems to be one of the underlying 
mechanisms of σ1R’s neuroprotective effect in the brain48,56. These studies demonstrate the 
essential role of σ1Rs in the regulation of the ER-mitochondria inter-organelle signalling at 
MAMs where σ1R with its interacting partners regulates underlying mechanisms of 
bioenergetics, as well as the response to ROS during ER stress conditions.  
1.1.5.2 The functional roles of σ1R at the ER-PM junctions  
The ER-PM junctions are membrane contact sites (MCS) between ER and PM that 
serve as a regulatory platform for important physiological functions of the mammalian cells, 
including non-vesicular lipid transfer between the ER and the PM, excitation–contraction 
coupling, and store-operated Ca2+ entry (SOCE)57.  These junctions are distinct subcellular 
regions where smooth, peripheral parts of ER membrane form close appositions with PM, 
allowing the tethering of their protein complexes. Recent imaging of HeLa cells by super-
resolution microscopy described ER–PM junctions as oblong-shaped contact sites with the 
size of 120x80nm57,58.  
Early inquiries into the subcellular distribution of σ1Rs in mouse neuroblastoma 
NG108-15 cells marked their ability to translocate to ER-PM junctions just by placing cells 
in Hank’s balancing solution22,59. The localisation of σ1Rs to the PM was confirmed through 
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various studies that included surface biotinylation followed by Western blot analysis and total 
internal reflection fluorescence microscopy (TIRFM)34,60,61.  Since then, σ1R has been 
described to interact with mechanistically diverse types of ion channels at MCSs, including 
voltage-operated ion channels (VOICs), receptor-operated ion channels (ROICs), volume-
operated and acid-sensitive ion channels (ASICs), and store-operated ion channels (SOCs).  
1.1.5.2.1 Regulation of VOICs by σ1R 
VOICs are channels formed by transmembrane proteins that allow the passage of 
ions across the membrane in response to changes in the electrical membrane potential in 
the channel’s proximity. σ1Rs have been reported to interact, directly and/or indirectly with 
following VOICs: (1) sodium (Na+) channels, such as Nav1.5, (2) potassium (K+) channels, 
including Kv1.3, Kv1.4, Kv1.5, and Kv11.1 (hERG)62, and (3) N, L, P, Q and R types of Ca2+ 
channels. Additionally, σ1Rs have been reported to regulate small-conductance Ca2+-
activated K+ channel called SK. Although SK channels are not purely voltage-dependent 
their activity can control the membrane potential, subsequently affecting the activity of other 
transmembrane proteins and inducing changes in the cellular metabolism63. 
1.1.5.2.2 Regulation of voltage-operated sodium channels by σ1R 
Using co-immunoprecipitation studies and atomic force microscopy (AFM), 
Balasuriya et al. provided evidence that σ1Rs interact directly with Nav1.5 channel in MDA-
MB-231 cells, where σ1R has been shown to regulate Nav1.5 channel currents and 
subsequently, promote the invasiveness of cancer cells64. Direct interaction of σ1R with 
Nav1.5 channel resulted in the inhibition of Nav1.5 channel currents. Interestingly, σ1Rs 
have also been shown to inhibit Na+ current indirectly. In slice preparation of the prefrontal 
cortex,  σ1Rs were activated by the neurosteroids dehydroepiandrosterone sulphate 
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(DHEAS), which was followed by the inhibition of a persistent Na+ currents65,66. As in 
numerous studies demonstrated before, this effect of σ1Rs was also successfully modulated 
by treatment with different σ1Rs ligands64.  
1.1.5.2.3 Regulation of voltage-operated potassium channels by σ1R 
Co-immunoprecipitation studies in HEK293 cells precipitated σ1R with the human 
ether-a-gogo-K+ channel (hERG), which is essential for cardiac repolarization67. In a 
chaperone-like manner, σ1Rs also increased the stability of the K+ channel subunit, as well 
as K+ currents in leukemic cells68.  
The regulatory role of σ1R has also been reported in another type of K+ channels, in 
SK channels. SK channels are involved in the variety of physiological processes by 
regulating Ca2+ influx through the control of the membranes' resting potential and 
Ca2+ driving force. Martina et al. demonstrated that targeting σ1Rs with agonist (+)-
pentazocine prevented SK channels from opening In CA1 pyramidal cells of rat 
hippocampus. Inhibitory effect of σ1R on SK channels modulated and enhanced Ca2+ influx 
via N-methyl-D-aspartate receptors (NMDAR), which are essential for the regulation of 
synaptic plasticity and memory69. 
1.1.5.2.4 Regulation of voltage-operated calcium channels by σ1R 
Pharmacological studies of σ1R identified that agonists of σ1R are broadly 
neuroprotective. Voltage-operated Ca2+ channels are predominantly present in excitable 
cells and activated as a response to depolarization of the PM. Based on the degree of PM 
depolarization necessary to activate the channel, voltage-operated Ca2+ channels can be 
categorized in two distinct groups: (1) a high degree includes L,N,P, Q and R subtype, and 
(2) a low degree includes T channel subtype.  
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 Treatment by the agonists of σ1R was shown to block Ca2+ currents mediated by 
N,L,P,Q and R type voltage-operated Ca2+ channels, guarding against the cytotoxic Ca2+ 
overload which often characterizes neurodegenerative diseases70,71. An extensive increase 
in cytosolic [Ca2+] can cause the saturation of mitochondrial buffering capacity, mitochondrial 
damage and, eventually, neuronal death72,73.  Treatment of rat sympathetic and 
parasympathetic neurons by σ1R agonists diminished currents of almost all Ca2+ channel 
subtypes. This effect suggested that σ1R attenuates all subtypes of voltage-operated Ca2+ 
channels found on the cell body of these neurons.70 Co-localization and co-
immunoprecipitation studies of the role of σ1Rs in the regulation of L-type voltage-operated 
Ca2+ channels, suggests that σ1R exerts this inhibitory effect through direct interaction with 
voltage-operated Ca2+ channels at the PM60.  
1.1.5.2.5 Regulation of ROICs by σ1R 
ROICs are structurally and functionally diverse ion channels, predominantly found in 
the secretory cells and synapses. ROICs are activated by ligand binding to the receptor 
which induces conformational changes of the channel, opening the channel pore. Examples 
of ROIC include purinergic (P2X) receptors, serotonin (5-HT3 receptors, and ionotropic 
glutamate receptors, such as AMPAR and NMDAR.  
 NMDAR is a heterotetrameric ionotropic receptor which is activated by the binding 
of two ligands: glutamate and glycine74. A pioneering study by Monnet et al. identified the 
effect of σ1R and its agonists on NMDAR-induced Ca2+ influx in CA3 hippocampal 
neurons75. NMDAR-potentiated Ca2+ influx can be regulated through σ1Rs inhibitory effect 
on the SK-channels, but more recent proximity ligation studies also reveal that σ1R interacts 
directly with the GluN1, subunit of NMDARs69,76. In mice, the impairment of learning can be 
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induced by the treatment with NMDAR antagonist. A treatment with σ1R’s agonist PRE084 
attenuates the effects of induced NMDAR antagonists, improving learning and memory77.  
These studies clearly demonstrate that in addition to its role at MAMs, σ1R also 
exhibits an essential role at ER-PM junctions. Although it is currently accepted that σ1Rs 
are predominately located at MAMs, experimentally-demonstrated interactions of σ1R with 
Nav1.5, SK, L-type voltage-operated Ca2+ channels, and NMDARs suggests that σ1R can 
either be located at the PM or translocate to the ER-PM junctions from MAM regions. 
However, while the functional interactions of σ1R with various ion channels have been 
identified through pharmacological studies and the receptor’s implication in a wide variety of 
disease, underlying mechanisms of σ1R role at ER-PM junctions still remain poorly 
understood.  
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Figure 3 Interaction of σ1R with proteins at MAM and ER-PM junctions 
Fig1.13 Interactions of σ1R with proteins at MAM and ER-PM junctions. Upon dissociation from BiP, 
σ1R can chaperone proteins at MAM, or translocate to ER-PM junctions where it interacts with different 
channels. At MAM, σ1R stabilizes 1) type 3 IP3R which allows Ca2+ from the ER to mitochondria, 2) Ankyrin 
which stabilizes ER Ca2+ homeostasis, and 3) IRE1 which stabilizes ER during stress through physical 
interaction. At ER-PM junctions, σ1R has been identified to inhibit 4) Nav1.5, Kv1.4/1.5 channels, voltage 
operated Ca2+ channels, and to enhance activity of 5) Kv1.2/HERG channels and NMDA gated Ca2+ 
channels.  
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1.2 The store-operated calcium entry (SOCE)  
1.2.1 Introduction to Ca2+ signalling  
Ca2+ ions are ubiquitous and versatile intracellular messengers. At a cellular level, 
Ca2+ ions modulate various cellular processes, such as cell proliferation, gene transcription, 
neurotransmitter release, cellular plasticity, exocytosis, endocytosis, cellular viability, and 
apoptosis78,79. At the anatomical level, Ca2+ is a crucial regulator of numerous physiological 
functions, including muscle contractions, sensory perceptions, learning, memory formation, 
fertilisation, and aging78,79.  
  Under resting conditions, cytosolic Ca2+ concentration ([Ca2+]cyt) is tightly regulated 
at 50-100 nM, which varies between the cell types and their microenvironment. The 
imbalance in Ca2+ regulation often characterises various neurodegenerative diseases, 
including Alzheimer’s disease, Huntington disease, and ALS70,71,80–83. Dysregulation of Ca2+ 
signalling is also considered hallmarks of various cancers, contributing to the cancer 
progression and invasiveness84. Mammalian cells adapted a finely coordinated network of 
Ca2+ regulators to buffer, compartmentalise and extrude excess in [Ca2+]cyt, which makes 
Ca2+ homeostasis an energy costly process. Due to the energy investment, the maintenance 
of  Ca2+ homeostasis became evolutionary interlinked with the regulation of numerous, often 
simultaneous, and essential cellular processes.   
The elevated [Ca2+]cyt can be toxic for the cells over long period of time, and thus, 
the increase in [Ca2+]cyt results in the prompt activation of two distinct classes of proteins: (1) 
Ca2+ buffering proteins, and (2) Ca2+ sensitive signalling proteins. Ca2+ buffering proteins, 
such as calretinin, calbindin-D28K, and parvalbumin, buffer Ca2+ ions to maintain cytosolic 
Ca2+. Ca2+ sensitive proteins, such as calmodulin, annexins, synaptotagmin, troponin C, and 
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calcineurin, are triggered into the action mode by their binding to Ca2+.  In contact with Ca2+-
binding motifs, Ca2+ ions alter the conformation of Ca2+ sensitive proteins, initiate the 
transduction of Ca2+ encoded signals, and subsequently, trigger the specific, downstream 
cellular processes. Ca2+-binding motifs of both Ca2+ buffering proteins and Ca2+ sensitive 
signalling proteins also vary in their affinities for Ca2+ over a million-fold range (nM to mM). 
As a consequence, proteins with low-affinity motifs are unresponsive to global Ca2+ 
fluctuations whilst proteins with high-affinity motifs are unresponsive to low, elementary Ca2+ 
fluctuations, also known as quarks, puffs, or sparks. Hence, distinct frequencies and 
amplitudes of Ca2+ transient signals activate a specific combination of the Ca2+ buffering 
proteins and Ca2+ sensitive signalling proteins. As a result, the formation of Ca2+ 
microdomains occurs at the mere point of Ca2+ entry, allowing a precise, spatiotemporal 
organisation of Ca2+ signalling.   
1.2.2 Ca2+ microdomains 
Ca2+ microdomains are formed at the point of Ca2+ entry to the cell. An influx of Ca2+ 
to cytosol can originate from two primary sources: the extracellular environment, which 
contains ~ 1.2 mM Ca2+ in physiological conditions, and intracellular stores, where [Ca2+] 
varies from μM to mM range 85.  
Most of the Ca2+ influx occurs through Ca2+-permeable PM channels, such as 
voltage-operated Ca2+ channels, receptor-operated Ca2+ channels, the store-operated Ca2+ 
channels (SOC) and the transient receptor potential (TRP) channels. 
During maintenance of cellular Ca2+ homeostasis, the excess in [Ca2+]cyt is 
compartmentalised to the intracellular Ca2+ stores, which also serve as a source of Ca2. ER 
is the main Ca2+ store in mammalian cells with luminal free [Ca2+] in the region of 100 – 300 
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µM. Other organelles, including the nucleus, mitochondria, or the organelles of the secretory 
pathway, such as the Golgi apparatus and lysosomes, can also act as the intracellular 
source of Ca2+. 
From both sources, Ca2+ moves readily to the cytosol after the opening of the ion-
channel pores, and down the steep concentration gradient around the entry site which gives 
rise to nonhomogeneous activation of Ca2+-buffering and Ca2+-sensitive signalling proteins 
with similar Ca2+ affinities86. Ca2+ binding triggers signal transduction cascade, whilst 
additional excess in [Ca2+]cyt is compartmentalised to the intracellular stores in the proximity 
of Ca2+ entry, or finally, extruded out the cell. Thus, the freedom of Ca2+ ions is measured in 
nano- and microseconds, localising the effect of generated Ca2+ signal within its 
microdomain.  
Ca2+ microdomains consist of the elementary, local Ca2+ events which can also 
combine and serve as building blocks of larger microdomains. Such local Ca2+ microdomains 
allow for the spatial organisation of Ca2+ signalling and functional specificity in the different 
regions of the cell. In neurons, pre- and postsynaptic events are organized in the form of 
highly localised pulses of Ca2+, allowing a single neuron to process a remarkable amount of 
information. This miniaturisation of Ca2+ signalling allows for individual synapses to be 
selectively modified to activate specific postsynaptic events while leaving their neighbouring 
synapses unchanged. In T cells, the activation of Ca2+-dependent transcription factor called 
nuclear factor of activated T cells (NFAT) depends on the formation of Ca2+ microdomains 
during a process known as store-operated Ca2+ entry (SOCE). An increase in [Ca2+]cyt during 
SOCE activates calmodulin which in turn activates calmodulin-dependent phosphatase 
calcineurin. Once activated, calcineurin dephosphorylates NFAT triggering its nuclear 
translocation, and subsequent cytokine production, proliferation, and immune competence. 
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1.2.3 History of store-operated Ca2+ entry (SOCE) 
In 1986, Putney proposed a concept of “capacitative Ca2+ entry”, a biphasic and 
sustained Ca2+ influx to cytosol that began as IP3-activated Ca2+- mobilisation through 
intracellular “pool” and continued as influx across PM after IP3 degradation and the “pool” 
closure87. Per the scientific understanding of the time, Putney referred to the ER as 
intracellular “pool” or “Ca2+ capacitor” working under the assumption that the ER was in the 
continuity with the extracellular compartment. Following discoveries that Ca2+ crosses the 
PM before reaching the ER and that Ca2+ entry by emptying ER compartment of Ca2+could 
be activated, independently of IP3, Putney revised his initial model of “capacitative Ca2+ 
entry”. Instead, the new model was proposed which would come to be known as “store-
operated Ca2+ entry” (SOCE) – a Ca2+ influx induced by depletion of ER Ca2+ stores88,89.  
Following the publication of Putney’s revised “capacitative Ca2+ entry”, SOCE was 
still merely speculation. In 1992, the whole-cell electrophysiology experiments in rat mast 
cells finally provided the evidence for Putney’s SOCE model90. After depleting ER Ca2+ 
stores by application of IP3, the ionophore ionomycin or the excess of the Ca2+ chelator 
EGTA, Hoth and Penner described Ca2+ release-activated Ca2+ current (ICRAC) which had 
the following characteristics: (1) slow development, (2) voltage–independent gating, (3) 
small amplitude (pA range) and unitary conductance, (4) inwardly rectifying current-voltage 
relationship, (5) very high Ca2+ selectivity over Ba2+, Sr2+ and Mn2+ ions, (6) sensitivity to 
heavy metals such as Gd3+, La3+, Ni2+ and Cd2+, (7) potentiation by extracellular Ca2+, and 
(8) inhibition by intracellular Ca2+, named “Ca2+–dependent inhibition” (CDI). However, the 
mechanism by which depleted intracellular Ca2+ stores activated SOCE remained unknown 
for the following decade. 
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 Development of RNA interference (RNAi) led towards the discovery of the key 
SOCE regulators.  In 2005, two independent publications identified stromal cell surface 
protein Stromal Interaction Molecule 1 (STIM1) as the ER Ca2+ sensor and regulator of 
SOCE in both Drosophila melanogaster S2 and mammalian HeLa cells91,92. Further genomic 
screenings in S2 cells also identified SOCE/CRAC channel unit-forming protein – Orai193–
95. Today, the scientific community acknowledges members of STIM and Orai protein family 
as key regulators of SOCE.   
1.2.4 Key regulators of SOCE 
1.2.4.1 STIM protein family  
STIM proteins are Ca2+ binding proteins that act as ER Ca2+ sensors. STIM proteins 
belong to type 1A single-span membrane protein family characterised by unique anchor 
sequence motif targeted to the lipid membrane and N-terminal domain targeted to the ER 
lumen during synthesis. In response to ER Ca2+ store-depletion, STIM proteins trigger the 
opening of Orai/SOCE channels allowing Ca2+ to enter the cytosol, which results in the 
formation of Ca2+ microdomain at STIM-Orai interaction site89.  
STIM proteins are highly conserved across species from Drosophila melanogaster 
to humans96,97 Two STIM homologs are identified in vertebrates: 685 amino acids long STIM, 
and 748 amino acids long STIM2, also known as STIM2.289. Human STIM homologs exhibit 
~65% sequence similarity. Both homologs are ubiquitously expressed throughout the 
tissues, whilst the expression of STIM2 predominates in the brain98. 
STIM1 is the most studied member of protein of STIM family as it was first discovered 
at the PM through the signal-sequence trap screening on the stromal cell surface 99. Since 
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its discovery, the presence of both STIM homologs has been confirmed at the PM, but they 
are predominately found at the ER89,100,101.  
1.2.4.1.1 Molecular mechanisms of STIM1 and STIM2.2 proteins’ activation 
The crystal structure of full-length STIM protein in resting-state remains elusive. 
However, smaller portions of STIM proteins have been structurally assessed and support 
current scientific consensus stating that in resting bound-to-Ca2+ state, both STIM homologs 
form dimers while undertaking the conformational form where channel-activating regions are 
hidden from the Orai/SOCE channel102. 
The Ca2+ binding region of STIM protein is located in its luminal portion (Fig1.21), 
while channel activating region can be found in its cytosolic portion. The luminal portion of 
STIM proteins consists of N-terminal ER targeting signal sequence (SS), canonical EF (cEF) 
and non-canonical or “hidden” EF (hEF) hands followed by a sterile alpha motif (SAM) and 
the transmembrane domain. cEF hand serves as ER Ca2+ sensor while SAM is required for 
protein-protein interaction96. The cytosolic portion of STIM proteins consists of three coiled-
coil domains (CC1, CC2 and CC3), an inhibitory domain (ID), and a polybasic (lysine-rich) 
tail. Following ER store-depletion, polybasic tail anchors STIM protein at the PM through the 
tail’s interaction with PIP289,91,103,104. Three coiled-coil regions contain the STIM-Orai 
activating region (SOAR) that has also been identified as CAD (CRAC activation domain), 
required for Orai1 binding and activation105. 
Despite the high similarity of STIM homologues, reported divergences in luminal and 
cytosolic portions of STIM1 and STIM2 reflect through their different functional properties. 
In resting state, Ca2+ is bound to the cEF-hand of both homologs via negatively charged 
aspartates and glutamates promoting a compact monomeric state of EF-SAM domain, which 
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is stabilised by hEF-hand102. When intraluminal Ca2+ drops below the threshold, EF-SAM 
domain undergoes yet undefined conformational change and dimerises106. However, what 
is currently accepted as “dimerisation” of the two monomeric luminal domains of STIM 
proteins can also be explained as a simultaneous reorientation of two EF-SAM domains 
which are already in contact106. Mutations in EF-SAM domain incapacitate Ca2+ association 
of STIM proteins causing constitutive SOCE 89.  
The first main difference between STIM1 and STIM2 lies in the affinity of their EF-
hands for Ca2+.  Due to higher Ca2+ dissociation constant (Kd) in comparison to STIM1, 
STIM2 is more sensitive to low changes in ER [Ca2+] (EC50 of 406 µM) while functional 
activation of STIM1 proteins in SOCE requires a more significant drop in ER Ca2+ (EC50 of 
210 µM)107. Once Ca2+ dissociates from cEF, STIM proteins oligomerize before relocating to 
the peripheral ER where at ER-PM junctions they form distinct PM puncta105,108.  
Oligomerisation is caused by the unfolding of the monomeric EF-SAM domain, which 
is a key mediator of resting conformational stability109. The combination of high-resolution 
structural data and live-cell functional analyses for STIM1 and STIM2 respective EF-SAM 
domains helped to identify functionally relevant differences in the stability of two 
homologues. In comparison to STIM2, STIM1 possesses lower SAM stability and less robust 
EF-SAM interface. Hence, STIM1 exhibits increased kinetics of oligomerisation compared 
to STIM2106,108. Also, the increased stability of STIM2 EF-SAM domain decreases protein’s 
propensity for oligomerisation, which attenuates STIM2-association kinetics and prevents 
hyperactivation of SOCE due to low drops in intraluminal Ca2+106.  
The conformational changes of STIM proteins that begin within the luminal domain, 
dimerisation and oligomerisation propagate to the cytosolic domain through the mechanism 
that is not yet entirely understood106. However, the conformational change in a cytosolic 
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portion of STIM protein has been widely proposed to expose protein’s C-terminal polybasic 
(lysine-rich) PM-targeting tail, as well as SOAR/CAD domain to the proteins at the PM, 
including SOCE channel major forming unit Orai191,105,106,108. After oligomerisation, the C-
terminal polybasic (lysine-rich) tails anchors STIM proteins at the PM through interaction 
with PIP2110. Deletion of the tail of STIM1 prevents proteins translocation to peripheral ER 
sites and distinct PM puncta after store depletion105. Hence, the polybasic tail of STIM 
proteins plays a crucial role in stabilising STIM proteins at contact sites between ER and PM 
allowing STIM proteins to interact with the proteins at the PM. In comparison to STIM1, 
STIM2 has a higher affinity of the polybasic tail for lipids that stabilises protein’s localisation 
at the PM even at the resting conditions111. 
 As a result of the higher sensitivity to intraluminal Ca2+ drops, increased EF-SAM 
stability, decreased the propensity for oligomerisation, and higher affinity of the C-terminal 
polybasic (lysine-rich) tail for PIP2, STIM2 homolog has been proposed as a weaker 
regulator of SOCE with the more homeostatic role during discrete drops in the ER [Ca2+]. 
Contrary, STIM1 is considered the primary activator of SOCE during prominent Ca2+ store 
depletion. However, during the dissociation of Ca2+ from their respective EF-hands, both 
STIM homologs can also interact with each other forming heterooligomers, which further 
adds to the complexity of SOCE activation103.  
1.2.4.1.2 STIM2.2 and its splice variant STIM2.1 
Due to its latter discovery and the more prominent activation of SOCE by STIM1, 
STIM2 homolog has been understudied. During early siRNA screenings of the human 
signalling proteome, STIM2 was proposed as a feedback regulator of basal cytosolic and 
ER Ca2+ concentrations that activated Ca2+ influx upon smaller decreases in ER Ca2+, but 
also, similarly to STIM1, caused Ca2+ influx via activation of Orai1112. In this study, 
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downregulation of STIM2, but not STIM1, significantly lowered basal cytosolic [Ca2+] as well 
as basal ER Ca2+ levels. However, another study described an inhibitory effect of STIM2 on 
STIM1-mediated SOCE, including its constitutive and store-independent activation of 
Orai1113.   
A more recent study of STIM2 revealed that neurons from STIM2(-/-) mice had 
significantly increased viability under hypoxic conditions compared to neurons from wild-
type controls, both in culture and in acute hippocampal slice preparations114. While initially, 
SOCE was considered a major Ca2+ signalling pathway of non-excitable cells, in recent 
years, the proposal of neuronal SOCE (nSOCE) has gained much attention for influencing 
a variety of nerve cell responses114,115. With an increased scientific interest in nSOCE, more 
studies have focused on STIM2 homolog which expression predominates in CNS.   
The initial inquiries in SOCE activation by STIM2 resulted in conflicting conclusions 
reporting both channel activation and inhibition by STIM2. In 2015, Mierderer et al. 
characterised splice variant of STIM2, known as STIM2.1116. Initially, STIM2.1 was 
characterised as the first member of the STIM protein family that negatively regulated SOCE. 
The inhibitory effect of STIM2.1 on SOCE was proposed to be due to the insertion of the 
additional exon (VAASYLIQ) into the channel-activating domain (CAD), which made 
STIM2.1-Orai1 interaction impaired. However, in the following study, this initial proposal was 
re-assessed and replaced with another, suggesting that  STIM2.1 exerts a potent, inhibitory 
effect on SOCE most likely through preventing Orai1 channel cross-linking117.  
A remarkable contribution of Mierderer et al. study was in providing a mechanistic 
explanation for the previous controversies regarding STIM2 regulation of SOCE. STIM2.1 
was found to express in many cell types, where its relative expression ratio to the known 
variant STIM2, also known as STIM2.2, can differ up to eightfold116. Overexpression of 
45 
 
STIM2.2 in HEK293 increased basal Ca2+ and still elicited additional activation of Orai1 
channel. Co-expression of STIM2.1 with STIM2.2  significantly decreased Orai1-mediated 
SOCE. In further parts of this thesis, terminology introduced by Mierderer et al., which refers 
to STIM2 as STIM2.2, is adopted when it is possible to make a distinction between two 
STIM2 variants.  
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Figure 4 Features of STIM protein family 
Fig1.21 Features of STIM protein family. Schematic illustrates proposed bound-to-Ca2+ STIM dimer. STIM 
proteins consist of an EF hand which binds luminal Ca2+ and serves as a Ca2+ sensor. EF hand is followed 
by sterile alpha motif (SAM) which is required for protein-protein interaction and transmembrane 
domain. The cytosolic portion of STIM proteins consists of three coiled-coil domains (CC1,CC2, and CC3), 
inhibitory domain (ID) and polybasic (lysine-rich) tail. Following ER store-depletion, polybasic tail anchors 
STIM protein at the PM through the tail’s interaction with PIP2. Three coiled-coil regions contain the 
STIM-Orai activating region (SOAR) that has also been identified as CAD (CRAC activation domain), 
required for Orai1 binding and activation. The main difference between STIM1 and STIM2 lies in the 
affinity of their EF-hands for Ca2+, which makes STIM2 more sensitive to the low drops in ER [Ca2+]. STIM2 
has two splice variants: STIM2.2 and STIM2.1. STIM2.1 has been proposed as first STIM protein that 
exerts inhibitory effect on SOCE.  
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1.2.5 Orai protein family 
Another key regulator of SOCE is the primary forming unit of CRAC channel, Orai1. 
Orai1 is a member of a highly conserved Orai protein family with no discernible homology 
with other ion channel proteins118. Orai proteins possess four putative transmembrane 
domains (M1-M4) with the N- and C-termini located inside the cytosol 94,118. A SOAR region 
of STIM1 interacts with the cytosolic extension of the M4 segment (residues 263 to 301) of 
human Orai1. Human Orai1 also has second STIM1-binding site in proximity of its N-terminal 
region (residues 70 to 91)105. Crystallographic studies confirmed initial predictions that gating 
of Orai1-channels occurred through STIM1-binding across this two sites105,118 
The crystal structure of Drosophila Orai1 revealed a hexameric arrangement of 
subunits around a central channel pore with a ring of glutamate residues forming the 
selectivity filter118. The hexameric assembly of Orai1 subunits was further demonstrated by 
AFM studies in HEK293 cells using recombinant human full-length Orai1. Balasuriya at el. 
showed that human Orai1 form hexamers at both resting and store-depleted conditions119. 
In store-depleting conditions, Orai1 hexamers clustered at ER-PM contact sites in STIM1-
dependent manner119. More recently, functional analysis of Orai1 concatemers also 
supported Orai1 hexameric assembly120.    
In humans, the Orai family consists of three isomers with approximately 62% 
sequence identity: Orai1, Ora2, and Orai3109. In comparison to Orai1, the upregulation of its 
homologs Orai2 and Orai3 yields smaller ICRAC and is unable to substitute Orai1121.  While 
Orai1 is considered the primary forming unit of the CRAC channel, Vaeth et al. demonstrated 
that Orai1 and Orai2 also form heteromeric CRAC channels, in which the Orai2 subunit fine-
tuned the magnitude of SOCE to modulate immune responses122. Orai1 and Orai3 have 
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been found to form STIM1-independent CRAC channel that requires activation by 
arachidonic acid in receptor-operated manner121.  
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Figure 5 Features of Orai1 
Fig1.22 Features of Orai1. A) Schematic illustrates location of cytosolic, transmembrane (M1-M4) and 
extracellular domains of Orai1 protein. A location of native variant Arg (R) 91 is marked in red before the 
M1. B) Cartoon of Orai1 hexameric arrangement of subunits around a central channel pore from cytosolic 
side created using Swiss PDB viewer. Location of Arg (R) is shown within the Orai1 channel pore. A change 
of Arg to tryptophan (W) results in a sizeable aromatic side chain within the channel pore, presumably 
preventing channel from opening.  
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1.2.6 The molecular mechanism of SOCE activation 
STIM and Orai1 proteins are key regulators of SOCE, and the mechanism of their 
functional interaction can be explained in a stepwise manner, as shown in Fig1.23.  
1. The current body of evidence suggests that at the resting state STIM proteins 
form homodimers108,123,124. The formation of STIM1 homodimers is supported 
NMR crystallography, STIM2.2 homodimers are proposed based on STIM1 
homology modelling116. Although functional studies provide evidence that 
STIM2.1 interacts with other STIM proteins, its resting assembly remains 
unknown116. In resting state, STIM and Orai1 proteins localise diffusely at the ER 
and PM, respectively120.  
2. The hydrolysis of phosphatidylinositol 4, 5-bisphosphate PI (4, 5) P2 (PIP2) at 
the PM, induced by ligand activation of GPCRs and tyrosine kinase receptors, 
generates IP3125.   
3. IP3 acts as a secondary messenger and binds to the IP3Rs at the ER membrane. 
Upon IP3 binding, Ca2+ leaves ER through the IP3R.  
4. Following a drop in ER [Ca2+] below the threshold, Ca2+ dissociates from STIM 
proteins initiating the conformational change via EF-SAM domain102.   
5. Unfolding and interaction of EF-SAM domains promote an extended 
conformation of the cytosolic portion of STIM proteins and exposure of CRAC-
channel activating domain (SOAR/CAD) and polybasic tail110.  
6. Conformational change of STIM proteins promotes their oligomerisation via 
coiled-coil domains and consequently, their translocation to ER-PM contact sites.  
Polybasic K-rich tail of STIM proteins interacts directly with lipids of PM, 
anchoring proteins at ER-PM contact sites108,110.  
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7. Accumulated at ER-PM contact sites, STIM proteins tether and activate Orai1 
channel via SOAR/CAD domain 117.  
8. Binding of SOAR/CAD domains of STIM proteins to the assembled Orai1-
hexamer opens the CRAC channel, allowing a Ca2+ to enter cytosol105,108. Current 
evidence suggests that at least 6 binding sites of Orai1 hexamer have to be 
occupied to detect signature CRAC properties (high Ca2+ affinity, low unitary 
conductance and high CDI)126. 
9. Sarco/ER Ca2+-ATPase (SERCA) pumps the excess in [Ca2+]cyt against a 
dominant-negative concentration gradient from the cytosol to ER. 
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Figure 6 The molecular mechanism of SOCE activation 
Fig1.23 The molecular mechanism of SOCE activation as described in Section 1.26 of this chapter.  
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1.2.7 SERCA-STIM1 complex 
Sarco/ER Ca2+-ATPase (SERCA) pump is an ATP dependent Ca2+ pump which 
refills ER Ca2+ stores. Several different mechanisms can deplete ER Ca2+ stores. The first 
mechanism is introduced in the earlier section, where IP3 binding to IP3Rs promotes Ca2+ 
efflux from ER, activating SOCE. SOCE can also be activated independently of IP3Rs by 
inhibition of SERCA pump which promotes Ca2+ leak through ER Ca2+ leak channels, such 
as Sec61 and presenilins while blocking the movement of Ca2+ to ER127,128. A substantial 
leak of ER Ca2+ subsequently leads to the store-depletion and activation of SOCE. 
Experimentally, the SERCA inhibition can be realized by the application of thapsigargin – a 
sesquiterpene lactone from Thapsia garganica, and cyclopiazonic acid (CPA) – which is a 
toxic fungal metabolite.  
In HEK293 cells, depletion of ER Ca2+ stores also stimulated the formation of STIM1-
SERCA complex at ER-PM junctions which was identified using co-immunoprecipitation 
techniques and TIRF microscopy129. Downregulation of STIM1 reduced ER Ca2+ uptake, 
which suggested that the formation of STIM1-SERCA complex activated SERCA pump 
during SOCE allowing for the immediate Ca2+ transfer from SOCE microdomain directly to 
ER129. However, upregulation of Orai1 reduced ER Ca2+ store content, suggesting that Orai1 
may act as an inhibitor of STIM1-SERCA complex129.   
1.2.8 The molecular mechanism of SOCE inactivation 
To prevent excessive Ca2+-influx, Orai1 channel is additionally regulated through a 
negative feedback mechanism known as Ca2+-dependent inactivation (CDI). CDI can be 
subdivided into (1) slow CDI (SCDI), and (2) fast CDI (FCDI), which possess different sites 
of action and kinetics. 
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 Following SOCE activation, global increases in [Ca2+] activate SCDI that then occurs 
gradually in tens of seconds. SCDI is reported to be regulated by various proteins, including 
SARAF, caveolin, E-syt1, septin4, and PI(4,5)P2130,131. For SARAF-STIM1 interaction and 
the SARAF-regulation of SCDI, STIM1-Orai1 complex has to form within SOCE 
microdomain which is tethered by E-syt1, stabilised by septin4 and enriched in 
PI(4,5)P2132. More recently, calmodulin has been reported to bind STIM1 following SOCE 
activation, disassembling STIM1-Orai1 complexes and STIM oligomers133.  
FCDI is activated by Ca2+ binding to a site located ~8 nm from the channel pore. 
Thus, FCDI occurs within several milliseconds after channel activation, and is modulated by 
a range of factors, including a negatively charged amino acid region of STIM1 (residues 
475–483), the intracellular loop of Orai1 between M2-M3, the STIM1-Orai1 expression ratio, 
and the N-terminus of Orai1 (residues 68–91). 
1.2.9 The role of TRPC in SOCE 
The transient receptor potential canonical (TRPC) channels are channels that 
permeate Ca2+, as well as Na+ and Mg2+. TRPCs are activated downstream of PLC activation 
and PIP2 hydrolysis. Besides the STIM and Orai protein families, TRPCs were also identified 
as a molecular component of SOCE, but none of the seven isoforms of TRPCs (1- 7) 
displays currents that resemble ICRAC134. However, various reports suggest that TRPC1 
forms ternary complexes with STIM1 and Orai1 at ER-PM junctions135. Kim et al. have shown 
that the simultaneous expression of siRNAs targeted to TRPC1 and Orai1 diminished SOCE 
in HEK293 cells136. Overexpression of either Orai1 or TRPC alone failed to restore SOCE136. 
However, while overexpression of Orai1 in TRPC1 stable HEK293 cell line potentiated Ca2+ 
entry, several studies detected no change in ICRAC during either upregulation or 
downregulation of TRPC1 levels94,135. More recent studies show that STIM1 can directly 
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activate both Orai1 and TRPC1, but via distinct residues135. The activation of TRPC1 occurs 
via C-terminal polybasic domain of STIM1, whilst Orai1 is activated by the Orai1-activating 
domain, SOAR126,137. Additionally, the activation of TRPC1s required Orai1-mediated 
Ca2+ entry to trigger their recruitment at PM, where they were then activated by STIM1138. 
Expression of dominant-negative mutant and natural variant Orai1R91W attenuated TRPC1-
STIM1 dependent SOCE, whilst overexpression of Orai1 potentiated it138. Together, these 
studies suggest that TRPC1-STIM1-mediated SOCE functional requires Orai1. However, 
additional work is still necessary for further understanding of TRPCs’ involvement in SOCE.   
1.2.10 STIM and ORAI1 related disorders  
 ORAI1 and STIM proteins are ubiquitously expressed throughout the tissues, where 
they act as key regulators of SOCE process, and subsequently, of physiological processes 
downstream of SOCE. Numerous studies, including studies of human patients, have 
discovered severe irregularities of SOCE process in various immunopathies, cancers and 
diseases of CNS14,93,122,139.  
1.2.10.1  SOCE in the immune system  
Linkage analysis in an extended consanguineous family of patients diagnosed with 
the severe combined immunodeficiency (SCID) identified ORAI1, bearing R91W mutation, 
as a loss-of-function mutant that abolishes CRAC currents93,140. The crystal structure of 
Drosophila Orai provided an insight into the location of the K163 residue, the equivalent of 
R91 in human Orai1. K163 residue was found in the elongated pore of the channel with its 
side chain constricting the channel’s pore diameter (Fig1.22)118,122. This observation 
suggested that the mutation of R91 to tryptophan resulted in a sizeable aromatic side chain 
within the channel pore, presumably preventing the channel from opening141. Additionally, 
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the R91W mutation was found undisruptive of ORAI1 expression at the PM or ORAI1 
interaction with STIM1140,141. Hence, R91W mutation of Orai1 abolished CRAC and SOCE 
by impairing Orai1 channel function. In SCID patients, heterozygous expression of Orai1R91W 
had a dominant-negative effect on the CRAC channel, suggesting that mere incorporation 
of mutant into the hexameric channel structure was sufficient to impair the channel 
function141.   
Loss-of-function STIM1 mutants have also been detected in immunodeficient 
patients. STIM1 bearing R429C mutation located in its CAD/SOAR domain abolished SOCE 
in patient B cells142.  As CAD/SOAR domain is essential for STIM1-Orai1 interaction, 
expression of STIM1R429C abolished STIM1-ORAI1 interactions. Additionally, expression of 
STIM1R429C also impaired the oligomerization of STIM1 cytosolic portion, suggesting that 
R429C mutation most likely altered the conformation of the STIM1 C terminus.  
1.2.10.2 SOCE in cancers  
STIM and ORAI proteins have become associated with various oncogenic processes 
such as apoptosis, proliferation, angiogenesis, antitumor immunity, and metastasis. 
Dysregulation of SOCE has been implicated in the tumour initiation stage, promoting genetic 
changes in premalignant cells and promoting malignant transformation143. In human prostate 
cancer cells, Orai1 represents the major molecular component of SOCE, which serves as a 
primary source of Ca2+ during cellular apoptosis144. The downregulation of Orai1 and 
overexpression of its dominant-negative mutant Orai1R91W decreased the rate of 
thapsigargin-induced apoptosis in prostate cancer cells. Contrary to this finding, other 
evidence suggests that STIM/Orai‐mediated SOCE actually promotes tumour growth and 
metastasis in a variety of cancer types. Upregulation of ORAI1 and STIM1, which led to the 
enhanced SOCE, were reported in therapy‐resistant ovarian carcinoma cells145. 
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Downregulation or pharmacological targeting of STIM1/ORAI1 complex has been 
demonstrated to restrain the growth and metastasis of breast, colorectal, cervical, liver, 
nasopharyngeal, epidermoid, glioma, and melanoma13,146–148. 
1.2.10.3 SOCE in neurodegenerative disorders  
While SOCE is the main Ca2+ entry pathway of non-excitable cells, accumulating 
evidence also indicates its role in the CNS, particularly in the hippocampal pyramidal 
neurons, cortical pyramidal neurons,  and cerebellar Purkinje neurons149–152. The expression 
of both STIM homologs has been reported in hippocampal neurons where STIM1 was 
observed to colocalized Orai1 upon depletion of intracellular Ca2+ stores in dendrites and 
soma114,151,152. Activation of STIM1 and nSOCE was achieved via activation of type I 
metabotropic glutamate receptors (mGluR) or muscarinic acetylcholine receptors153,154. 
However, in hippocampal neurons, STIM1 was also reported to exert nSOCE-independent 
functions154. The mice with engineered forebrain-specific knockout exhibited a mild learning 
delay during STIM1 knockout, whilst the effect on learning and memory in STIM2 knockout 
mice was insignificant155. However, simultaneous knockout of both STIM homologs caused 
a pronounced impairment in spatial learning and memory and in enhanced long-term 
potentiation at CA3-CA1 hippocampal synapses155.  
STIM2 is predominately expressed in the hippocampus where it has been reported 
to regulate nSOCE in hippocampal synapse essential for the long-term maintenance of 
mushroom spines139,156. In Alzheimer disease mice model, treatment with novel nSOCE 
modulator NSN21778 rescued mushroom spine loss and synaptic plasticity impairment156. 
Furthermore, downregulation of STIM2 was observed in cells from AD patients, suggesting 
that STIM2 may have a protective role in amyloid synaptotoxicity157. These studies suggest 
that underlying mechanisms of SOCE and SOCE-responsive proteins may be a potential 
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therapeutic target in various pathological systems. However, considering the ubiquitous 
expression of ORAI1 and STIM proteins, as well as differential roles of STIM homologs, 
further inquiries and understanding of SOCE and SOCE-responsive proteins are required 
before designing target-specific treatment.  
1.2.11 The role of σ1R in SOCE 
In 2016 and 2017, several studies demonstrated the ability of σ1R to regulate SOCE 
but disagreed about the underlying mechanism of σ1R’s involvement. Brailoiu et al. have 
shown that treatment of rat brain endothelial cells with cocaine, which is a σ1R agonist, 
inhibited SOCE158.  Pre-treatment with the selective σ1R antagonists BD-1063 and NE-100 
eliminated cocaine-induced SOCE inhibition, which suggested that it most likely occurred in 
σ1R-dependent manner158. This study was followed by another where Srivats et al. 
demonstrated that following store-depletion σ1R formed a complex with STIM1 and Orai1 
at ER-PM junctions of HEK293 cells34. TIRFM, AFM and immunoprecipitation results 
showed that σ1Rs translocated in STIM1-dependent manner to the ER-PM junctions where 
they reduced the effectiveness of STIM1 to Orai1 interaction. Additionally, calcium functional 
assays showed that upregulation of σ1R in HEK293 cells inhibited SOCE. Treatment of CHO 
cells, which expressed σ1Rs endogenously, with (+)SKF10047, σ1R agonist, increased 
binding of STIM1 to σ1R and resulted in reduced SOCE, whereas treatment with BD1047, 
the antagonist, had the opposite effects. 
Gueguinou et al. reported the potentiation of Orai1-mediated Ca2+ influx by σ1R14. In 
breast cancer and colorectal cancer cells, silencing or inhibiting σ1R using either siRNA or 
σ1R ligands prevented functional coupling of calcium-activated K+ channel SK3 with Orai1, 
and subsequently, resulted in lower Orai1-mediated Ca2+ influx. Hence, this study reported 
the opposite effect of σ1R in comparison to earlier studies, proposing that the role of σ1Rs 
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in the regulation of SOCE could also depend on the cellular dynamics and the expression 
and availability of its interactive partners. Studying the effect of σ1R bearing ALS-inducing 
E102Q mutation, Dreser et al. also reported that overexpression of wild-type σ1R 
potentiated SOCE in MCF-7 breast cancer cell line159. Contrary, the overexpression of 
σ1RE102Q failed to affect SOCE, but significantly reduced STIM1 proteins levels in MCF-7 
cells. These conflicting results suggest that σ1R possesses the ability to regulate SOCE, but 
the underlying mechanisms of its action require further investigation.  
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1.3 Aims 
This thesis investigates the role of the σ1R in regulating SOCE microdomains and 
the underlying mechanism of action. The main objectives of this thesis are as follows:  
(1) To determine how enhanced expression of σ1R affects SOCE. This was 
investigated by creating σ1R baculovirus and the appropriate viral control. 
Cytosolic Ca2+ signals were measured in response to store-depletion and during 
Ca2+ influx in the population of HEK293 cells using fluorescent Ca2+ dyes and 
genetically encoded Ca2+ indicator GCaMP6f. This is discussed in Chapter III.  
(2) To develop a reliable method to measure the Orai1-mediated Ca2+ signal 
within the SOCE microdomain, and to compare the effect of the σ1R on the 
amplitude of this signal. This was achieved by utilising targeted Ca2+ reporter 
protein fused to the Orai1 channel, named G-GECO1.2-Orai1, and applying the 
semi-automated approach in G-GECO1.2-Orai1 detection, signal extraction and 
analysis. Cytosolic Ca2+ signals were measured in response to store-depletion 
and during Ca2+ influx using TIRFM. This is discussed in Chapter IV. 
(3) To determine whether the enhanced expression of σ1RE102Q ALS-inducing 
mutant affects SOCE. This was investigated by creating σ1R bearing E102Q 
mutation. Cytosolic Ca2+ signals were measured in response to store-depletion 
and during Ca2+ influx using both GCaMP6f and G-GECO1.2-Orai1. This is 
discussed in Chapter V. 
(4) To determine whether σ1R interacts with STIM1 and STIM2 proteins in situ. 
This was investigated using proximity ligation assay (PLA) and imaging 
techniques. This is discussed in Chapter VI.  
61 
 
(5) To determine how enhanced expression of σ1Rs affects STIM2.2/Orai1 
mediated SOCE. This was investigated by upregulation of STIM2.2 in HEK293 
cells transduced with σ1R baculovirus. Cytosolic Ca2+ signals were measured in 
response to store-depletion and during Ca2+ influx using both GCaMP6f and G-
GECO1.2-Orai1. This is discussed in Chapter VII. 
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2 Chapter II:  
Methods 
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2.1 Cell Culture 
2.1.1 Cell lines  
Four immortalised cell lines were used in this study: Flp-In™ human embryonic 
kidney (HEK) 293, HEK293, HEK293-IP3R-/-  and HeLa cell lines.  Flp-In™-HEK293 cell line 
was a generous gift from Sussex Drug Discovery Center (SDDC). HEK293 and HEK293-
IP3R-/- cell lines were a generous gift from Collin W. Taylor’s Lab (University of Cambridge). 
Flp-In™-HEK293 cell line was used for Ca2+ measurements in response to store-depletion 
by thapsigargin using Flexstation III, and for NFAT translocation. This cell line was used due 
to good transfection yield via PEI method. HEK293 and HEK293-IP3R-/- cell lines were used 
for Ca2+ measurements in response to store-depletion by ATP and carbachol (ATP/Cch) 
using Flexstation III. Additionally, HEK293 cell line was used for TIRFM experiments as it 
had a flatter footprint in comparison to Flp-In™-HEK293 cell line, which facilitated TIRFM 
recordings. HeLa cell line was used to visualise protein-protein interaction in situ (proximity 
ligation assay; PLA) and subcellular distribution of proteins.  
2.1.2 Cell maintenance 
Flp-In™-293 and HeLa cell lines were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM; ThermoFisher), supplemented with 10% foetal bovine serum (FBS, Gibco) 
and 1% penicillin/streptomycin (P/S, Hyclone). HEK293 and HEK293-IP3R-/- cell lines were 
cultured in DMEM/F-12 with GlutaMAX (ThermoFisher) supplemented with 10% FBS and 
1% P/S. All cells lines were maintained in 75cm2 flasks (T75) at 37°C in humidified air with 
5% CO2 and passaged every 3–4 days using in-house-made PBS and 0.05% Trypsin-EDTA 
(ThermoFisher). Approximately 1.5 million cells were passaged to a new T75 flask to obtain 
75-80% confluency in 3-4 days.  
64 
 
PBS 1L, pH=7.40 
NaH2PO4* H2O 1.3 mM 
Na2HPO4 8.1 mM 
NaCl 145 mM 
Table 2.1-1 Composition of phosphate buffered saline (PBS) 
2.2 Molecular biology 
2.2.1 Plasmid DNA Preparation  
Plasmid DNA was isolated from a bacterial culture grown from a single transformed 
colony in 3 ml of LB medium with appropriate antibiotics at 37°C. overnight. For this purpose, 
Monarch Miniprep kit was used according to the manufacturer’s instructions.  
2.2.2 2.3.2 Polymerase chain reaction (PCR)  
The PCR reaction mix was prepared in a final volume of 50 μl using 20ng of DNA 
and NEB reagents (Table 2.21). A general thermocycling condition can be found in Table 
2.22. Annealing Tm temperature was calculated for each set of primers using NEB Tm 
calculator. All primers used within this study can be found in Table 2.23. All PCR products 
were analysed using agarose gel electrophoresis.  
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COMPONENT 
FINAL 
CONCENTRATION 
5X Q5 
Reaction Buffer 
1X 
10 mM dNTPs 200 µM 
10 µM Forward 
Primer 
0.5 µM 
10 µM Reverse 
Primer 
0.5 µM 
Template DNA < 1,000 ng 
Q5 High-Fidelity DNA 
Polymerase 
0.02 U/µl 
5X Q5 High GC 
Enhancer (optional) 
(1X) 
Nuclease-Free Water  
Table 2.2-1 List of NEB PCR reagents  
 
 
STEP TEMPERATURE TIME 
Initial Denaturation 98°C 30 seconds 
25–35 Cycles 
98°C 
*50–72°C 
72°C 
5–10 seconds 
10–30 seconds 
20–30 seconds/kb 
Final Extension 72°C 2 minutes 
Hold 4–10°C  
Table 2.2-2 Thermocycling PCR  conditions 
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2.2.3 Agarose gel electrophoresis  
A custom made 0.8% agarose gels were used for analysis of PCR products. Agarose 
was added to 1x TBE buffer (89 mM Tris base, 89 mM g/l boric acid, 2.5 mM EDTA,) at final 
concentration of 0.8%. The solution was repeatedly microwaved until boiling and swirled 
until the agarose had dissolved. The agarose was cooled for 10-15min at room temperature 
before 5 µl ethidium bromide was added to the solution. The solution was poured into a mini 
gel cast with a gel comb and allowed to polymerize for 45 min minutes at room temperature. 
To load samples, the comb was removed, and the gel was submerged in 1x TBE buffer. 
Samples were diluted in DNAse free-water, where appropriate, and mixed with 5x loading 
buffer before loading into wells. The sample on the gel was run at 100V for 30–45 minutes. 
2.2.4 Site directed mutagenesis 
 GeneArt Site Direct Mutagenesis kit (ThermoFisher) was used to induce mutations. 
Complementary primers were designed using GeneArt® Primer and Construct Design Tool. 
Primers (Table 2.23) contain mutagenic sequence flanked on either side by 15 nucleotides 
which complement the template sequence. AccuPrime™ Pfx (2.5 U/µL) polymerase was 
used in a 50μl reaction according to manufacturer guidelines. Negative control reaction was 
set up for each PCR containing no primers. 5 µL of the PCR product was analyzed on a 
0.8% agarose gel as above. Following confirmation of PCR product, 4 µL of the product was 
used in recombination reaction. Recombination mix was incubated at room temperature for 
10 min when the recombination reaction was stopped by adding 1 µL 0.5 M EDTA. 2 µL 
from the recombination reaction was used for transformation.  
Transformation reaction was performed using One Shot® MAX Efficiency® 
DH5αTM-T1R competent cells supplied with the GENEART® Site-Directed Mutagenesis 
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System. 50-μL vial of DH5αTM-T1R cells was thawed for 5- 7 minutes on ice for each 
transformation. 2 μL of the Recombination mix was transferred directly into each vial of cells 
and incubated on ice for 12 minutes. Following incubation, vials were heat-shocked for 
exactly 30 seconds at 42°C using Eppendorf Thermo-Mixer C, then incubated on ice for 
additional 2 min. After incubation, the vials were removed from ice. 250 μL of pre-warmed 
SOC medium was added to each vial, using aseptic conditions. For kanamycin-resistant 
plasmids, the vials containing SOC medium were placed sideways in the Infors HT Ecotron 
shaking incubator at 225 rpm and 37oC for exactly 1 hour. 1h-incubation was not necessary 
for ampicillin-resistant plasmids, and we proceeded to the next step immediately after 
addition of pre-warmed SOC medium. 10 μL of each transformation reaction was additionally 
diluted with 90 μL of SOC medium, and then transferred to the pre-warmed agar plates with 
appropriate antibiotic resistance Plates were inverted and incubated in SciQuip Incu-50S 
incubator at 37°C for 16–20 hours. Following incubation, plasmid DNA isolation as 
performed as above (Section 2.21). Plasmids were sequenced by Eurofins-Genomics.  
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Primer name Sequence  
DNA Cloning Primers 
σ1R-V5-FWD 5’-CACCATGCAGTGGGCCGTGG-3’ 
σ1R-V5-REV 5’-TCAATGGTGATGGTGATGATG-3’ 
PCR Analysis Primers  
M13-FWD  5’-GTTTTCCCAGTCACGAC-3’ 
M13-REV 5’-CAGGAAACAGCTATGAC-3’ 
Mutagenesis Primers 
Orai1R91W-FWD 5’- CTTAAAGCCTCCAGCTGGACCTCGGCTCTGC-3’ 
Orai1R91W-REV 5’- GCAGAGCCGAGGTCCAGCTGGAGGCTTTAAG-3’ 
σ1REndCodon-FWD 5’- TTTGGCCAGGACCCTTGACTAGAGGGCCCGCGG -3’ 
σ1REndCodon-REV 5’- CCGCGGGCCCTCTAGTCAAGGGTCCTGGCCAAA-3’ 
σ1RE102Q-FWD 5’-CACGCCTCGCTGTCCCAGTATGTGCTGCTCT-3’ 
σ1RE102Q-REV 5’- AGAGCAGCACATACTGGGACAGCGAGGCGTG-3’ 
Table 2.2-3 List of primers  
2.2.5 Bacmid transposition and recombinant bacmid DNA isolation 
σ1R-V5/BacMam pCMV-DEST transfer vector was utilized to generate the 
recombinant σ1R-V5 baculovirus. This transfer vector was generated as described in 
ViraPower™ BacMam Expression System and BacMam pCMV-DEST Vector Kit protocol160 
(Life Technologies) using following DNA cloning primers: σ1R-V5-FWD (5’-
CACCATGCAGTGGGCCGTGG-3’) and σ1R-V5-REV (5’-
TCAATGGTGATGGTGATGATG-3’).  BacMam pCMV-DEST transfer vector without 
insertion was employed to generate appropriate viral control  - WTVC baculovirus. σ1R-V5 
was transposed into bacmid using E.coli DH10 MultiBac competent cells (Invitrogen). 1 µg 
of σ1R-V5/BacMam pCMV-DEST and BacMam pCMV-DEST was incubated on ice for 30 
min with 100 µl of E.coli DH10 MultiBac competent cells. Each mix was heat-shocked for 45 
seconds at 42˚C, returned to the ice for 2min. resuspended in 900 µl of S.O.C medium 
69 
 
(Invitrogen). Insertion of σ1R-V5 into bacmid occurred by Tn7 transposition mediated by the 
Tn7 transposase. Each mix was incubated at 37˚C at 225rpm for 6 hours. After 6 hours, the 
cultures were plated onto bacmid transposition plates (agar plates with 50 µg/ml kanamycin, 
10 µg/ml tetracycline, 7 µg/ml gentamycin, 100 µg/ml Bluo-gal, and 40 µg/ml IPTG) and 
incubated for 48 hours. The positive transposition was determined using blue-white 
screening. Successful transposition of fragment via Tn-7 sites disrupts the lacZα gene 
coding for β-galactosidase – an enzyme which is necessary to hydrolyse Bluo-gal, allowing 
growth of the blue colonies. Therefore, individual white colonies were picked and replated 
onto bacmid transposition plates for additional 24 hours to verify positive transposition. 
Individual white colonies were picked to inoculate bacmid transposition medium (LB medium 
with 50 µg/ml kanamycin, 10 µg/ml tetracycline, 7 µg/ml gentamycin). The cultures were 
incubated at 37˚C at 225rpm for 24 hours. After 24 hours, bacmid cultures were harvested 
by centrifugation (4000rpm for 10 minutes). Cell pellets were resuspended in 0.4ml of Buffer 
P1 and Buffer P2 (QIAprep Spin MiniPrep kit) and incubated at room temperature for 5 
minutes, following by incubation with 0.4ml 3M potassium acetate (pH 5.5) and additional 
incubation on ice for 10 min. The supernatant was resuspended in 0.8ml of ice-cold 
isopropanol, incubated at -20°C for 10 minutes, and then centrifuged at room temperature 
for 15 minutes at 13000rpm. The pellet was washed in 0.7ml 70% ethanol and centrifuged 
at room temperature for 15 minutes at 13000rpm. The supernatant was carefully discarded. 
The DNA pellet was air-dried for 20 minutes and dissolved in 40 µl DNAse and RNAse-free 
water. Transposition was verified by PCR analysis of the pellet.  
2.2.6 Insect cells transfection and baculovirus amplification 
The bacmid contains the polyhedrin (polH) promoter sequence required for protein 
expression in the insect cells. To express a σ1R-V5 protein, Sf9 insect cells were selected. 
70 
 
Sf9 cells were transfected with the recombinant bacmid DNA, according to manufacturer 
instructions160, to start production of recombinant baculovirus particles containing DNA of 
interest.  To amplify the WTVC and σ1R-V5 P1 recombinant baculovirus particles, Sf9 insect 
cells were placed in a 35-mm petri dish and diluted with antibiotic-free SF900IISFM medium 
(ThermoFisher) to achieve cell density of 1 × 106 cells/ml. Following dilution, Sf9 cells were 
left to adhere during incubation at 27°C for 1 hour. Following incubation, 2 ml of the P1 
(passage 1) baculovirus was used to transfect the cells during further incubation at 27°C for 
3–5 days. To check for contamination and for the number of insect cells infected, transfected 
Sf9 cells were monitored every 24 hours. 5 days after transfection, newly generated 
generation of baculovirus was collected from supernatant and transferred to sterile 
cryotubes containing 1% heat-inactivated FCS (Gibco). The cryotubes containing now P2 
baculovirus were stored at 4°C in the dark. Whole-cell extracts were prepared to check 
protein expression levels by western blotting. P2 recombinant baculovirus has been 
amplified as above, to achieve a higher volume of P3 recombinant baculovirus – which was 
then used for transduction. Infected Sf9 cultures were incubated at 28°C, at 150 rpm for 72 
hours. 100ml of P3 recombinant baculovirus was obtained in Sf-900 II SFM medium (w/o 
antibiotic). During baculovirus amplification, the pellet was harvest and analyzed by Western 
Blotting (Fig2.21). 
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Figure 7 
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2.2.7 Plaque assay 
Plaque assays were performed to determine the viral titer (pfu/ml). The viral titer 
[plaque-forming units per ml (pfu/ml)] was determined for each P3 baculovirus stock. The 
P3 viral stock was diluted from 106 to 107-fold, of which 100 µl was added into plates for 
plaque assay containing Sf9 insect cells in SF900IISFM media. Plates were incubated at 
room temperature for 1 hour. Liquid medium was removed and replaced with 1% agarose 
containing medium, which was allowed to polymerise. 1 ml of SF900IISFM medium was 
added on the agarose in the plates before the plates were incubated at 27°C for 3–4 days. 
Cells were stained by adding 0.02% neutral red per plate and incubated at 27°C in the dark 
for 2 hours before removing all the liquid. Plates were stored overnight at room temperature. 
Viral plaques were identified as “clear zones” in the agarose generated by infection of Sf9 
insect cells. The number of plaques was calculated as a viral titer. The results of the plaque 
assay are recorded below. P3 baculovirus stock was stored at 4˚C and protected from light. 
Expression of σ1R-V5 baculovirus after transduction using 15 multiplicity of infection 
(MOI15) of P3 baculovirus generation was verified in HEK293 using immunostaining 
(Fig2.21). Calculation and transduction protocol can be found in Section 2.4 of this chapter. 
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Bacmid  
Plaque count in 107 
dilution 
Plaque count in 
106 dilution Average viral 
titer 
 Calculated titer in original stock 
First P3 Stock 
WTVC 
14 5 72 49 
2.75x108 
2.5x108 3x108 
σ1R-V5 
6 10 50 59 
2.85x108 
3x108 2.7x108 
Second P3 Stock 
WTVC 
 2 21  
1.05x108 
1 x108 1.1 x108 
σ1R-V5 
 3  23 
1.3x108 
1.5 x108 1.2 x108 
Table 2.2-4 Viral titer of WTvc and σ1R-V5 baculovirus stock. Viral titer is estimated  by number of plaque-
forming units per l ml of (pfu/ml) based on number of plaques counted 96 hours after infection of Sf9 cells 
using series of dilutions. Initial dilution of baculovirus stock before plaque essay was 5x in Sf-900 II SFM 
medium. Titer of original stock is calculated using following formula: Plaque count Average x Dilution x 
Initial Dilution. 
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Figure 8 σ1R-V5 expresses in HEK293 cells 24h post-transduction with σ1R-V5 baculovirus. 
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2.3 Transfection 
2.3.1 Poly-ethyl enimine (PEI) method 
PEI method was used for Flexstation and NFAT translocation assays. HEK293 cells 
were grown to 80-85% confluence. For one well of a 6-well plate, 1µg of plasmid DNA was 
mixed with 1µl of 1.3µg/µl PEI aqueous solution (Polysciences, Inc.) and then diluted with 
150µl of OptiMEM (Gibco). This mixture was incubated for 15min at room temperature and 
added to wells containing 1mL of serum-free DMEM. A transfection media was replaced 4-
6 hours after incubation with fresh DMEM growth medium. Cells were incubated for a further 
40-48 hours before being used for experiments.  
2.3.2 Lipofectamine method 
Lipofectamine method was used for TIRFM and imaging assays. HEK293 and HeLa 
cells were grown to 70% confluence and transfected using lipofectamine 2000 (Life 
Technologies). For one well of a 6-well plate, 1µg of plasmid DNA was mixed with 50 µl of 
Opti-MEM (Gibco). This mixture was incubated at room temperature for 5 min and combined 
with another 50 µl of Opti-MEM containing 2µL of lipofectamine. A new mixture was 
incubated for a further 20 minutes at room temperature. This mixture was then added to 
cells in 1 ml of serum-free DMEM. A transfection media was replaced 4-6 hours after 
incubation with fresh DMEM growth medium. Cells were incubated for either 24h or 48 hours 
at 37⁰C, depending on the experimental requirements.  
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Plasmid Description Reference 
BacMam Gene Delivery System 
σ1R-V5 
Plasmid coding for V5-tagged human σ1R created using 
pcDNA3.1/V5-His-TOPO using HindIII and AgeI. 
34 
pENTR/dTOPO 
Linearized pENTR/dTOPO vector used as an entry 
vector for  σ1R-V5 Gateway cloning and bacmid 
generation 
160 
BacMam pCMV-
Dest 
BacMam pCMV-Dest Vector used as destination vector 
for  Gateway cloning and bacmid generation 
160 
NFAT translocation assay 
NFAT1-GFP 
The expression plasmid for mouse NFAT1-GFP which 
was a gift from A. Parekh (University of Oxford, Oxford, 
England) 
161 
Calcium assays 
pGP-CMV-
GCaMP6f 
Vector for mammalian expression of ultrasensitive 
protein calcium sensor. 
162 
mCh-STIM1 
Human STIM1 subcloned into mCherry-C1 (Takara Bio 
Inc.) using XbaI and NotI. 
34 
mCh-STIM-CAD mCherry-targeted human STIM CAD domain 34 
HA-STIM1 HA-tagged human STIM1 163 
STIM2.2 
The expression plasmid for human STIM2.2 which was a 
gift from B. Niemeyer (School of Medicine, Saarland 
University, Germany). 
116 
STIM2.2-mCh 
The expression plasmid for mCherry-tagged human 
STIM2.2 where mCherry-coding sequence replaced the 
variable domain (I648-K711), retaining 121 C-terminal aa 
residues. 
116 
STIM2.1-mCh 
The expression plasmid for mCherry-tagged human 
STIM2.1 where mCherry-coding sequence. 
 
Orai1R19W 
The expression plasmid for human dominant-negative 
mutant of Orai1 which was a gift from C.Taylor 
(University of Cambridge, Cambridge, England). 
164 
σ1R-mKate mKate-targeted human σ1R 34 
σ1R-EGFP EGFP-targeted human σ1R 34 
ER-dsRED ER-targeted marker  
PMEM-td-
Tomato 
PM-targeted marker  
Table 2.3-1 List of plasmids 
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2.4 Transduction 
Cells were plated at 80-90% confluence allowed to adhere. After cell adhesion, 
media si removed and baculovirus was added at an MOI (Multiplicity of Infection)15 in 
infection medium (Sf-900 II SFM medium and DMEM without any antibiotic and serum). 
Appropriate volume for MOI 15  is calculated using titer results (table) and equation below: 
Equation 2.4-1 Calculation of volume for transduction with baculovirus particles 
MOI (pfu/number of cells) x number of cells = titer (pfu/ml) x 
volume (ml)  
Cells were incubated at 37 C for 12 h before using where appropriate (transfection, 
calcium imaging assays, biochemistry).  
2.5 Calcium imaging assays  
2.5.1 Measurements of [Ca2+]c in the cell population 
For measurements of [Ca2+]c in the cell population, Flp-In™ HEK 293, HEK293, 
HEK293-IP3R-/- cells were seeded into poly-L-lysine coated 96-well plates. 6 hours after 
seeding, cells were transduced with the multiplicity of infection (MOI) 15 of WTVC or σ1R-V5 
baculovirus particles and used for experiments 24- or 72-hours post-transduction using Ca2+ 
fluorescent dyes or genetically encoded Ca2+ indicator GCaMP6f.  
2.5.1.1 Using Ca2+ fluorescent dyes 
After 24 hours, cells were incubated with 2µM Fluo-4-AM (Life technologies) or Fluo-
8-AM (ATT Bioquest) in house-prepared HEPES-buffered saline (NES) for 40 min at room 
temperature. In nominal Ca2+-free NES, Ca2+ was omitted, and 1 mM EGTA was added. 
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Fluorescence (excitation 490 nm, emission 520 nm) was measured at room temperature 
using Flexstation III plate-reader with automatic additions. At the beginning of the assay, 
extracellular Ca2+ was quenched using 1 mM EGTA and Ca2+ stores were depleted using 
either 1 µM thapsigargin (Thermo Fisher), CPA (Tocris) or 100 µM ATP and carbachol 
(Sigma). Subsequently, 2mM Ca2+ was added to assess Ca2+ entry. Fmax and Fmin are the 
fluorescence values determined after addition of Triton X-100 (0.1%) in NES with 10 mM 
Ca2+ and EGTA respectively. The composition of NES can be found in Table.2.31. 
NES 1L, pH=7.40 
NaCl 150 mM 
KCl 10 mM 
MgCl2 1 mM 
CaCl2 2 mM 
Glucose 10 mM 
HEPES 10 mM 
Table 2.5-1 Composition of NES buffer 
2.5.1.2 Using GCaMP6f  
After 24 hours, cells were transfected with GCaMP6f using PEI method.  48h after 
transfection cells fluorescence (excitation 485 nm, emission 520 nm) was measured at room 
temperature using Flexstation III plate-reader with automatic additions. At the beginning of 
the assay, extracellular Ca2+ was quenched using 1 mM EGTA, and Ca2+ stores were 
depleted using 1 µM thapsigargin (Thermo Fisher). Subsequently, 2mM Ca2+ was added to 
assess Ca2+ entry. Fmax and Fmin are the fluorescence values determined after the addition 
of Triton X-100 (0.1%) in NES with 10 mM Ca2+ and EGTA respectively.  
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HBSS 1L, pH=7.40 
1 powder flask Sigma H1387 
HEPES 2.383g (10 mM) 
HBSS wo Ca2+/Mg2+ 1L, pH=7.40 
1 powder flask Sigma H4891 
MgCl2 0.095g (1mM) 
HEPES 2.383g (10 mM) 
Table 2.5-2 Composition of HBSS buffers 
2.5.2 Measurements of [Ca2+]c in the single cells 
2.5.2.1 Using G-GECO1.2-Orai1 
For measurements of [Ca2+]c in the single cells, HEK293 cells were seeded onto 
poly-L-lysine coated coverslips (16mm for epifluorescence microscopy, 24mm for TIRFM). 
6 hours after seeding, cells were transduced with the multiplicity of infection (MOI) 15 of 
WTVC or σ1R-V5 baculovirus particles and used for experiments 48- or 72-hours post-
transduction using genetically encoded G-GECO1.2-Orai1 (Kd value of 1,150 nM; 
Addgene). After 24 hours, cells were transfected with G-GECO1.2-Orai1 using lipofectamine 
method.  48h after transfection cells fluorescence (excitation 488 nm, emission 535 nm) was 
measured at room temperature using epifluorescence microscope and TIRFM. The 
exception was made during simultaneous overexpression of G-GECO1.2-Orai1 with STIM 
constructs to avoid prolonged constitutive Ca2+ influx and cytotoxicity; these cells were used 
from 15h (mCh-STIM-CAD construct) to 30h from transfection. At the beginning of the assay, 
extracellular Ca2+ was quenched using 0.1 mM EGTA, and Ca2+ stores were depleted using 
1 µM thapsigargin (Thermo Fisher). Subsequently, 2mM Ca2+ was added to assess Ca2+ 
entry. Fmax is the fluorescence value determined after the addition of 5µM ionomycin in HBSS 
containing 2mM Ca2+. The analysis of recordings using G-GECO1.2-Orai1 is more 
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thoroughly assessed in Chapter IV, Section 4.21. The composition of HBSS can be found in 
Table 2.32.  
2.5.3 NFAT translocation assay  
HEK293 cells were seeded onto poly-L-lysine-coated 24-mm coverslips, mock-
transduced (WT) or transduced with 15 MOI of either WTVC or σ1R-V5 baculovirus, 
transfected with GFP-NFAT plasmid using PEI method and used after 48 hours. The rate of 
NFAT nuclear translocation was measured as the distribution of GFP fluorescence before 
and after addition of thapsigargin (5 µM) to cells at 37⁰C in NES. Fluorescence (excitation 
at 488 nm, emission at 510-540 nm) was collected using a Leica SP8 confocal microscope 
with an oil-immersion 40x objective (NA 1.25). Analyses of nuclear translocation of GFP-
NFAT were performed as a blinded study by two independent analysts. In total, 6 coverslips 
per group were analysed from 3 independent experiments (n=3) with ~ 20 cells within the 
field of view.   
2.6 Biochemistry 
2.6.1 Analysis of protein expression 
HEK293 and HeLa cells were grown in 1 well of 6W plate. Where appropriate, cells 
were transduced and transfected as previously described. At appropriate timepoints, cells 
were washed 3x in 1ml of ice-cold PBS and collected in 80µl of 1X RIPA buffer (Sigma) 
containing 1X of protease inhibitor cocktail (Sigma). Collected cells were then agitated at 
+4⁰C for 60 min. The samples were centrifuged at 16000xg at +4⁰C for 10 min. Supernatant 
was transferred in a clean tube for storage at -20⁰C and the pellet was discarded. Protein 
expression was analysed by protein gel electrophoresis followed by immunoblotting. 
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2.6.2   Western blot 
Precast NuPAGE Bis-Tris gels (Invitrogen, 4-12%) and 1XMES buffer (Thermo 
Fisher) were used for protein electrophoresis to separate proteins based on their size. The 
wells were loaded with 40µl of total volume for each protein sample, alongside with 5µl of 
ladder (PageRuler Plus, Prestained; Thermo Fisher). Total loading volume was made using 
4X laemlli (0.25 M Tris-HCl pH6.8, 8 % SDS, 40 % glycerol, 0.04 % Bromophenol blue, 10 
% B-mercaptoethanol), PBS and calculated sample volume for ~20µg of protein. Protein 
transfer was made using IBlot2 system and nitrocellulose membrane transfer packs 
(Invitrogen). Membranes were blocked with 5% milk dissolved in TBS-Tween at +4⁰C 
overnight, followed by the incubation with the primary antibody made up in 2.5% milk in TBS-
Tween for 2 hours at room temperature. Membranes were washed with TBS-Tween and 
incubated for 1h with secondary antibody coupled to horseradish peroxidase made up in 
2.5% milk. Membranes were washed with TBS-Tween and protein was detected using ECL 
Western blotting substrate (Thermo Fisher). The images were captured using DNR 
Bioimaging systems.  
TBS 1L,  pH=7.40 
Tris-HCl 25 mM 
NaCl 150mM 
EDTA 10mM 
Table 2.6-1Composition of Tris-buffered saline (TBS) 
  
82 
 
Primary Antibody   Concentration Manufacturer 
α-σ1R 
1:500 Santa Cruz 
Biotechnology 
α-STIM1 1:1000 Protein Tech 
α-STIM2 1:200 Alomone 
α-Orai1 1:500 Sigma 
α-βactin 1:1500 Sigma 
Secondary Antibody   
α-mouse HRP 1:1000 Dako 
α-rabbit HRP 1:1000 Bio-rad 
Table 2.6-2 List of antibodies used in Western blotting 
2.7 Microscopy 
2.7.1 Immunofluorescence 
Protocol for immunofluorescence can be found in Chapter VI, Section 6.21.  
2.7.2 Proximity ligation assay (PLA)  
Protocol for PLA can be found in Chapter VI, Section 6.22.  
2.7.3 Total internal reflection microscopy (TIRFM) 
TIRF imaging was performed on a custom-built inverted TIRF microscope. Cells 
were seeded onto poly-L-lysine-coated 24-mm coverslips at 70-80% confluency. The 
microscope system consisted of 60x oil-immersion objective (Olympus, NA 1.45), the 
electron-multiplying charged-coupled device camera (Photometrics Cascade 512B), 
Thorlabs SC10 - Optical Beam Shutter Controller, 535/50 and 630/60 emission filters, and 
488-nm  (70 mW output measured, Cobolt MLD) and 561-nm (55 mW output measured, 
Cobolt Jive) diode lasers.  The system was controlled using Micro-Manager Open Source 
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Microscopy Software. Using the 60× TIRF objective, a pixel corresponded to a 240-nm by 
240-nm square.  Single channel images were acquired at the rate of image/5 seconds. Two 
channel images were acquired sequentially (colour-stack/5 seconds) with exposure time of 
100 ms. 
2.7.4 Data analysis 
Most of results are presented as mean±SEM from “n” independent experiments as 
indicated in the figure legends. Number of biological replicates is marked with “N”. Statistical 
analysis for dataset from normal population ( D'Agostino-Pearson normality test, P>0.05) 
used unpaired Student’s test or ANOVA followed by Tukey’s post hoc test, as appropriate. 
Statistical analysis for dataset significantly different from normal population ( D'Agostino-
Pearson normality test, P<0.05) used unpaired Mann-Whitney test or Kruskal-Wallis test 
followed by Dunn-Bonferroni post hoc test, as appropriate. Line and bar graphs, and 
statistical analysis were generated using GraphPad Prism v6.   
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3 Chapter III  
Measurements of [Ca2+]cyt in the population of cells and the 
functional role of σ1R in regulation of SOCE 
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3.1 Introduction 
Tight and precise regulation of changes in [Ca2+]cyt is crucial for numerous cellular 
processes. Store-operated Ca2+ entry (SOCE) is a key pathway for the replenishment of 
intracellular Ca2+ in non-excitable cells, and recently, it has emerged as an important 
pathway for the maintenance of Ca2+ homeostasis in excitable cells115,139.  
σ1R, a neuroprotective ER chaperone with established therapeutic potential, has 
been proposed as a functional regulator of Orai1-mediated SOCE14,34. However, σ1R has 
been reported to inhibit, promote, and even potentiate SOCE in different cell lines requiring 
further investigation14,34,158,159. 
3.1.1 Use of fluorescent Ca2+ dyes and GCaMP6f to measure SOCE 
Ca2+ indicators are molecules that increase in fluorescence upon Ca2+ binding. The 
current understanding of cellular Ca2+ signals can be contributed to the continuous 
improvements in Ca2+ indicators, including fluorescent (synthetic) Ca2+ dyes and genetically 
encoded Ca2+  indicators (GECI).  
The fluorescent Ca2+ dyes were first introduced by Dr. Roger Tsien, together with 
instructions for loading fluorescent dyes into the cells via membrane-permeant ester forms 
165–167. Fluo-4-AM and Fluo-8-AM are fluorescent Ca2+ dyes that are used in this chapter. 
Both Fluo-AM dyes are the non-polar esters that readily cross live cell membranes; upon 
crossing both dyes are hydrolysed by cellular esterases and, thus, “trapped” inside 
mammalian cells, allowing for measurements of [Ca2+]cyt. On binding of Ca2+, Fluo-4-AM and 
Fluo-8-AM exhibit substantial changes in fluorescence that can be normalized by ratio of 
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chelated fluorescence (Fmin) to fluorescence obtained after saturating levels of cytosolic 
Ca2+(Fmax).  
In parallel to fluorescent Ca2+ dyes, GECI were developed as promising in vivo 
sensors for imaging of changes in neuronal [Ca2+]cyt168.  A significant advantage of GECI over 
fluorescent Ca2+ dyes includes targeting to distinct populations of cells and/or subcellular 
locations using cell-specific promoters and targeting sequences over indiscriminate 
uptake168. GCaMP6f is GECI used in this chapter. It is a more recent iteration of the original 
GCaMP sensor which consists of green fluorescent protein (GFP) fused to the calmodulin 
(CaM) binding region of chicken myosin light kinase (M13)168. On binding of Ca2+, GCaMP6f 
undergoes conformational change resulting in the interaction of its CaM and M13 regions 
and consequently, an increase in fluorescence.   
 GCaMP6f has been reported to outcompete various synthetic indicator dyes when 
compared to their sensitivity and dynamic range162,168. The dissociation constant (Kd) 
describes how tightly a Ca2+ indicator binds Ca2+  169, and GCaMP6f has several reported Kd 
values ranging from 290 to 375nM170,171. In comparison, Fluo-4-AM has a Kd value of 345nM, 
and Fluo-8-AM has a Kd value of 389nM, suggesting similar buffering affinity. To investigate 
the functional role of σ1R in the regulation of SOCE, Fluo-4-AM, Fluo-8-AM, and GCaMP6f 
were utilized as Ca2+ indicators while performing Ca2+ functional assay using Flexstation III 
microplate reader.  
3.1.2 Use of BacMam gene-delivery system to express σ1R  
Various research tools may be used to manipulate the expression levels of a gene 
of interest in mammalian cell lines. In recent years, the modified insect cell baculovirus 
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(BacMam virus) has emerged as an efficient gene delivery technology to mammalian cells 
resulting in very little to no microscopically observable cytotoxicity172. 
BacMam virus carries cDNA of gene of interest under the control of the CMV 
promoter. The transduction of mammalian cells by BacMam virus requires small liquid 
addition to the culturing media after which BacMam particles enter the cell via endocytosis6. 
After endocytosis, the BacMam DNA is trafficked to the nucleus where the mammalian 
transcriptional machinery transcribes the CMV-promoted gene but fails to recognize 
baculovirus promoters. The transcription of BacMam-delivered gene under CMV promoter 
begins within 4–6 hours after transduction and in most of the cell types is completed 
overnight. 
 In the drug discovery environment, BacMam gene-delivery system is routinely used 
to achieve the transient and controllable expression of target proteins in cell-based assays 
for high-throughput screenings (HTS)172,173. While the development of a stable-cell line is a 
time-costly process which can result in several shortcomings, including the accumulation of 
mutations due to continuous selection pressure required to maintain the transgene, BacMam 
gene-delivery system allows for highly reproducible and titratable transient expression within 
24 hours from transduction172,173.  
To express σ1R in mammalian cell lines and asses its role within SOCE, I have 
developed σ1R baculovirus carrying cDNA for expression of σ1R tagged with small V5 
epitope (σ1R-V5). Also, I have developed appropriate viral control named WTVC using 
BacMam vector without σ1R-V5 cDNA. 
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3.1.3 Use of HEK293 cell line as an experimental system 
Human embryonic kidney (HEK) 293 is immortalized cell line extensively used in 
research, including studies of neuronal related diseases. First HEK293 cells were cultured 
by transforming the primary cultures of HEK cells with sheared Adenovirus 5 DNA174. As 
embryonic kidneys consist of heterogeneous mix of cell types, the precise type of kidney or 
kidney-adjacent cell that gave rise to HEK293 cell line has been unknown. For decades, this 
immortalized cell line was considered kidney epithelial or even fibroblasts175,176, but 
subsequent studies, as well as advances in immunocytochemistry and transcriptomics, have 
revealed that HEK 293 cells express markers of renal progenitor cells, adrenal gland, and 
neuronal cells177,178. Cell-type unspecific phenotype of HEK293 cells that includes 
expression of over sixty neuron-specific proteins, such as neurofilaments, subunits of 
neuron-specific ion channels, neuroreceptors, and synaptic-vesicle-associated proteins, 
have led towards current hypothesis that HEK 293 and neurons originate from the same 
precursor line177,179. 
As a choice of experimental system, HEK293 do not provide identical cellular and 
sub-cellular organization nor biochemistry associated with neuronal cells and tissue 
preparations. Moreover, HEK293 cells are devoid of several ion channels, chaperons, 
receptors, and enzymes crucial for neuronal biology. However,  preserved functionality of 
both endogenous and exogenous neuron-specific proteins in HEK293 cells has been 
experimentally demonstrated, suggesting high similarity of fundamental biological 
processes and regulatory mechanisms between HEK293 cells and neurons. For example, 
currents of endogenously expressed voltage-gated Ca2+, K+, and Na2+ channels have been 
recorded179. HEK293 cells were also found sensitive to agonists implicated in neuronal 
signaling, such as histamine, neurotensin, and ATP179. Additionally, HEK293 cells 
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underwent synaptogenesis in a mixed assay cultures with neurons after exogenous protein 
expression of neuronal-specific proteins179. This evidence suggests that HEK293 cells 
represent a good “low-noise” model for studying basic cellular mechanism of neuroprotective 
chaperone, such as σ1R.  
In this thesis, HEK293 cells are used as experimental system to determine how 
enhanced expression of σ1R affects SOCE regulated by a) endogenous levels of STIM and 
Orai1 proteins, and b) following upregulation in STIM and Orai1 expression levels.     
3.1.4 Aims 
(1) To determine how enhanced expression of σ1R affects SOCE 
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3.2 Methods 
3.2.1 Experimental timeline of Chapter III 
 
  
Figure 9 Experimental timeline of calcium assays in Chapter III 
Fig3.21 Experimental timeline of calcium assays in Chapter III. Day (0) Cell culture and plating of cells on the 
appropriate recording dishes, followed by baculovirus transduction. (Day 1) Transfection using PEI/Flexstation 
III experiments using fluorescent Ca2+ dyes. (Day 3) Flexstation III and NFAT translocation assay experiments. 
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3.3 Results 
3.3.1 Overexpression of σ1R-V5 significantly inhibits store-depletion and 
SOCE 
For initial testing of the functional role of σ1R in the regulation of SOCE, σ1R-V5 was 
transiently expressed in HEK293 cells using PEI transfection method. Plasmid for 
expression of σ1R-V5 was developed by Srivats et al34. 48 h post-transfection, cells were 
loaded with Fluo-4-AM for 45 min and tested using Flexstation III microplate reader. Cells 
were put in nominal Ca2+-free NES and treated with 1 µM thapsigargin to induce store 
depletion, which can be observed as the first rise in cytosolic Ca2+ (1st peak). This was 
followed by the restoration of 2 mM extracellular Ca2+ where Ca2+ influx (SOCE) was 
recorded as the second rise in cytosolic Ca2+ (2nd peak). Additionally, at this stage of the 
assay, cell were treated with either 1 µM Gd3+, a known SOCE inhibitor, or the equivalent 
volume of DMSO.  
Fig3.31 shows Fluo-4-AM traces of mock-transfected and σ1R-V5 HEK293 cells 
treated with 1µM of thapsigargin in nominal Ca2+-free NES followed by the restoration of 2 
mM extracellular Ca2+ with either 1µM Gd3+ or the equivalent volume of DMSO. Store-
depletion and SOCE peaks of each experimental group were obtained and compared with 
one-way ANOVA using α of 0.05. The overexpression of σ1R-V5 resulted in a significant 
decrease in both store-depletion and SOCE when compared to mock-transfected HEK293 
cells (Fig3.31B, ****, P < 0.0001), which suggests that σ1R-V5 inhibits store-depletion and 
SOCE. Addition of 1µM Gd3+ significantly inhibited SOCE in both mock-transfected and σ1R-
V5 cells, suggesting that experimentally measured Ca2+ influx occurs through CRAC 
channel. These results agree with the previously reported34. Results of statistical analysis 
have been summarized in Table3.31. 
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Figure 10 Overexpression of σ1R-V5 and treatment with 1µM Gd3+ inhibit SOCE in HEK293 cells 
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Group 
Store-
depletion 
Mean±SEM 
SOCE 
Mean±SEM 
N 
Tukey summary 
of store-
depletion 
σ1R-V5+DMSO 
Tukey summary 
of SOCE 
σ1R-V5+DMSO 
Mock-
transfected + 
DMSO 
0.2431 ± 
0.009906 
0.5901± 
0.01768 
23 
****, P < 0.0001 
 
****, P < 0.0001 
 
σ1R-
V5+DMSO 
0.1391± 
0.004416 
0.3386± 
0.01159 
24   
Mock-
transfected + 
Gd3+ 
0.2152± 
0.01294 
0.2149± 
0.01890 
18 
*, P < 0.05 
 
****, P < 0.0001 
 
σ1R-V5+Gd3+ 
0.1306± 
0.008676 
0.1863± 
0.02192 
17 
n.s, P > 0.05 
 
****, P < 0.0001 
 
Group 
Store-
depletion 
Mean±SEM 
SOCE 
Mean±SEM 
N 
Tukey summary 
of store-
depletion 
Mock-transfected 
+ Gd3+ 
Tukey summary 
of SOCE 
Mock-transfected 
+ Gd3+ 
Mock-
transfected + 
DMSO 
0.2431 ± 
0.009906 
0.5901± 
0.01768 
23 
n.s, P > 0.05 
 
****, P < 0.0001 
 
Table 3.3-1 Summary of one-way ANOVA for the thapsigargin-evoked increase in [Ca2+]cyt during store-
depletion and either DMSO or Gd3+ treatment during SOCE. Store-depletion and SOCE measurements (Peaks, 
Fig 3.31) were taken 48h post-transfection with σ1R-V5 construct across three independent experiments 
(n=3). A population of HEK293 cells within one well of 96W plate was used as a biological replicate (N) for 
statistical analysis. 
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3.3.2 Sustained store-depletion is not sufficient to inhibit SOCE 
σ1R promotes Ca2+ influx from ER to mitochondria by stabilizing IP3Rs at the MAM22. 
Thus, enhanced expression of σ1R can result in sustained efflux of luminal Ca2+ and Ca2+ 
overload of mitochondria. Up-to-date evidence shows that mitochondria possesses 
unknown mechanism to inhibit SOCE during mitochondrial depolarisation180. Hence, the 
observed ability of σ1R to inhibit SOCE could be linked with its ability to promote efflux of 
luminal Ca2+ and cause sustained store-depletion before even before experimental 
assessment. To test whether sustained store-depletion might itself cause downregulation of 
SOCE, HEK293 cells were treated with cyclopiazonic acid (CPA) to reversibly inhibit the ER 
Ca2+ pump for 2 and 18h.   
Fig3.32 shows Fluo-4-AM traces of mock-treated, 2h CPA-treated and 18 h CPA-
treated HEK293 cells treated with 1µM of Thapsigargin in nominal Ca2+-free NES followed 
by the restoration of 2 mM extracellular Ca2+. Store-depletion and SOCE peaks of each 
experimental group were obtained and compared with one-way ANOVA using α of 0.05. In 
comparison to the mock-treated cells, the treatment with CPA for 2h and 18h resulted in a 
significant decrease in store-depletion (Fig3.32B, ****, P < 0.0001), indicating the sustained 
store-depletion by CPA-treatment. However, no significant inhibition of SOCE was detected, 
suggesting that sustained store-depletion is not sufficient to inhibit SOCE. These results 
agree with the previously reported34. Results of statistical analysis have been summarized 
in Table3.32. 
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Table 3.3-2 Summary of one-way ANOVA tests for the sustained depletion of intracellular Ca2+ stores 
(Fig3.32) 
  
Group 
Store-
depletion 
Mean± 
SEM 
SOCE 
Mean± 
SEM 
N 
ANOVA      
store-
depletion 
18h 0.1µM 
CPA 
ANOVA      
SOCE 
18h 0.1µM 
CPA 
ANOVA      
store-
depletion 
2h 0.1µM 
CPA 
ANOVA      
SOCE          
2h 0.1µM 
CPA 
Mock-
treated 
0.2119±  
0.02068 
0.5302 ±  
0.03305 
12 
****, P < 
0.0001 
 
n.s, P> 0.05 
****, P < 
0.0001 
 
n.s, P> 0.05 
2h 
0.1µM 
CPA 
0.1114± 
0.009684 
0.4911± 
0.04345 
12 n.s, P> 0.05 n.s, P> 0.05   
18h 
0.1µM 
CPA 
0.08550±  
0.005639 
0.4596± 
0.02630 
12   
 
 
 
Figure 11 Sustained store-depletion is not sufficient to inhibit SOCE 
Fig3.32 Sustained store-depletion is not sufficient to 
inhibit SOCE. A) Representative averageSEM traces of 
HEK293 cells after mock-treatment (black), 2h treatment 
(red) and 18h treatment of HEK293 cells with 0.1 m 
CPA. During recor ings, cells were treated with 1 m 
thapsigargin in nominal Ca2+-free NES followed by the 
restoration of 2 mM extracellular Ca2+. B) and C) Results 
summary of store depletion (1st peak, B) and SOCE (2nd 
peak, C) values across n=2. One-way ANOVA. n.s, P>0.05; 
****, P<0.0001. 
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3.3.3 Overexpression of σ1R-V5 using BacMam gene delivery system inhibits 
store-depletion and SOCE 24 h post-transduction 
After determining that the overexpression of σ1R-V5 inhibits SOCE, the cDNA of 
σ1R-V5 was inserted into the BacMam pCMV-Dest vector which was used to develop σ1R-
V5 baculovirus. A viral control (WTVC) was developed using BacMam pCMV-Dest vector 
without σ1R-V5 cDNA. To functionally assess the BacMam gene delivery system, HEK293 
were transduced with MOI15 of WTVC and σ1R-V5 baculovirus particles. To test whether 
σ1R-V5 inhibits SOCE 24h post-transduction, cells were loaded with Fluo-8-AM for 30 min 
and tested using Flexstation III microplate reader.  
Fig3.33 shows Fluo-8-AM traces of WTVC and σ1R-V5 HEK293 cells treated with 
1µM of Thapsigargin in nominal Ca2+-free NES followed by the restoration of 2 mM 
extracellular Ca2+. Store-depletion and SOCE peaks of each experimental group were 
obtained and compared with Student’s t-test using α of 0.05. The overexpression of σ1R-V5 
using BacMam gene delivery system resulted in a significant decrease in both store-
depletion and SOCE when compared to WTVC HEK293 cells (Fig3.33B, **, P < 0.01; 
Fig3.33C, ****, P < 0.0001 ), which suggests that σ1R-V5 inhibits store-depletion and SOCE. 
Results of statistical analysis have been summarized in Table3.33. 
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Figure 12 Overexpression of σ1R-V5 inhibits store-depletion and SOCE in HEK293. 
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Group 
Store-depletion 
Mean± 
SEM 
SOCE 
Mean± 
SEM 
N 
t-test summary 
of store-
depletion 
σ1R-V5 
t-test summary of 
SOCE 
σ1R-V5 
WTVC 
0.2531 ± 
0.006405 
0.6358± 0.01461 30 
**, P < 0.01 
 
****, P < 0.0001 
 
σ1R-V5 
0.2200 ± 
0.008220 
0.4563± 0.01345 24   
Table 3.3-3 Summary of unpaired Student’s t-test for the thapsigargin-evoked increase in [Ca2+]cyt during 
store-depletion and SOCE 24h post-transduction. Store-depletion and SOCE measurements (Peaks, Fig 3.33) 
were taken across three independent experiments (n=3). A population of HEK293 cells within one well of 96W 
plate was used as a biological replicate (N) for statistical analysis.   
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3.3.4 Overexpression of σ1R-V5 in HEK293 cells inhibits SOCE independently 
of efflux of intracellular potassium (K+) 
Gueguinou et al14. reported that σ1R modulates SK3-dependent Ca2+ homeostasis 
by promoting Orai1:SK3 coupling in colorectal and breast cancer cells, which leads to an 
increase in thapsigargin-evoked and constitutive Orai1-mediated Ca2+ influx 15. SK3 is small 
conductance Ca2+ activate potassium (K+) channel that activated by high intracellular Ca2+ 
hyperpolarizes cell by allowing K+ efflux. To test whether σ1R modulates SOCE in HEK293 
cells independently of K+ efflux, WTVC and σ1R-V5 transduced HEK293 cells were tested in 
nominal Ca2+-free NES with increased concentration of extracellular K+ (142 mM).  
Fig3.34 shows Fluo-8-AM traces of WTVC and σ1R-V5 HEK293 cells treated with 
1µM of Thapsigargin in nominal Ca2+-free NES (high K+) followed by the restoration of 2 mM 
extracellular Ca2+. Store-depletion and SOCE peaks of each experimental group were 
obtained and compared with Student’s t-test using α of 0.05. The overexpression of σ1R-V5 
resulted in a significant decrease in SOCE when compared to WTVC HEK293 cells 
(Fig3.34C, ****, P < 0.0001 ), which suggests that in HEK293 cells, σ1R-V5 modulates 
SOCE via a different mechanism than reported by Gueguinou et al14.  Results of statistical 
analysis have been summarized in Table3.34. 
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Figure 13 Overexpression of σ1R-V5 in HEK293 inhibits SOCE in high potassium ([KCl]ex = 142 mM) 
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Group 
Store-depletion 
Mean± 
SEM 
SOCE 
Mean± 
SEM 
N 
t-test summary 
of store-
depletion 
σ1R-V5 
t-test summary of 
SOCE 
σ1R-V5 
WTVC 
0.2241 ± 
0.007425 
0.4522 ± 0.01467 24 
n.s., P > 0.05 
 
****, P < 0.0001 
 
σ1R-V5 
0.2180 ± 
0.008954 
0.3294 ± 0.02434 24   
Table 3.3-4 Summary of unpaired Student’s t-test for the thapsigargin-evoked increase in [Ca2+]cyt during 
store-depletion and SOCE following membrane depolarization (high KCl). Store-depletion and SOCE 
measurements (Peaks, Fig 3.34) were taken across three independent experiments (n=3). A population of 
HEK293 cells within one well of 96W plate was used as a biological replicate (N) for statistical analysis.   
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3.3.5 σ1R-V5 reduces ATP/Cch-evoked increase in [Ca2+]cyt during store-
depletion and SOCE 
In HEK293 cells, the depletion of intracellular Ca2+ stores can be induced by the 
inhibition of the SERCA ATPase pump by thapsigargin, or by the stimulation of endogenous 
receptors that activate PLC using adenosine triphosphate (ATP) and carbachol (Cch). To 
test whether the overexpression of σ1R-V5 reduces store-depletion and SOCE after 
activation of PLC and downstream activation of IP3Rs, HEK293 cells were transduced with 
either WTVC or σ1R-V5 baculovirus. 24h post-transduction, the populations of WTVC and 
σ1R-V5 HEK293 cells were treated with the addition of 100µM of ATP/Cch, and changes in 
[Ca2+]cyt were measured using Fluo-8-AM and Flexstation III microplate reader.  
HEK293 cells in this section and following sections 3.36 and 3.37 of this chapter 
were a gift from C. Taylor lab (University of Cambridge), and are also a control cell line for 
IP3R-/- HEK293 cell line introduced in the following section.  
Fig3.35 shows Fluo-8-AM traces of WTVC and σ1R-V5 HEK293 cells treated with 
100µM of ATP/Cch in nominal Ca2+-free NES followed by the restoration of 2 mM 
extracellular Ca2+. Store-depletion and SOCE peaks of WTVC and σ1R-V5 HEK293 cells 
were compared with unpaired Student’s t-test using α of 0.05. The overexpression of σ1R-
V5 resulted in a significant decrease in both store-depletion and SOCE when compared to 
WTVC HEK293 cells (Fig3.35B, ****, P < 0.0001).  This result suggests that σ1R-V5 inhibits 
SOCE following active store-depletion via PLC pathway. Also, a significantly lower efflux of 
luminal Ca2+ to cytosol agrees with the previously reported results34. Results of statistical 
analysis have been summarized in Table 3.35. 
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Group 
Store-depletion 
Mean± 
SEM 
SOCE 
Mean± 
SEM 
N 
t-test summary 
of store-
depletion 
σ1R-V5 
t-test summary of 
SOCE 
σ1R-V5 
WTVC 0.6569 ± 0.01376 
0.4543 ± 
0.009763 
18 
****, P < 0.0001 
 
****, P < 0.0001 
 
σ1R-V5 
0.2867 ± 
0.009353 
0.2219 ± 
0.006639 
18   
Table 3.3-5 Summary of unpaired Student’s t-test for ATP/Cch-evoked increase in [Ca2+]cyt during store-
depletion and SOCE. Store-depletion and SOCE measurements (Peaks, Fig 3.35) were taken across three 
independent experiments (n=3). A population of HEK293 cells within one well of 96W plate was used as a 
biological replicate (N) for statistical analysis.   
 
 
  
Figure 14 σ1R-V5 inhibits ATP/Cch-evoked store-depletion and  SOCE. 
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3.3.6 Treatment with ATP/Cch fails to evoke store-depletion and SOCE in 
IP3R-/- HEK293 cells  
To further characterize the role of σ1R within the SOCE pathway, IP3R-/- HEK293 
cell line was obtained from Taylor Lab181 with its appropriate control which is used in Section 
3.35 of this chapter. Subtype three of IP3Rs has been introduced in Section 1.151 of Chapter 
I as interactive partner of σ1R at the MAM where activated, promotes Ca2+ influx from ER to 
mitochondria. In IP3R-/-  stable cell line, all three subtypes of IP3R have been knocked-out 
eliminating IP3R-mediated store-depletion and SOCE activation. Before using IP3R-/- 
HEK293 cells in experiments with WTVC and σ1R-V5 baculovirus, IP3R-/-  stable cell line was 
briefly characterized during Ca2+ functional assay by applying 100µM of ATP/Cch treatment, 
which is upstream stimuli of IP3R-mediated store-depletion and SOCE activation.  
 Fig3.36 shows Fluo-8-AM traces of WT (black) and IP3R-/- (red) HEK293 treated 
with 100µM of ATP/Cch in nominal Ca2+-free NES followed by the restoration of 2 mM 
extracellular Ca2+. Store-depletion (1st peak)  and SOCE (2nd peak) of experimental groups 
were compared with unpaired Student’s t-test using α of 0.05. ATP/Cch treatment failed to 
induce store-depletion and to activate SOCE in IP3R-/- cell line, confirming absence of 
IP3Rs.  
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Figure 15 ATP/Cch fails to evoke store-depletion and SOCE in IP3R-/- HEK293. 
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3.3.7 σ1R-V5 inhibits SOCE in IP3R-/- HEK293 cells, but fails to reduce store-
depletion  
A significant drop in [Ca2+]ER promotes dissociation of σ1R from BiP and its 
translocation to the MAM where it promotes flux of Ca2+ from ER to mitochondria by 
stabilizing IP3Rs. Recently, two groups reported that depletion of intracellular stores by the 
activation of IP3Rs also promotes IP3R-STIM1 association at ER-PM junctions181,182. These 
results prompt us to address whether previously observed functional interaction of σ1Rs 
with IP3Rs at the MAM plays a role in underlying cellular mechanism of SOCE inhibition by 
σ1R.  To determine whether the functional role of σ1R in the regulation of ER Ca2+ content 
and SOCE is IP3R-dependent, HEK293 cell line deficient for all three subtypes of IP3Rs 
(IP3R-/- HEK293 cells) was transduced with WTVC and σ1R-V5 baculovirus.  24h post-
transduction, the populations of WTVC and σ1R-V5 IP3R-/- HEK293 cells were treated with 
1µM of thapsigargin, and changes in [Ca2+]cyt were measured using Fluo-8-AM Ca2+ dye and 
Flexstation III microplate reader.  
Fig3.37 shows Fluo-8-AM traces of WTVC and σ1R-V5 IP3R-/- HEK293 cells treated 
with 1µM of thapsigargin in nominal Ca2+-free NES followed by the restoration of 2 mM 
extracellular Ca2+. Store-depletion and SOCE peaks of WTVC and σ1R-V5 HEK293 cells 
were compared with unpaired Student’s t-test using α of 0.05. The overexpression of σ1R-
V5 resulted in a significant decrease of SOCE, but not the store-depletion when compared 
to WTVC HEK293 cells (Fig3.37C, ****, P < 0.0001; Fig3.37B, n.s., P > 0.05).  This result 
suggests that σ1R-V5 inhibits SOCE independently of IP3Rs. Also, this result suggests that 
previously demonstrated inhibition of store-depletion by σ1R-V5 could be the result of the 
increased efflux of luminal Ca2+ to mitochondria via IP3Rs.  Results of statistical analysis 
have been summarized in Table 3.36. 
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Figure 16Figure 3.3 7 σ1R-V5 inhibits SOCE, but not store-depletion in IP3R-/- HEK293 
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Group 
Store-depletion 
Mean± 
SEM 
SOCE 
Mean± 
SEM 
N 
t-test summary 
of store-
depletion 
σ1R-V5 
t-test summary of 
SOCE 
σ1R-V5 
WTVC 0.2349±  0.01123 0.6523 ± 0.02816 24 
n.s., P > 0.05 
 
****, P < 0.0001 
 
σ1R-V5 
0.2093±  
0.007734 
0.4408 ± 0.01266 24   
Table 3.3-6 Summary of unpaired Student’s t-test for Tg-evoked increase in [Ca2+]cyt during store-depletion 
and SOCE in IP3R-/- HEK293 cells. Store-depletion and SOCE measurements (Peaks, Fig 3.37) were taken across 
four independent experiments (n=4). A population of HEK293 cells within one well of 96W plate was used as 
a biological replicate (N) for statistical analysis.   
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3.3.8 Overexpression of σ1R-V5 does not significantly reduce endogenous 
levels of STIM1 and STIM2.2 proteins in HEK293 cells   
The regulation of SOCE is dependent on expression levels of ER Ca2+ sensor 
proteins, STIM1 and STIM2.2, and thus, the inhibition of SOCE can be achieved by 
downregulation of STIM levels183. To determine whether the overexpression of σ1R reduces 
expression of endogenous STIM proteins, lysates of HEK293 cells were transduced with 
either WTVC or σ1R-V5 baculovirus and collected 24, 48 and 72h post-transduction –at time 
points that reflect conditions of different Ca2+ functional assays used in this thesis. Collected 
lysates were analysed by Western blotting.  
Fig3.38 shows endogenous levels of STIM1 and STIM2.2 in lysates collected 48h 
post-transduction with either WTVC and σ1R-V5 baculovirus. Endogenous levels of STIM1 
and STIM2.2 were compared to overexpression of HA-STIM1 and STIM2.2, respectively. 
Lysates of HA-STIM1 and STIM2.2 HEK293 cells were collected 48h post-transfection with 
STIM constructs. This comparison was performed to test the specificity of STIM1 and STIM 
primary antibodies.   
Fig3.39 shows Western blot analysis of endogenous levels of STIM homologs 24, 
48 and 72h post-transduction with either WTVC or σ1R-V5 baculovirus.  Fig3.39B, C and D 
summarize normalized STIM2.2, STIM1, and σ1R-V5 intensity across three independent 
experiments (n=3) analysed with one-way ANOVA using α of 0.05. No significant difference 
in endogenous levels of STIM proteins was detected between WTVC or σ1R-V5 HEK293 
cells.  
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Figure 17 Western blot of endogenous STIM1 and STIM2 expression in  WTVC and σ1R-V5 HEK293 cells 48h 
post-transduction compared to HEK293 cells expressing HA-STIM1 and STIM2.2 48h post-transfection 
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Figure 18 Western blot analysis of endogenous STIM1 and STIM2 expression in  WTVC and σ1R-V5 HEK293 
cells 24, 48 and 72h post-transduction 
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3.3.9 Overexpression of dominant-negative mutant Orai1R91W diminishes 
majority of GCaMP6f-measured SOCE 
After investigating the functional effect of σ1R on SOCE using fluorescent Ca2+ dyes, 
SOCE was also measured using GCaMP6f. A benefit of GECI approach over using 
fluorescent Ca2+ dyes presented itself in measurements from only transfected cells. To 
determine the amount of SOCE mediated by Orai1, dominant-negative mutant Orai1R91W  
was co-expressed with GCaMP6f and ER Ca2+ sensors mCh-STIM1 and STIM2.2-mCh. 48h 
post-transfection, HEK293 cells were treated with 1µM of thapsigargin, and changes in 
[Ca2+]cyt were measured using GCaMP6f and Flexstation III microplate reader.  
Fig3.310 shows GCaMP6f traces of HEK293 cells expressing GCaMP6f-only (WT; 
black), Orai1R91W (red), mCh-STIM1 (blue), mCh-STIM1+Orai1R91W (orange), STIM2.2-mCh 
(green), and STIM2.2-mCh+Orai1R91W (pink). Cells were treated with 1µM of thapsigargin in 
nominal Ca2+-free NES followed by the restoration of 2 mM extracellular Ca2+. SOCE peaks 
of HEK293 cells were compared with one-way ANOVA using α of 0.05. The overexpression 
of Orai1R91W resulted in a significant decrease of SOCE (Fig3.310, ****, P < 0.0001). The 
overexpression of two STIM homologs potentiated SOCE which was also diminished in the 
presence of dominant negative mutant Orai1R91W. These results suggest that majority of 
GCaMP6f-measured SOCE occurs in association with functional Orai1 subunit. Results of 
statistical analysis have been summarized in Table 3.37. 
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Figure 19 The overexpression of dominant-negative mutant Orai1R91W inhibits the majority of GCaMP6f-
measured SOCE in HEK293 cells 
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Group 
SOCE 
Mean± 
SEM 
N 
ANOVA      
SOCE 
Orai1R91W 
ANOVA      
SOCE 
mCh-STIM1 + 
Orai1R91W 
 
ANOVA   
SOCE 
STIM2.2-mCh 
+ Orai1R91W 
WT 
0.5099± 
0.01808 
18 
****, P < 
0.0001 
 
****, P < 
0.0001 
 
****, P < 
0.0001 
Orai1R91W 
0.1441± 
0.01747 
18    
mCh-STIM1 
0.6822± 
0.02132 
18 
****, P < 
0.0001 
 
****, P < 
0.0001 
 
 
****, P < 
0.0001 
mCh-STIM1+ 
Orai1R91W 
0.2413± 
0.022 
18 
**, P < 0.01 
 
 
 
n.s, P > 0.5 
 
STIM2.2-mCh 
0.7276± 
0.02456 
18 
****, P < 
0.0001 
 
****, P < 
0.0001 
 
 
****, P < 
0.0001 
STIM2.2-mCh+ 
Orai1R91W 
0.2263± 
0.008085 
18 
*, P < 0.05 
 
n.s, P > 0.5 
 
 
Table 3.3-7 Summary of one-way ANOVA tests for GCaMP6f-measured SOCE during overexpression of 
dominant-negative Orai1R91W. SOCE measurements (Peaks, Fig 3.310) were taken across three independent 
experiments (n=3). A population of HEK293 cells within one well of 96W plate was used as a biological replicate 
(N) for statistical analysis.   
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3.3.10 σ1R-V5 inhibits GCaMP6f-measured SOCE 
After establishing that the majority of GCaMP6f-measured SOCE occurs through the 
Orai1 channel, SOCE was measured in WTVC and σ1R-V5 HEK293 cells 72h post-
transduction with baculovirus particles and 48h post-transfection with GCaMP6f. HEK293 
cells were treated with 1µM of thapsigargin, and changes in [Ca2+]cyt were measured using 
GCaMP6f and Flexstation III microplate reader.  
Fig3.311 shows GCaMP6f traces of HEK293 cells transduced with WTVC (black) or 
σ1R-V5 (red) baculovirus particles. Cells were treated with 1µM of thapsigargin in nominal 
Ca2+-free NES followed by the restoration of 2 mM extracellular Ca2+. SOCE peaks of WTVC 
and σ1R-V5 HEK293 cells were compared with unpaired Student’s t-test using α of 0.05. 
The overexpression of σ1R-V5 resulted in a significant decrease of SOCE (Fig3.311B, ****, 
P < 0.0001), suggesting that σ1R inhibits GCaMP6f-measured SOCE. Results of statistical 
analysis have been summarized in Table 3.38. 
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Group 
SOCE 
Mean±SEM 
N 
t-test summary of 
SOCE 
σ1R-V5 
WTVC 0.5271 ± 
0.01807  
36 ****, P < 0.0001 
 
σ1R-V5 0.2105 ± 
0.01646  
36  
Table 3.3-8 Summary of unpaired Student’s t-test for GCaMP6f-measured SOCE in WTVC and σ1R-V5-
transduced HEK293 cells. Store-depletion and SOCE measurements (Peaks, Fig 3.311) were taken across three 
independent experiments (n=3). A population of HEK293 cells within one well of 96W plate was used as a 
biological replicate (N) for statistical analysis.  
 
  
Figure 20  σ1R-V5 inhibits GCaMP6f-measured SOCE in HEK293 cells 
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3.3.11 σ1R-V5 inhibits NFAT nuclear-translocation 
Nuclear factor of activated T cells (NFAT) is a Ca2+-dependent transcription factor 
that translocates from the cytosol to nucleus in response to activated SOCE161,184. In SCID 
T-cells, cells with a defect in SOCE due to the expression of Orai1R91W, NFAT nuclear-
translocation is impaired and associated with immunodeficiency185. To further test the 
functional effect of σ1R on SOCE, the rate of nuclear translocation of GFP-tagged NFAT 
was measured in WT, WTVC and σ1R-V5 HEK293 cells 72h post-transduction with 
baculovirus particles and 48h post-transfection with NFAT-GFP. HEK293 cells were treated 
with 5µM of thapsigargin for 15 minutes while kept in 2 mM Ca2+ NES, and changes in the 
rate of NFAT-GFP nuclear translocation were measured using confocal microscopy.  
Fig3.312 summarizes results of NFAT nuclear translocation experiment. Fig3.312A 
shows images of NFAT-GFP expressing HEK293 cells before (Basal) and after (SOCE) 
treatment with 5µM of thapsigargin in 2mM Ca2+ NES. The rate of NFAT nuclear 
translocation was measured using Time Series V3 Analyzer in Fiji/ImageJ; For purposes of 
analysis, an oval (height = 10px, width = 10px) region of interest (ROI) was placed within 
nuclei of NFAT-GFP transfected cells to measure changes in nuclear fluorescence, and 
within the cytosol to measure changes in cytosolic fluorescence. Measured traces were 
normalized using nuclear/cytosolic fluorescence ratio (N/C). The rate of NFAT nuclear 
translocation was calculated using the area under the curve (AUC).  
Fig3.312B and C summarize the rate of NFAT-GFP translocation in WT (blue), WTVC 
(black) and σ1R-V5 (red) HEK293 cells across three independent (n=3) experiments.  The 
rate of NFAT-GFP translocation between experimental groups was compared with one-way 
ANOVA using α of 0.05. The overexpression of σ1R-V5 resulted in a significant decrease in 
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the rate of NFAT nuclear-translocation (Fig3.312C, **, P < 0.01), suggesting the inhibitory 
effect of σ1R upstream of the activation of NFAT nuclear-translocation. 
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Figure 21 σ1R-V5 inhibits rate of NFAT-translocation in HEK293 cells 
Fig3.312 σ1R-V5 inhibits rate of NFAT-nuclear translocation in HEK293 cells . A) Representative images 
of HEK293 cells before (basal) and after 15-min treatment with 5 µM thapsigargin (SOCE). B) Average±SEM 
traces of NFAT fluorescence (nuclear/cytosolic) in WT (blue), WTVC (black) and σ1R-V5 HEK293 cells. C) 
Results summary of NFAT translocation calculated using area under the curve (AUC) values across three 
independent experiments (n=3). One-way ANOVA. **, P<0.01.  
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3.4 Discussion 
3.4.1 σ1R inhibits SOCE in HEK293 cells 
Enhanced expression of σ1R-V5 in HEK293 cells significantly inhibited Ca2+ influx 
24h post-transduction – as measured by Ca2+ fluorescent dyes, and 72h post-transduction 
– as measured by GCaMP6f. This Ca2+ influx was characterised as SOCE as it was a) 
dependent on the store-depletion, b) inhibited by the addition of 1µM Gd3+, and c) diminished 
by the expression of dominant-negative mutant OraiR91W. Additionally, overexpression of 
σ1R reduced store-depletion, indicating reduced Ca2+ content of intracellular stores. 
However, chronically reduced ER Ca2+ content after treatment with reversible SERCA 
blocker CPA failed to inhibit SOCE, which suggests reduced store-depletion is not sufficient 
to inhibit SOCE and that σ1R exerts its inhibitory role as SOCE regulator via different 
mechanism.  
These results are consistent with two of previous reports. Brailoiu et al. have shown 
that treatment of rat brain endothelial cells with cocaine, which is a σ1R agonist, inhibited 
SOCE158. Similar results were obtained by Srivats et al. in CHO cells where treatment with 
another σ1R agonist, (+)SKF10047, yielded similar results34. In both studies, treatments with 
unrelated σ1R antagonist exerted opposite effect on the regulation of SOCE. σ1R agonists 
promote dissociation of σ1R/BiP complex, allowing σ1R to interact with proteins at MAMs 
and ER-PM junctions, and forming of monomeric and lower oligomeric forms of σ1R 48. 
Contrary, σ1R antagonist oppose agonist effect preserving σ1R/BiP complex and favouring 
higher oligomeric forms186. 
Srivats et al. also demonstrated that enhanced expression of σ1R inhibited 
thapsigargin-evoked SOCE in the σ1R-HEK293 stable-cell line34. Thapsigargin is the 
121 
 
irreversible blocker of the SERCA ATPase pump at the ER, and its administration promotes 
a substantial leak of ER Ca2+, subsequently causing store-depletion. A substantial drop in 
ER [Ca2+] also promotes dissociation of σ1R/BiP complex, suggesting that observed 
inhibitions of SOCE in these two studies occurred during the availability of σ1Rs for 
interaction with other SOCE regulators22. Moreover, upregulation of σ1R reduced the rate 
of NFAT nuclear translocation. Natively, NFAT proteins are found in the cytoplasm of the T 
cells187. To translocate from cytoplasm to nucleus, NFAT requires direct dephosphorylation 
by the Ca2+-regulated phosphatase calcineurin which is activated by CRAC-mediated Ca2+ 
influx. Hence, the rate of NFAT translocation is often used as an independent measure for 
the possible action of protein on SOCE activity. Previously, a negative regulator of SOCE 
called SARAF was characterised by measuring of rate of NFAT translocation131. As part of 
STIM-Orai1 complex, SARAF  promoted a slow inactivation of STIM-dependent SOCE 
activity, possibly by facilitating the de-oligomerization of STIM proteins, and thus, turning off 
Orai-channel to prevent the overload of the cell with excessive Ca2+. During ER Ca2+ 
depletion by SERCA inhibitor BHQ, the rate of NFAT nuclear translocation was inhibited 
after upregulation of SARAF in HEK293 cells and downstream of its regulation of SOCE. 
Upregulation of σ1R yielded equivalent results, suggesting that σ1R inhibited SOCE and 
subsequently, reduced rate of NFAT translocation as a downstream effect of SOCE 
regulation. From pharmacological aspect, this ability of σ1R to reduce NFAT translocation 
is of particular interest as cocaine, known σ1R agonist, compromises immune system188. 
Hence, this result provides an insight into a possible mechanism how the administration of 
σ1R agonist can affect immune system, and what approach, such as administration of σ1R 
antagonist, should be considered to counteract/prevent it.  
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3.4.2 σ1R inhibits SOCE independently of K+ efflux in HEK293 cells 
Gueguinou et al14. reported that σ1R modulates SK3-dependent Ca2+ homeostasis 
by promoting Orai1:SK3 coupling in colorectal and breast cancer cells14. SK3 is small 
conductance Ca2+ activate potassium (K+) channel that hyperpolarizes cell by allowing K+ 
efflux. In mechanism proposed by Gueguinou et al., hyperpolarization of PM via SK3 
channel enhances Ca2+ influx through Orai1 channel. In HEK293 cells, SK3 channels are 
not normally expressed. Nonetheless, for further characterization of  regulation of SOCE by 
σ1R in HEK293 and whether it is coupled to K+ efflux, HEK293 cells expressing σ1R were 
placed in high extracellular K+ (142nM). Firstly, reduced SOCE in WTVC HEK293 cells was 
observed when compared to the previous experiments. This was expected due to 
depolarization of the membrane potential in high extracellular K+ which reduced the electrical 
driving force for Ca2+ entry through Orai1 channels. However, under those conditions, 
enhanced expression of V5-tagged σ1R still inhibited SOCE, suggesting that inhibitory effect 
of σ1R on SOCE in HEK293, as observed by this study, is independent of K+ efflux.  
3.4.1 σ1R inhibits SOCE independently of IP3Rs in HEK293 cells 
Enhanced expression of σ1Rs reduced efflux of Ca2+ from the intracellular stores, 
suggesting reduced ER [Ca2+] concentration. A reduction in ER [Ca2+] might arise from σ1R 
stabilizing type 3 of IP3Rs at MAMs and thereby, enhanced movement of Ca2+ from the ER 
to mitochondria22. Also, σ1R may indirectly promote Ca2+ leak via Sec61 channels. 
Interaction of ER chaperone BiP with Sec61 inhibits ER Ca2+ leak189. Upregulation of σ1R 
might result in increased number of σ1R/BiP  complexes and consequently, enhance Sec61-
mediated Ca2+ leak. Another possibility is that σ1R could also attenuate basal SOCE through 
interaction with STIM2 proteins based on the model by Srivats et al. where σ1R attenuated 
SOCE through interaction with STIM134.  
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The results of this study suggest that reduced Ca2+content of intracellular stores by 
σ1R was most likely a consequence of its interaction with IP3Rs. In IP3R-/- HEK293 stable 
cell line, enhanced expression of σ1R resulted in inhibition of thapsigargin-evoked SOCE 
but failed to significantly reduce store-depletion. Recent study using ER Ca2+ indicator Mag-
Fluo-4 showed enhanced Ca2+ depletion during upregulation of IP3R in HEK293 cells, which 
could also be observed as enhanced rise in cytosolic [Ca2+ ]182. By stabilizing IP3Rs at 
MAMs, σ1R promotes efflux of luminal Ca2+ to mitochondria. Thus, non-significant  reduction 
in ER [Ca2+] content in the absence of IP3Rs could be a result of σ1R inability to promote 
Ca2+ flux from ER to mitochondria. However, this data set lacks additional experiments, such 
as ionomycin-evoked store depletion or measurements using combination of ER- and 
mitochondria-targeted Ca2+ indicators for more precise evaluation of σ1R’s role in the 
regulation of Ca2+ content of intracellular stores.  
Interestingly, these results also show that σ1R can inhibit SOCE in the absence of 
IP3Rs. While a role of IP3Rs as a channel of ER Ca2+ release is well understood, recent 
studies also demonstrated that IP3R could associate with STIM1 proteins which results in 
the modulation of SOCE181,182. Moreover, a subdivision of IP3Rs into “mobile” and “immobile” 
fractions has been proposed to explain the underlying mechanism of IP3Rs regulation of 
Ca2+ influx181. These “immobile” IP3Rs were detected at ER-PM junctions where they served 
as sites of frequent STIM1 accumulation after store-depletion, but precise molecular 
explanation behind this mechanism, or what causes differentiation of “mobile” and 
“immobile” IP3Rs remains unknown. However, combination of FRET experiments with Ca2+ 
assays revealed that association of IP3Rs with STIM1 resulted in reduced intraluminal Ca2+ 
environment at the sites of IP3R/STIM1 interaction which subsequently, increased diameter 
of STIM1/Orai1 puncta and enhanced SOCE182. Hence, current evidence suggests that 
IP3Rs are incorporated into SOCE complex at ER-PM junctions with ability to modulate 
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Ca2+. Both IP3R (type 3) and STIM1 have been reported as σ1R interactive proteins and 
σ1R has been reported in same immunoprecipitated complex with STIM1 and Orai122,34. 
While results in Chapter III do not exclude possibility that σ1R may participate or perhaps, 
modulate the association between IP3R and STIM1, they do demonstrate that the inhibitory 
role of σ1R in the regulation of SOCE is independent of IP3R, its known interactive partner.  
  
125 
 
 
4 Chapter IV:  
Measurements of [Ca2+]cyt at ER-PM junctions and the 
functional role of σ1R in SOCE microdomains 
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4.1 Introduction 
We have shown in Chapter III that σ1R inhibits SOCE during measurements of 
[Ca2+]cyt in a population of cells. Although these measurements of global [Ca2+]cyt provide 
essential information about the functional role of σ1R in the regulation of SOCE, they do not 
provide detailed information about the effects of σ1R on temporal and spatial aspects of 
SOCE within the microdomain of the ER-plasma membrane junction. It is changes here 
which are of key importance for triggering downstream signalling events.   
SOCE occurs at contact sites between the PM and ER membranes, where the 
distance separating the two membranes is below 40 nm. This allows proteins embedded in 
the ER to interact with proteins embedded in the PM190. These ER-PM junctions are 
essential for store-dependent Ca2+ entry. Upon depletion of the ER Ca2+ store, the STIM 
family of ER transmembrane proteins accumulate at the ER-PM junctions where they 
directly interact with phospholipids and PM proteins, in particular, the Orai family of Ca2+ 
channels. This interaction causes the docking, tethering and activation of the Orai1 
channel117,191. The restricted STIM-Orai1 microdomains result in local Ca2+ entry and the 
formation of Ca2+ microdomains, a key feature of Ca2+ signalling that gives a raise to specific 
cellular processes in different regions of the cell192. 
To investigate how σ1R affects Orai1-mediated SOCE, we utilized a targeted Ca2+ 
reporter protein fused to the Orai1 channel, named G-GECO1.2-Orai1193.  The G-GECO1.2-
Orai1 construct encodes for a fully functional Orai1 protein with a genetically encoded 
fluorescent Ca2+ reporter protein, G-GECO1.2, attached to its N-terminal domain. This was 
shown previously to allow the monitoring of Orai1 channel activity in transfected mammalian 
cells. Advantages of utilizing such a construct over electrophysiological techniques include 
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reduced invasiveness and improved spatial information with regards to the location of the 
SOCE response. Combined with total internal reflection fluorescence microscopy (TIRFM), 
that allows for optical sectioning of fluorescent molecules within the immediate vicinity of the 
PM, and a fast EMCCD camera, this approach provides spatial and temporal resolution of 
Orai1 mediated Ca2+ signals within the SOCE microdomain194.   
4.1.1 Aims 
The aim was (1) to develop a reliable method to measure the Orai1-mediated Ca2+ 
signal within the SOCE microdomain and (2) to compare the effect of the σ1R on the 
amplitude of this signal.    
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4.2 Methods 
4.2.1 Analysis procedures for optical recordings with G-GECO1.2-Orai1 and 
TIRFM 
For the analysis of optical measurements of G-GECO1.2-Orai1, we defined and 
implemented several stages of analysis (Figure 4.2.1) that allowed us an efficient and semi-
automated approach for detection, extraction and analysis of G-GECO1.2-Orai1 fluorescent 
traces.  
4.2.1.1 Pre-processing of G-GECO1.2-Orai1 TIRFM recordings  
TIRFM recordings were generated via MicroManager (ome format) and imported into 
Fiji/ImageJ for pre-processing. The pre-processing step consisted of background-
subtraction that was performed by subtracting the baseline image (median filtered, 2x pixel 
radius) from the recording. This step corrected for uneven illumination and camera 
deficiencies. A baseline image and pre-processed recording (BS stack) were saved in an 
original folder (.tiff format).   
4.2.1.2 ROI detection using thresholding based on the Laplace operator 
ROIs were detected in the pre-processed recording in IgorPro7 using an integrated 
set of software tools, named SARFIA (Semi-Automated Routines for Functional Image 
Analysis)195. The segmentation of the recordings was carried out using a threshold 
calculated as a multiple of the standard deviation (SD) of all the pixel values in the Laplace 
operator196. ROIs were then displayed in a temporary window allowing us to verify whether 
ROIs corresponded to visible G-GECO1.2-Orai1 puncta, and to adjust the threshold with 
immediate feedback. In our experiments, we used the threshold of 2.5-3 × SD. 
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4.2.1.3 Fluorescence analysis 
Selected ROIs were converted in the mask that we applied on the G-GECO1.2-Orai1 
pre-processed recording. SARFIA allowed us to extract and compare dynamic fluorescent 
traces for each ROI. Fluorescent traces were extracted as changes in the relative 
fluorescence (RFUs) over a period of time. We normalised each individual trace using two 
methods of normalization. First, we used SARFIA in-built ΔF/F formula where the baseline 
was defined as the bin centre of the highest peak of a histogram of all fluorescence values 
in a given trace. The number of bins was 1 + log2 N, where N was the number of points in 
a given trace.  
As a second normalisation approach, we considered the nature of our Ca2+ reporter 
targeted to Orai1 protein. ROI of G-GECO1.2-Orai1 can consist of a) different number of G-
GECO1.2-Orai1 per active Orai1 channel (1 to 6), and b) clusters of Orai1 channels. 
Therefore, we decided to implement an additional point of reference into our recordings that 
would maximise fluorescent signal for each ROI – Fmax. Fmax was recorded immediately after 
SOCE by treating cells with 5 µM Ionomycin in 2 mM Ca2+, allowing us to acknowledge the 
variation in the number of G-GECO1.2-Orai1 per ROI and normalise each extracted G-
GECO1.2-Orai1 trace using F/Fmax formula. 
4.2.1.4 Hierarchical clustering 
Implementing SARFIA for data analysis allowed us to perform hierarchical clustering 
with extracted and normalised G-GECO1.2-Orai1 traces. Clustering methods are often 
utilized for sorting functional classes of the response. SARFIA allows for comparison of 
traces using different metrics: Pearson’s r, Euclidean, normalised Euclidean, Manhattan, or 
Chebyshev. To sort G-GECO1.2-Orai1 traces into functional classes, we opted for 
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Euclidean metric that has been commonly used for sorting of time-series traces. G-
GECO1.2-Orai1 traces were compared pair-wise to yield a distance matrix where the 
distance between traces provided qualification for the dissimilarity between two traces. 
Within the distance matrix, a distance of 0 indicated a perfect correlation between the traces. 
A cut-off for grouping traces into the same functional cluster was chosen manually as a 
percentage of the highest distance. We used a cut-off of 15% to detect dissimilar G-
GECO1.2-Orai1 traces. Considering the majority of examined traces were grouped within 
the same cluster, suggesting a very similar response, we used hierarchical clustering option 
within SARFIA to define and exclude artefacts from the overall analysis. 
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22 Outline of analysis procedures for optical recordings with G-GECO1.2-Orai1 and TIRFM 
132 
 
4.3 Results 
4.3.1 Determining the angle for TIRFM recordings in ER-PM junctions using 
G-GECO1.2-Orai1 and ER-DsRed co-expression in HEK293 cells 
To perform TIRFM recordings, the angle of incidence has to surpass the critical 
angle. However, the critical angle depends on the refractive index of the sample, and 
biological samples have unknown and variable refractive indices197. Therefore, we co-
expressed G-GECO1.2-Orai1 with ER-DsRed to estimate the angle of incidence for TIRFM 
recordings in ER-PM junctions.  
Figure 4.3.1 shows HEK293 cells expressing G-GECO1.2-Orai1 (green) and ER-
DsRed (red) in epifluorescent and TIRF mode. ER-dsRED is genetically encoded 
fluorescent marker for ER. In the epifluorescent mode, ER-DsRed was distributed in a 
typical, reticular, ER manner, surrounding nuclei and extending towards edges of the cells. 
However, once we manually adjusted the angle for TIRF, surpassing the critical angle, only 
near-PM ER was visible over the entire footprint of the cell. Simultaneously, the distribution 
of G-GECO1.2-Orai1 went from uneven and blurry within the epifluorescent mode of our 
TRIFM, to a sharper and more even distribution across the entire footprint of the cell in TIRF 
mode. These changes in both channels were accompanied by a noticeable change in signal-
to-noise ratios (SNRs) between the biological sample and the background immediately after 
surpassing the critical angle. Across our TIRFM experiments, we used both morphological 
and SNR changes as guidelines for angle adjustments when moving from epifluorescent to 
TIRF mode. 
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23 Epifluorescent and TIRF mode of G-GECO1.2-Orai1 co-expressed with ER-DsRed in HEK293 cells. 
134 
 
4.3.2 Local Ca2+ entry recorded at the PM using G-GECO1.2-Orai1 co-
expressed with PMEM-dTomato in HEK293 cells 
After establishing the angle for TIRFM recordings in ER-PM junctions by G-
GECO1.2-Orai1 and ER-DsRed, we wanted to test whether we could record local Ca2+ influx 
in sub-PM regions, using G-GECO1.2-Orai1. Therefore, G-GECO1.2-Orai1 was co-
expressed with PM marker PMEM-dTomato in HEK293 cells.  
Figure4.3.2 shows HEK293 cells co-expressing G-GECO1.2-Orai1 and PMEM-
dTomato in 0.1 mM EGTA, before treatment (column 1), and in 2 mM Ca2+, after treatment 
with 1 µM Thapsigargin for 6 minutes (column 2). A change of extracellular [Ca2+] to 2mM 
increased G-GECO1.2-Orai1 fluorescence intensity at the PM. Under the same conditions, 
the fluorescence intensity of PMEM-dTomato remained relatively unchanged, suggesting 
that the observed changes in the fluorescence of G-GECO1.2-Orai1 were due to shifting in 
the indicator’s calmodulin domain caused by Ca2+-binding. As G-GECO1.2 is attached to 
the intracellular N-termini of Orai1 protein193, a change in the fluorescent intensity also 
suggests a change in [Ca2+] in the proximity of the intracellular domain of G-GECO1.2-Orai1 
– thus, a local Ca2+ entry. 
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24 Changes in fluorescence of G-GECO1.2-Orai1 co-expressed with PMEM-dTomato in HEK293 cells 
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4.3.3 Local Ca2+ entry recorded using G-GECO1.2-Orai1 co-expressed with 
mCh-STIM-CAD in HEK293 cells 
For further testing of G-GECO1.2-Orai1 on our home-built TIRFM system, G-
GECO1.2-Orai1 was co-expressed with mCh-STIM-CAD what was sufficient to induce 
clustering and activation of Orai1 channels, independently of Ca2+ stores depletion (Figure 
4.34). Considering that co-expression of Orai1 proteins with STIM-CAD domains results in 
the constitutively active Ca2+ entry – which under prolonged conditions is toxic for cells – we 
attempted TIRFM recordings 10-, 15- and 20-hours post-transfection (data not shown). At 
15 hour-point post-co-transfection of HEK293 cells with mCh-STIM-CAD, G-GECO1.2-
Orai1 was expressed at sufficient levels to obtain TIRFM images from healthy-looking cells.  
In the presence of mCh-STIM-CAD and G-GECO1.2-Orai1, we tested for store-
independent Ca2+ dynamics at ER-PM junctions in response to changes in extracellular 
[Ca2+] while recording at a rate of one frame every 5s. Figure 4.33A shows representative 
images of G-GECO1.2-Orai1 (green) and mCh-STIM-CAD (red) co-expressed in HEK293 
cells in 0.2 mM Ca2+ (column 1), 2mM Ca2+ (column 2) and 2 mM EGTA (column 3). 
Figure4.33B shows an average change in the relative fluorescence (RFU) of G-GECO1.2-
Orai1 (green) and mCh-STIM-CAD (red) during a recording. Dashed lines indicate the 
precise time point of image extraction from the recording.  
 A change of [Ca2+]ex from 0.2 mM to 2mM resulted in the robust elevation of G-
GECO1.2-Orai1 fluorescence intensity, while the addition of 2 mM EGTA diminished G-
GECO1.2-Orai1 signal. This result was consistent with previously reported CAD-evoked and 
Orai1-mediated Ca2+ influx105,193. Under the same conditions, the fluorescence intensity of 
mCh-STIM-CAD remained relatively unchanged, suggesting that the observed changes in 
the fluorescence of G-GECO1.2-Orai1 were due to a local Ca2+ entry. 
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25 Changes in fluorescence of G-GECO1.2-Orai1 co-expressed with mCh-STIM-CAD in HEK293 cells 
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4.3.4 A subtraction of initial local background allows for the extraction of 
comparable G-GECO1.2-Orai1 traces 
The TIRFM recordings occur in the evanescent field, which is not discrete, but 
exponentially decays with a distance from the coverslip194,198. Thus, the excitation intensity 
is dependent on the distance of fluorophore from the coverslip, as well as the penetration 
depth of the evanescent field. The advantage of G-GECO1.2-Orai1 is that it is localized in 
the PM (Figure 4.32), resulting in discrete fluorophore distribution and limiting the error of 
data interpretation that can occur due to the distance of fluorophore from the coverslip. 
However, the position and relative fluorescence of the fluorophore can be additionally 
affected by the “flatness” of the cell footprint against the coverslip, as well as uneven 
illumination across the field of view and camera deficiencies.  
To correct for these numerous factors that could impact quantification and 
comparison of G-GECO1.2-Orai1 responses, the initial local background was subtracted. 
We created the median-filtered (2-pixel radius) baseline image and subtracted it from the 
rest of the stack.  
Figure 4.34 compares average images of recordings before (Raw-Stack) and after 
(BS stack) background subtraction. Uneven illumination during TIRFM is apparent in the 
average image of the Raw-Stack (Figure4.34A) where the background intensity (white trace) 
decreased going from left to right of the image. The average image of the BS stack had a 
more even background.  
Figure4.34B compares plot profiles across two cells in 0.2mM and 2mM extracellular 
Ca2+ and 2 mM EGTA. Baseline intensity across two cells in 0.2mM Ca2+ (low Ca2+, Raw 
Stack) resembles an intensity across two cells in 2mM EGTA. After background-subtraction, 
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these intensities were almost nullified within the recording (Figure4.34B, BS-stack), allowing 
us to focus on the change in fluorescence caused by the addition of physiological [Ca2+] (2 
mM).  
Figure4.34C compares G-GECO1.2-Orai1 traces along the plot-line of two cells in 
the field of view (Cell1 and Cell2). In the original recording (Raw image column), G-
GECO1.2-Orai1 traces had a different baseline in 0.2 mM Ca2+, peak in 2 mM Ca2, and 
fluorescent intensity after chelation with 2 mM EGTA. After pre-processing (BS-stack 
column), traces were very similar in 0.2 mM Ca2+ and after chelation with 2 mM EGTA, 
allowing us a better comparison of their peaks in physiological [Ca2+] (2 mM).  
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26 A comparison of raw and pre-processed TIRFM recordings of G-GECO1.2-Orai1 in HEK293 cells. 
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4.3.5 Implementation of SARFIA for analysis facilitates the detection, 
extraction, and analysis of G-GECO1.2-Orai1 fluorescent traces 
Manual detection of ROIs is a time-consuming process that can introduce bias and 
reduce the consistency and accuracy of the obtained dataset, especially when the position 
and relative fluorescence of the fluorophore can affect data quantification. To minimize 
personal bias and increase the consistency, we implemented a set of tools called SARFIA 
for semi-automatic analysis of dynamic imaging experiments using G-GECO1.2-Orai1. 
Figure 4.35 shows an example of ROI detection of G-GECO1.2-Orai1 puncta in 
HEK293 cells. ROIs were obtained using a full focal plane and a threshold calculated as a 
multiple of the standard deviation (SD) of all the pixel values in the Laplace operator (3 x 
SD). During segmentation in SARFIA, a temporary SD-image was produced to allow visual 
comparison between detected ROIs and visible G-GECO1.2-Orai1 puncta. The position and 
size of each ROI were then saved in the ROI mask with the same x and y dimensions as the 
initial image sequence. Based on their position within the focal plane, ROIs were coloured 
and indexed (Figure 4.35A). A visual comparison of SD-image with detected ROIs confirmed 
that chosen ROIs corresponded to the G-GECO1.2-Orai1 in puncta-like structures.  
Overall, 164 ROIs were detected within the representative recording, and further 
analysis of the ROI mask showed that ROIs varied in size. Considering that our 
segmentation parameters excluded ROIs ≤ 2px to exclude off-target regions, our smallest 
ROI consisted of 3 px (~0.72 µm) while the largest was 157 px (~37.56 µm). Frequency 
distribution of ROIs’ size revealed that majority of ROIs were smaller in size (25% percentile 
= 4 px, median = 7 px, 75% percentile = 13 px). However, in comparison to the previously 
reported sizes across the Orai1 hexamer (8 nm) and Orai1 clusters (100 – 200 nm)117, the 
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size of our ROIs suggested that detected G-GECO1.2-Orai1 puncta-like structures 
corresponded to clusters of G-GECO1.2-Orai1 clusters.   
Once ROIs were detected, we applied the ROI mask to the recording to extract G-
GECO1.2-Orai1 time-series information. SARFIA allowed us to assess this information in 
the form of individual traces and fluorescent data showing a change in fluorescence per ROI 
over time. 
 Figure 4.36 shows the extracted time series of G-GECO1.2-Orai1 in both formats – 
individual traces and fluorescent data of changes in relative fluorescence (RFU) per ROI 
over time. Individual traces were then normalized using the ΔF/F formula (Figure 4.36B, see 
4.2 Methods). Following normalization, we performed hierarchical clustering of time-series 
to differentiate between potential functional clusters.  
Figure 4.36C summarizes exemplary responses of G-GECO1.2-Orai1 in the 
presence of mCh-STIM-CAD domain into three distinct categories. The most abundant 
category (Category-1) consisted of traces that were consistent with previously reported 
CAD-evoked and Orai1-mediated Ca2+ influx105,193. The other two categories (Category-2 
and Category-3) made 4.3% of overall traces and consisted of traces exhibiting unusual 
shape due to very slow Ca2+ influx, as well as a slow response to chelation with 2 mM EGTA.  
We traced these traces to the two groups of ROIs, with each category corresponding to the 
particular area at the edge of the cell, which would suggest that the measured functional 
responses within these two categories were most likely results of motion artifact. Led by this 
example, we later performed hierarchical clustering to all G-GECO1.2-Orai1 recordings 
post-normalization. We individually assessed whether detected functional clusters were 
actual SOCE responses – and to be included in the analysis -  or a consequence of motion 
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artefact. Recordings with over 5% of traces that resembled noise or motion artefacts were 
not included in the analysis.   
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27 ROI detection of G-GECO1.2-Orai1 puncta in HEK293 cells using SARFIA in IgorPro. 
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28 Comparison of RFU and normalized G-GECO1.2-Orai1 traces in HEK293 cells using SARFIA in IgorPro 
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4.3.6 Comparison of the expression and subcellular distribution of G-
GECO1.2-Orai1 and G-GECO1.2-Orai1R91W  
Having established the criteria for obtaining reliable TIRFM recordings and the 
analysis of G-GECO1.2-Orai1 datasets, we wanted to ensure that changes in fluorescence, 
as measured with G-GECO1.2-Orai1, genuinely corresponded to the local SOCE mediated 
by Orai1. We therefore looked to generate a non-functional mutant of Orai1 which would 
have similar PM expression but fail to allow Ca2+ influx, thus acting as a negative control. 
The R91W mutation in Orai1 occurs in the region of the channel that lines the pore and it 
was originally identified as a naturally occurring mutation that caused severe combined 
immune deficiency (SCID) syndrome93. Homozygous expression of Orai1R91W mutant 
diminishes CRAC currents, and is shown to have a dominant-negative effect on Orai1 
mediated Ca2+ entry93,199,200.  
The R91W mutation was introduced into G-GECO1.2-Orai1 and initially, the 
expression of this mutant compared to the wild-type G-GECO1.2-Orai1 was done using 
Western blot analysis of HEK293 lysates collected 24h post-transfection with either G-
GECO1.2-Orai1 or G-GECO1.2-Orai1R91W construct (Figure 4.37). Nitrocellulose 
membranes were blotted with primary antibodies targeted to Orai1, and βactin anti-Orai1 
antibody.  
The Western blot in Figure 4.37 shows bands of very similar intensity at the predicted 
size for G-GECO1.2-Orai1 (~80kDa) for the wild-type protein (lane 1) and R91W mutant 
protein (lane 2).  There is more than one band which are likely to correspond to the different 
glycosylation states of Orai1201. β-actin was used as a loading control. The predicted size 
for endogenous Orai1 protein is ~30 kDa for non-glycosylated and ~50 kDa for glycosylated 
Orai1 and we also detected similar levels of the endogenous Orai1 protein. Thus, we 
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conclude that introducing the mutation into Orai1 does not disrupt expression of the reporter-
tagged channel.  
To compare the subcellular distribution of the wild-type and mutant G-GECO1.2-
Orai1, HEK293 cells expressing these proteins were imaged by confocal fluorescence 
microscopy, 24h after transfection. Cells were treated with 5 µM ionomycin in 2mM Ca2+ 
HBSS, to saturate the Ca2+ binding sites of G-GECO1.2 and maximize the fluorescence 
signal and images obtained as shown in Figure 4.38.  These single confocal optical sections 
show that both proteins exhibited a similar distribution. Plot profiles of the relative 
fluorescence intensity for G-GECO1.2-Orai1 and G-GECO1.2- Orai1R91W (Fig4.38B) 
demonstrated intensity peaks at the edges of the cells, suggesting plasma membrane 
targeting for both for G-GECO1.2-Orai1 and G-GECO1.2- Orai1R91W.  
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29 Western blot analysis of G–GECO1.2–Orai1 and G-GECO1.2-Orai1R91W in HEK293 cells 
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30 Membrane targeting of G–GECO1.2–Orai1 and G-GECO1.2-Orai1R91W 
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4.3.7 G-GECO1.2-Orai1R91W blocked Orai1-mediated SOCE 
Before testing the effect of G-GECO1.2-Orai1R91W on Orai1-mediated SOCE by 
TIRFM, we utilized an epifluorescent microscope which allowed us to have more cells per 
field of view (~ 30 cells), and to record at a faster rate (1 frame/s) while avoiding 
photobleaching. Recordings were made 24 hours after transfection of HEK293 cells with G-
GECO1.2-Orai1 constructs by putting cells in Ca2+-free HBSS with 0.1 mM EGTA for 1 min 
and applying 1 µM thapsigargin for an additional 5 min. Following this,  2 mM Ca2+ was 
applied for 5 min to measure SOCE, and finally 5 µM ionomycin was added to provide the 
maximal response (Fmax) (Figure 4.39).   
Representative images for G-GECO1.2-Orai1 and GECO1.2-Orai1 R91W  are shown 
in Figure 4.39. Following 5-min treatment with 1 µM thapsigargin, the addition of extracellular 
2 mM Ca2+ caused very little or no change in intensity of GECO1.2-Orai1 R91W whilst clearly 
increasing G-GECO1.2-Orai1 fluorescence. Only after addition of 5 µM ionomycin was there 
an increase in intensity for both constructs. This suggests that the R91W mutation blocks 
the Orai1-mediated SOCE response.   
Figure 4.310B shows representative traces for G-GECO1.2-Orai1 and GECO1.2-
Orai1 R91W and each grey trace corresponds to the change of intensity within a single ROI 
normalized to its Fmax value (F/Fmax). Black and red traces show average ± SEM traces for 
G-GECO1.2-Orai1 and GECO1.2-Orai1 R91W, respectively. Only the last two-minutes of 
thapsigargin treatment and five minutes post Ca2+ addition are shown, to illustrate the 
difference in SOCE.  The box-and-whiskers plot in Figure 4.310C compares the peak 
amplitude of the SOCE response for G-GECO1.2-Orai1 and GECO1.2-Orai1 R91W. The data 
was analysed using the Mann–Whitney test and α of 0.05; SOCE measured with G-
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GECO1.2-Orai1 (0.4343) was significantly higher in comparison to SOCE measured with  
GECO1.2-Orai1 R91W (0.03863; ****, P < 0.0001). 
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31 G-GECO1.2-Orai1R91W blocks Ca2+ influx (SOCE) in HEK293 cells 
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32 Quantification of G-GECO1.2-Orai1- and G-GECO1.2-Orai1R91W- measured SOCE in HEK293 cells 
Fig4.310 Quantification of the G-GECO1.2-Orai1 and 
G-GECO1.2-Orai1R91W measured SOCE in HEK293 
cells. A) Illustration of G-GECO1.2-Orai1 and G-
GECO1.2-Orai1R91W experimental design.  B) 
Representative average traces of G-GECO1.2-Orai1 
(black) and G-GECO1.2-Orai1R91W (red) during SOCE. 
Grey traces show individual measurements within the 
recordings. Blue dashed line indicates addition of 2 
mM Ca2+ following store depletion. Scale bar = 50% 
F/Fmax in y-direction and 100 s in x-direction. C) Box-
and-whisker plot summary of Ca2+ influx (peaks) 
across three independent experiments (n=3). 
Whiskers show maximum and minimum of entire 
dataset. Boxes show upper, middle and lower quartile 
of entire dataset. The plus (+) sign marks mean. G-
GECO1.2-Orai1 and G-GECO1.2-Orai1R91W medians 
(0.4343 and 0.03863, respectively) were compared 
with the Mann-Whitney test. ****,P<0.0001.  
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4.3.8 G-GECO1.2-Orai1R91W blocked Orai1-mediated SOCE at ER-PM junctions 
To confirm G-GECO1.2-Orai1 also measures Orai1-mediated SOCE at ER-PM 
junction microdomains, TIRFM was used. Figure 4.311 shows representative images from 
cells expressing either G-GECO1.2-Orai1 or GECO1.2-Orai1 R91W. Following 5-min 
treatment with 1 µM thapsigargin, the addition of extracellular 2 mM Ca2+ caused very little 
or no change in the intensity of GECO1.2-Orai1R91W and only following the addition of 5 µM 
ionomycin did fluorescence increase.  The intensity of each ROI normalized locally  using 
ΔF/F (B) or F/Fmax (C) formula is shown in Figure 4.311 B and C.  
 Both normalization methods of TIRFM data obtained using the G-GECO1.2-Orai1 
constructs yielded very similar results. Therefore, we proceeded with the quantification of 
G-GECO1.2-Orai1 and GECO1.2-Orai1 R91W traces obtained using TIRFM in the same 
manner as we did with G-GECO1.2-Orai1 and GECO1.2-Orai1 R91W traces obtained using 
epifluorescent microscopy; we normalized each trace with its local Fmax using F/Fmax formula. 
Figure 4.312 shows representative traces for G-GECO1.2-Orai1 and GECO1.2-Orai1 R91W . 
Each grey trace corresponds to the change of intensity within a single ROI normalized to its 
Fmax value (F/Fmax). Black and red traces show average traces ±SEM for G-GECO1.2-Orai1 
and GECO1.2-Orai1 R91W, respectively. Figure 4.312B summarizes the effects of the R91W 
mutation on the SOCE response and again, SOCE measured with G-GECO1.2-Orai1 was 
significantly higher compared to SOCE measured with  GECO1.2-Orai1 R91W (****, P < 
0.0001). This indicates that using G-GECO1.2-Orai1, the fluorescence signal recorded 
following the addition of Ca2+, is dominated by Ca2+ entry through the G-GECO1.2-Orai1 
channel itself. There is minimal contamination of the response by Ca2+ entry through a 
different route.   
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33 G-GECO1.2-Orai1R91W blocks SOCE in ER-PM microdomains of HEK293 cells. 
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34 Quantification of SOCE (peak) for G-GECO1.2-Orai1 and G-GECO1.2-Orai1R91W in HEK293 cells. 
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4.3.9 σ1R-V5 reduces Orai1-mediated SOCE in ER-PM microdomains  
Utilizing this approach, the effects of σ1R expression on Orai1-mediated SOCE were 
tested. HEK293 cells were transduced 6h after plating using WTVC and σ1R-V5 baculovirus 
and the following day transfected with G-GECO1.2-Orai1. TIRFM recordings were made 
24h later.  
Figure 4.313 shows representative images and fluorescent data of G-GECO1.2-
Orai1 after infection with either WTVC or σ1R-V5. Following 6-min treatment with 1 µM 
thapsigargin, the addition of extracellular 2 mM Ca2+ caused an increase in the intensity of 
GECO1.2-Orai1 in both WTVC and σ1R-V5 HEK293 cells. The intensity as well as the 
kinetics of the SOCE response appeared to be different in cells expressing σ1R-V5.  
 Figure 4.314A shows representative traces with each grey trace corresponds to the 
change of intensity within a single ROI normalized to its Fmax value (F/Fmax) and the average 
traces shown in black and red as before. The results are summarized in the box-and-
whiskers plot in Figure 4.314B and SOCE measured in cells transduced with σ1R-V5 was 
significantly lower than in cells infected with the control virus  (P < 0.0001), suggesting σ1R-
V5 reduces Orai1-mediated SOCE in ER-PM microdomains.   
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35 σ1R-V5 reduces G-GECO1.2-Orai1-mediated SOCE in HEK293 cells 
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36 Quantification of G-GECO1.2-Orai1-mediated SOCE in WTVC and σ1R-V5 HEK293 cells 
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4.3.10 Segmentation and ROI size does not affect the final result 
In section 4.35 of this chapter, we reported how segmentation as a method of semi-
automated determination of G-GECO1.2-Orai1 puncta yielded ROIs of different sizes. 
Following the result that σ1R reduced local Orai1-mediated SOCE, we wanted to test 
whether the method of segmentation and ROI size had an impact on the quantification of 
local SOCE in WTVC and σ1R-V5 HEK293 cells.  
Figure 4.315A shows relative frequencies of G-GECO1.2-Orai1 ROI sizes (pixels) in 
WTVC (black) and σ1R-V5 (red)  HEK293 cells. Relative frequencies of G-GECO1.2-Orai1 
ROI sizes were obtained using three different SD values. As before, the threshold for ROI 
detection was calculated as a multiple of the standard deviation (SD) of all the pixel values 
in the Laplace operator; (1) 2xSD (SD2), (2) 3x SD (SD3), and (3) 4xSD (SD4). Under all 
three conditions of segmentation, ROI sizes were very similar and predominantly small in 
size.  
Figure 4.315B and C show a comparison of G-GECO1.2-Orai1 traces from WTVC (B) 
and σ1R-V5 (C) HEK293 cells obtained using threshold of SD2 (column 1), SD3 (column 2) 
and SD4 (column 3). The SD criteria for segmentation did not affect the final shape of G-
GECO1.2-Orai1 traces. Also, the quantification of SOCE as the ratio between local SOCE 
intensity and local Fmax intensity resulted in a 3% difference between SD2 and SD4 traces 
for G-GECO1.2-Orai1 in both  WTVC and σ1R-V5 HEK293 cells. Figure 4.315D shows the 
average±SD ROI sizes in  WTVC and σ1R-V5 HEK293 cells while using different threshold 
levels during segmentation.  
Considering that for analysis we used SD values between 2.5 and 3 SDs and that 
previously reported the difference in SOCE between WTVC and σ1R-V5 HEK293 cells was 
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~8%, the results summarized in Figure 4.315 suggest that the segmentation method and 
ROI size did not affect the final result in section 4.39. 
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37 Segmentation and ROI size do not affect SOCE quantification 
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4.3.11 σ1R-V5 reduces the frequency of highly-potentiated SOCE and affects 
its activation and deactivation kinetics  
The segmentation method groups neighbouring pixels into ROI based on the 
provided criteria, such as multiplicity of SD. A grouping as such can potentially hide outliers 
among the neighbouring pixels whilst providing their average. To understand how 
segmentation affects measured SOCE, we decided to extract individual pixels from ROIs 
and measure SOCE within each pixel normalized with its local Fmax value. The size of the 
pixel in TIRFM recordings was ~240nm which was closer to the previously reported size of 
Orai1 cluster (100 – 200nm)117 than the smallest ROI size (3px = 720nm). 
 Figure 4.316 compares results for G-GECO1.2-Orai1-measured SOCE in WTVC and 
σ1R-V5 HEK293 cells obtained using ROIs (column 1) and individual pixels (column 2). 
Quantification of SOCE at pixel-level also revealed that overexpression of σ1R-V5 
significantly reduced this process (0.3528 in WTVCHEK293 cells; 0.2289 in σ1R-V5 HEK293; 
**, p <0.009 ), suggesting that the segmentation method and ROI size did not affect SOCE 
quantification. However, with this approach, there was an increase in the SOCE range in 
σ1R-V5 HEK293 cells, suggesting the existence of highly-active Orai1 clusters ( SOCE > 
0.5 Fmax ) which were undetected using ROIs, possibility because of the surrounding, less-
active Orai1 clusters. Also, we noticed that most of the SOCE in σ1R-V5 HEK293 cells 
occurred within a very narrow range between 0.1536 of Fmax (25% percentile) and 0.2813 of 
Fmax (75% percentile). For comparison, most of the SOCE in WTVCHEK293 cells occurred 
within a range between 0.1924 of Fmax (25% percentile) and 0.5310 of Fmax (75% percentile). 
A further comparison of relative frequencies for local SOCE in WTVC and σ1R-V5 HEK293 
cells (Figure 4.316B) showed that, while the most frequent activity of local SOCE in both 
WTVC and σ1R-V5 HEK293 cells was ~0.20 of Fmax, highly-active Orai1 clusters were more 
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frequent in WTVCHEK293 cells. This result suggested that overexpression of σ1R allowed 
for tighter regulation of Orai1-mediated SOCE.   
Additionally, we compared the kinetics of Orai1-mediated SOCE in WTVC and σ1R-
V5 HEK293 cells using dataset normalized at pixel-level. Highly-active Orai1 clusters ( 
SOCE > 0.5 Fmax ) were used for the comparison as they provided the more robust 
fluorescent signal. Figure 4.317A shows fluorescent data containing 50 Fmax-normalised 
pixels obtained from WTVC and σ1R-V5 HEK293 cells. Figure 4.317B shows five individual 
traces extracted from the fluorescent data with a similar SOCE (peak) response. Highly-
active Orai1 clusters from σ1R-V5 HEK293 cells exhibited slower activation, and steeper 
deactivation kinetics.  
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38 Comparison of G-GECO1.2-Orai1-measured SOCE in WTVC and σ1R-V5 HEK293 cells using ROIs and 
individual pixels 
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39 Comparison of highly-active Orai1 clusters in WTVC and σ1R-V5 HEK293 cells 
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4.4 Discussion 
4.4.1 σ1R reduces frequency of highly active G-GECO1.2-Orai1 clusters 
As in Chapter III, enhanced expression of σ1R-V5 in HEK293 cells reduced 
cumulative SOCE. Co-expression of G-GECO1.2-Orai1 with ER- and PM-markers (Section 
4.31-4.32) confirmed that these SOCE measurements occurred at ER-PM junctions where 
TIRFM allowed for optical sectioning of fluorescent molecules within the immediate vicinity 
of the PM. Introducing dominant-negative mutant G-GECO1.2-Orai1R91W into the 
experimental design facilitated characterisation of measured Ca2+ influx as SOCE. SOCE 
measured by G-GECO1.2-Orai1 was significantly higher compared to SOCE measured with  
GECO1.2-Orai1 R91W (****, P < 0.0001) (Section 4.37-4.38), indicating that G-GECO1.2-
Orai1 truly measured Ca2+ entry occurring through the SOCE/CRAC channel and that there 
was a minimal contamination by Ca2+ entry through a different route. This also implies that 
enhanced expression of σ1R results in the inhibition of SOCE, as observed in Section 4.39, 
right at the point of Ca2+ entry  
Several advantages of utilizing G-GECO1.2-Orai1 construct over 
electrophysiological techniques include reduced invasiveness and improved spatial 
information with regards to the location of the SOCE response.  Surprisingly, overexpression 
of σ1R-V5 had more modest local effect within SOCE microdomain than initially predicted. 
This prediction had several previously established premises. Overexpression of Orai1 can 
result in changes of Orai1/STIM stoichiometry which determines the effectiveness of Orai1 
channel activation126. Also, Srivats et al. proposed that by translocating with STIM1 to ER-
PM junctions, σ1R reduced effectiveness of STIM1-binding to Orai134.Thus, I initially 
predicted that due to overexpression of G-GECO1.2-Orai1, σ1R would exert greater 
inhibitory effect within SOCE microdomains than observed during the measurements of 
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global Ca2+ influx. However, the comparison of SOCE frequencies (Fig. 4316) revealed that 
enhanced expression of σ1R simply resulted in a tighter control of Ca2+influx when 
compared to WTVC HEK293 cells. This result calls for further investigation as current model 
of SOCE modulation by σ1R - where σ1R simply reduces effectiveness of STIM1 binding to 
Orai1- does not entirely explain this result. Reduced frequency of highly active G-GECO1.2-
Orai1 clusters, while maintaining clusters of lower activity would suggest that  σ1R exerts its 
inhibitory effect by lowering the effectiveness of Orai1 activation, but not necessary the 
effectiveness of STIM1 binding to Orai1. This could be better explained by reduced number 
of STIM oligomers within STIM1/Orai1 complex, as observed by Srivats et al34. This study 
also proposed that σ1R requires STIM1 to translocate to ER-PM junction. Thus, to modulate 
SOCE, σ1R requires transport with its STIM1 “carrier” to the location of Orai1 activation, 
possibly reducing interaction of STIM oligomers in a process and number of STIM oligomers 
within SOCE microdomain complex.  
Further insights in the mechanism of SOCE modulation by σ1R could perhaps be 
withdrawn from the studies of its ability to modulate NMDARs. σ1R modulate synaptic 
plasticity, by enhancing NMDARs’ function202. At the first sight, this contradicts with the 
neuroprotective role of σ1R as excessive Ca2+ influx via activated NMDAR can cause 
excitotoxicity. However, while enhancing NMDARs’ function allowing Ca2+ influx,  σ1R also 
inhibits interaction of GluN2B, NMDAR subunit, with other interactive partners preventing 
excitotoxicity. Hence, during modulation of NMDARs, σ1R exerts dual role. It is also possible 
that during Orai1 activation, σ1R modulates SOCE complex in several ways promoting its 
partial activation but simultaneously preventing large Ca2+ influx. Comparison of highly active 
Orai1 clusters between WTVC and σ1R-V5 HEK293 (Fig.4.317) revealed slower activation 
but also steeper deactivation kinetics in the presence of σ1R. This suggest more complex 
role of σ1R within the SOCE complex and requires further investigation. 
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5 Chapter V 
Investigating the functional role of σ1RE102Q in the 
regulation of SOCE  
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5.1 Introduction 
Amyotrophic lateral sclerosis (ALS) emerges as the selective degeneration of motor 
neurons in the brain and spinal cord, resulting in the muscle weakness. σ1R is 
neuroprotective ER chaperone. E102Q mutation of σ1R has been identified as a cause of 
the juvenile-onset form of ALS36. Also, intracellular aggregates of σ1RE102Q have been 
reported as part of ALS pathology in lymphoblastoid cells of fALS patient, inducing 
mitochondrial toxicity and disrupting Ca2+ exchange at the MAM159,203. 
In 2017, Dreser et al. reported that activation of SOCE by ionomycin treatment 
significantly increased intracellular Ca2+ in breast cancer cell line MCF-7 expressing σ1R, 
but not in MCF-7 cells expressing σ1RE102Q 159. Considering expression of σ1RE102Q also 
disrupted Ca2+ exchange at the MAM, this study characterised σ1RE102Q as loss-of-function 
mutant. However, reported effect of σ1RE102Q supports one14, but conflicts with other two 
studies on the regulation of SOCE by σ1R34,158 . The conclusions of latter studies are 
experimentally supported in Chapter III and Chapter IV of this thesis.  
5.1.1 Aims 
(1) To determine whether the enhanced expression of ALS-inducing mutant σ1RE102Q 
affects SOCE. 
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5.2 Results 
5.2.1 The σ1R-V5E102Q  mutant is detected as a dimer using Western blot 
analysis 
To create cDNA for the σ1R-V5E102Q mutant, the single-point mutation was introduced 
into cDNA for σ1R-V5. Additionally, cDNA for “untagged” σ1R was created introducing stop 
codon into σ1R-V5 cDNA before the sequence for V5-epitope. A newly-created σ1R plasmid 
was used to create σ1RE102Q. All new cDNAs were verified by sequencing. The expression 
of σ1R, σ1RE102Q, σ1R-V5, and σ1R-V5E102Q in HEK293 cells was analysed by Western 
blotting.    
Fig5.21A shows protein levels of σ1R in lysates of HEK293 cells 24h and 48h after 
transfection with mock (WT), σ1R, σ1RE102Q and si-σ1R RNA. Overexpression of plasmid 
coding for σ1R resulted in increased levels of σ1R detected at ~ 25kDa – which is predicted 
protein size of σ1R monomer. Overexpression of σ1RE102Q resulted in no detectable 
upregulation of σ1R at ~ 25kDa.  
Fig5.21B shows protein levels of σ1R-V5 in lysates of HEK293 cells 24h and 48h 
after transfection with mock (WT), σ1R-V5, and σ1R-V5E102Q. Overexpression of plasmid 
coding for σ1R-V5 resulted in increased levels of σ1R slightly above 25kDa. Overexpression 
of σ1R-V5E102Q resulted in lesser protein levels of σ1R at the same molecular weight. The 
detected expression of σ1R-V5E102Q using 20µg of lysate was lower than the expression of 
σ1R-V5 using 10µg of lysates collected at 24h and 48h post-transfection.  
Further Western blot analysis of σ1R-V5E102Q expression in HEK293 cells resulted in 
detection of σ1R expression at higher molecular weight, slightly above 50kDa (Fig5.22).  
The expression of σ1R-V5 was also detected at a similar molecular weight (Fig5.22B) but in 
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a lesser amount (Fig5.22). Additionally, the expression of σ1R was detected slightly below 
50kDa (Fig5.22B). Considering cDNAs of σ1R, σ1R-V5, and σ1R-V5E102Q are delivered into 
the cell using the same type of vector (pcDNA3.1/V5-His-TOPO), and that the size of 
detected band changes with expression of V5-tagged and untagged protein, this result 
suggests increased clustering of σ1R-V5E102Q  mutant. This result is also in agreement with 
the initial report about E102Q mutation where σ1RE102Q was detected as a complex at ~ 
50kDa (instead of ~25kDa) even in the buffers containing 150mM DTT and 2% Triton‐X36.  
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Figure 40Western blot analysis of σ1R, σ1RE102Q and σ1R-V5E102Q expression in HEK293 cells 
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Figure 41 Western blot analysis of σ1R-V5E102Q expression in HEK293 cells 
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5.2.2 Overexpression of σ1R-V5E102Q  fails to inhibit SOCE in HEK293 cells 
To investigate the functional role of σ1RE102Q in the regulation of SOCE, the σ1R-
V5E102Q   was overexpressed in HEK293 cells and changes in [Ca2+]cyt were measured using 
GCaMP6f and Flexstation III microplate reader 48h post-transfection.  
Fig5.23 shows GCaMP6f traces of HEK293 cells expressing GCaMP6f-only (WT; 
black), σ1R (red), σ1R-V5 (green) and  σ1R-V5E102Q (purple). Cells were treated with 1µM 
of thapsigargin in nominal Ca2+-free NES followed by the restoration of 2 mM extracellular 
Ca2+. SOCE peaks of HEK293 cells were compared with one-way ANOVA using α of 0.05. 
The overexpression of σ1R and σ1R-V5 resulted in a significant decrease of SOCE 
(Fig5.23B, ****, P < 0.0001). The overexpression of σ1R-V5E102Q resulted in SOCE which 
was not significantly different in comparison to WT cells (Fig5.23B, n.s., P>0.05), but 
significantly increased in comparison to HEK293 cells expressing σ1R-V5 (Fig5.23B, ****, P 
< 0.0001). Results of statistical analysis have been summarized in Table 5.21. 
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Figure 42 Overexpression of σ1R-V5E102Q fails to inhibit SOCE in a σ1R- and σ1R-V5- manner 
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Group 
SOCE 
Mean± 
SEM 
N 
ANOVA       
SOCE 
σ1R 
ANOVA       
SOCE 
σ1R-V5 
 
ANOVA    
SOCE 
σ1R-V5E102Q 
WT 
0.4736 
±0.02305 
18 
****, P < 
0.0001 
 
****, P < 
0.0001 
 
n.s, P > 0.05 
σ1R 
0.3275 
±0.01733 
18  n.s, P > 0.05 
 
****, P < 
0.0001 
σ1R-V5 
0.2948 
±0.01774 
18   
 
****, P < 
0.0001 
σ1R-V5E102Q 
0.5263± 
0.02414 
18    
Table 5.2-1 Summary of one-way ANOVA tests for GCaMP6f-measured SOCE during overexpression of 
different σ1R constructs. SOCE measurements (Peaks, Fig 5.23) were taken across three independent 
experiments (n=3). A population of HEK293 cells within one well of 96W plate was used as a biological replicate 
(N) for statistical analysis. 
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5.2.3 The comparison of σ1R-mKate and σ1R-mKateE102Q  expression in HeLa 
cells 
In addition to previously introduced σ1R and σ1RE102Q constructs, I also created 
E102Q σ1R-mutant using σ1R-mKate construct which had been utilized in TIRFM studies 
by Srivats et al34.  Srivats et al. demonstrated that σ1R-mKate co-localizes with Orai1-EGFP 
following Ca2+ store-depletion of HeLa cells expressing HA-STIM1. Before the investigation 
of σ1RE102Q functional role in SOCE microdomains utilizing novel σ1R-mKateE102Q construct, 
its subcellular and cellular expression was compared to σ1R-mKate using confocal 
microscopy.   
Fig5.24 shows the subcellular distribution of σ1R-mKate in HeLa cells 48h after 
transfection. Fig5.25 shows the subcellular distribution of σ1R-mKateE102Q in HeLa cells 48h 
after transfection. Both mKate-tagged  σ1Rs expressed in a predominantly reticular shape. 
No significant aggregation of intracellular σ1R-mKateE102Q has been detected which 
contradicts results of the previous study by Dreser et al 159. Their study reported σ1RE102Q 
aggregates in primary lymphoblastoid cells derived from E102Q-SigR1 fALS patients, and 
in the MCF-7 cells.  
Fig5.26 compares the cellular expression of σ1R-mKate and σ1R-mKateE102Q in 
three different populations of HeLa cells 48h after transfection. Under identical recording 
conditions, higher intensity of σ1R-mKate was detected in comparison to  σ1R-mKateE102Q, 
suggesting higher levels of σ1R-mKate expression.  
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Figure 43 Subcellular distribution of σ1R-mKate 
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Figure 44 Subcellular distribution of σ1R-mKateE102Q 
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Figure 45 Comparison of σ1R-mKate and σ1R-mKateE102Q expression 48h post-transfection 
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5.2.4 σ1R-mKateE102Q  fails to inhibit Ca2+ influx in SOCE microdomains 
To investigate the functional role of σ1RE102Q in SOCE microdomains, σ1R-mKate  
and σ1R-mKateE102Q  were co-expressed with G-GECO1.2-Orai1 in HEK293 cells. 
Additionally, G-GECO1.2-Orai1 was co-expressed with ER-dsRED to mimic the σ1R’s ER 
distribution and the expression for the red channel. Changes in [Ca2+]cyt within SOCE 
microdomains were measured in HEK293 cells 48h post-transfection with G-GECO1.2-
Orai1 and using TIRFM. 
Fig5.27 shows representative TIRFM images of G-GECO1.2-Orai1 co-expressed 
with ER-dsRed (row1), σ1R-mKate (row2) and σ1R-mKateE102Q   in 0.1 mM EGTA (column 
1), 2mM Ca2+ (column 2) and 2mM Ca2+ with 5 µM Ionomycin (column 3). G-GECO1.2-
Orai1-measured SOCEs (peaks) were compared with the Kruskal-Wallis test using α of 0.05. 
In comparison to ER-dsRED, overexpression of σ1R-mKate significantly inhibited SOCE 
(Fig5.28, ***, P < 0.001). In comparison to ER-dsRED, overexpression of σ1R-mKateE102Q 
failed to significantly inhibit SOCE (Fig5.28, ***, P < 0.001). Results of statistical analysis 
have been summarized in Table 5.22. 
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Figure 46 σ1R-mKateE102Q  fails to inhibit Ca2+ influx in SOCE microdomains 
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Figure 47 Quantification of G-GECO1.2-Orai1-measured SOCE (peak) in HEK293 cells expressing ER-dsRED, 
σ1R-mKate and σ1R-mKateE102Q 
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Table 5.2-2 Summary of Kruskal-Wallis test for G-GECO1.2-Orai1-measured SOCE during overexpression of 
σ1R-mKate and σ1R-mKateE102Q constructs. SOCE measurements (Peaks, Fig 5.28) were taken across three 
independent experiments (n=3). Positionally-grouped ROIs were used as a biological replicate (N) for 
statistical analysis. 
  
Group Median  Mean±SEM N 
Kruskal-Wallis  
G-GECO1.2-Orai1+ 
σ1R-mKate 
Kruskal-Wallis  
G-GECO1.2-Orai1+ 
σ1R-mKateE102Q 
G-GECO1.2-
Orai1+ER-dsRED 
0.6330 0.6155±0.05699 30 ***, P < 0.001 n.s, P > 0.05 
G-GECO1.2-
Orai1+σ1R-mKate 
0.3322 0.3490±0.03638 36  **, P < 0.01 
G-GECO1.2-
Orai1+σ1R-
mKateE102Q  
0.4639 0.5396±0.04202 30   
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5.3 Discussion 
5.3.1 σ1RE102Q fails to effectively inhibit SOCE  
In this chapter, the effect of σ1RE102Q in the regulation of SOCE was tested using 
both GCaMP6f and G-GECO1.2-Orai1. Enhanced expression of  σ1R-V5 E102Q failed to 
inhibit SOCE in the population of HEK293 cells while σ1R-mKateE102Q exerted similar 
cumulative effect in SOCE microdomains. During western blot analysis of total protein 
expression, σ1R-V5 E102Q was detected as a complex  at ~ 50kDa (instead of ~25kDa) which 
is in agreement with previous report36. During fluorescent analysis of σ1R-mKateE102Q no 
significantly different protein aggregation was detected when compared to σ1R-mKate. This 
result is not in agreement with the most recent study which reported increased aggregation 
of σ1R-V5 E102Q in primary lymphoblastoid cells (PLCs) derived from E102Q-SigR1 fALS 
patients, and MCF-7 cell line159.  
Genotyping studies using single nucleotide polymorphism (SNP) approach identified 
E102Q-mutant of σ1R in the genomic DNA of patients diagnosed with juvenile-onset of 
ALS36. This study reported a shift of the σ1RE102Q to membranes of  lower density during 
sucrose gradient fractionation and the strong hydrophobic interaction between the 
monomers even in the buffers containing 150mM DTT and 2% Triton‐X 36. The results of the 
western blot analysis in this chapter support this report. When compared to the 
overexpression of “untagged” σ1R and σ1R-V5, overexpression of σ1R-V5E102Qresulted in 
the formation of complex detected slightly above 50kDa (Fig 5.22). Faint bands of similar 
sizes were also detected when overexpressing “untagged” σ1R and σ1R-V5, but majority of 
their protein expressions was still detected at size predicted for σ1R monomers. This 
suggests that E102Q-mutation indeed increases interaction between the monomers, 
especially considering all three constructs were delivered using the same type of vector 
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(pcDNA3.1/V5-His-TOPO). Functionally, the enhanced expression of both “untagged” σ1R 
and σ1R-V5 inhibited SOCE, suggesting that the small V5 epitope does not alter protein’ s 
function. Overexpression of σ1R-V5E102Q failed to inhibit SOCE, suggesting that E102Q point 
mutation results in the loss-of-function mutant. 
Following overexpression of σ1R-mKateE102Q in HeLa cells, no significantly different 
levels of protein aggregation were detected in comparison to σ1R-mKate. This result 
diverges from previous reports36,159, and suggests that fusion of large mKate fluorescent tag 
may have altered its subcellular distribution. However, earlier investigations of σ1R role in 
lipid trafficking reported only large-epitopes fused to its N-terminus to alter σ1R’s distribution 
and function, but not the epitopes fused to its C-terminus59. Additionally, the expression of 
σ1R-mKate and σ1R-mKateE102Q  was compared in HeLa cells 48h after transfection. Less 
σ1R-mKateE102Q expression was detected across three wide field-of-views using confocal 
microscopy. However, using TIRFM, the rich expression σ1R-mKateE102Q was successfully 
detected in SOCE microdomains (Fig 5.27). Calcium assay using G-GECO1.2-Orai1 
resulted in overall failure of σ1R-mKateE102Q to inhibit SOCE. However, comparing G-
GECO1.2-Orai1-measured SOCE peaks of cells expressing ER-dsRED and σ1R-mKate 
E102Q there is notable lower average, median and 25th percentile in cells expressing σ1R-
mKate E102Q. Comparing their traces, cells expressing σ1R-mKate E102Q have mixture of 
responses resembling both highly active G-GECO1.2-Orai1 clusters of ER-dsRED group, 
as well as reduced-activity of G-GECO1.2-Orai1 clusters observed in σ1R-mKate. These 
results suggest that σ1R-E102Q may still have ability to inhibit SOCE but increase in the 
hydrophobic interaction between its monomers decreases its effectiveness to do so.   
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6 Chapter VI 
Investigating the interaction of 1R with STIM1 and 
STIM2 during store-depletion 
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6.1  Introduction 
The results of Srivats et al.34 suggest that 1Rs inhibit SOCE by interacting with 
STIM1 and attenuating its coupling to Orai1. In addition to STIM1, Orai1-mediated SOCE 
can be regulated by another member of STIM protein family, STIM2, including its splice 
variant STIM2.1116,204. Despite STIM proteins sharing a highly conserved protein structure, 
there are some differences in their N-terminal Ca2+ sensing domains and Orai1-coupling 
SOAR domains which result in distinct functional properties103. This prompted us to address 
whether 1R also regulates STIM2/Orai1-mediated SOCE. 
In comparison to STIM1, STIM2 binds Ca2+ with lower affinity and has been identified 
as a weaker coupling partner to Orai1103. While STIM1 has been identified as a main 
activator of SOCE in non-excitable cells, STIM2 has been proposed to be a regulator of 
basal SOCE, responding to relatively small drops in the ER [Ca2+]. In 2015, two groups 
independently identified STIM2 splice variants STIM2.1, and STIM2.2116,204. Using 
conventional PCR, Miederer et al.116 tested for splice-specific expression in several cell lines 
and tissues and detected STIM2.1 and STIM2.2 in all tested human cell lines and primary 
cells, identifying STIM2.2 as a predominant expressed variant. Functional analysis of these 
two variants revealed that STIM2.1 is a negative regulator of SOCE in contrast to STIM2.2 
which is a positive regulator. Additionally, Rana et al.204  proposed that STIM2.1 exerts a 
dominant negative effect on STIM1, although this was disputed by Zhou et al.117, who 
showed that concatenated STIM1/STIM2.1 SOAR heterodimers fully activate Orai1 
channels.  
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6.1.1 Aim 
Given the importance of STIM2 as a regulator of SOCE, particularly in the central 
nervous system where it is known to have a neuroprotective role, the aim of my study was 
as follows: 
(1) To determine whether σ1R interact with both STIM1 and STIM2 isoforms in situ.  
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6.2 Methods 
6.2.1 Immunofluorescence (IF) 
HeLa cells were seeded onto sterile, PBS-rinsed, collagen-coated 13 mm coverslips 
individually placed into 24W plates. Cells were transduced with either WTVC or σ1R-V5 
baculovirus as previously described Chapter II, Section 2.4. Before fixation, cells were 
washed once with pre-warmed HBSS (37 °C). Cells were fixed with 4% paraformaldehyde 
for 20 minutes at room temperature, followed by three washes in PBS. Blocking and 
permeabilization was performed by applying Blocking Solution I (1% saponin, Sigma-
Aldrich; UltraCruz blocking solution, Santa Cruz) for 30 minutes. This was replaced with an 
appropriate mix of primary antibodies diluted into Blocking Solution I (Table 6.21) and 
incubated at 4°C overnight. Cells were washed three times with Blocking Solution I and 
secondary antibodies, Alexa Fluor 488 goat anti-mouse IgG and Alexa Fluor 647 goat anti-
rabbit IgG (1:800 dilution; H+L, ThermoFisher) applied in Blocking Solution I for 1h at the 
room temperature in the dark. Finally, cells were washed three times with PBS and mounted 
using 15 µl of Fluoroshield with DAPI. 
6.2.2 Proximity ligation assay (PLA) 
STIM1/Orai1, STIM2/Orai1, STIM1/σ1R, and STIM2/σ1R interactions were detected 
with Duolink® In Situ Detection Reagents Orange starter kit (Sigma Aldrich). This assay 
relies upon detection of the two proteins of interest with antibodies from different species (in 
this case mouse and rabbit). Following binding of the primary antibodies, secondary 
antibodies with complimentary oligonucleotides attached are added. If the two bound 
primary antibodies are sufficiently close (<40 nm), an in-situ PCR reaction is triggered upon 
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binding of the secondaries, and it is this amplification which is subsequently detected by 
confocal fluorescence microscopy (Fig 6.21 ).  
The starter kit contained secondary PLA probes, a Blocking Solution II, antibody 
diluents, a ligation solution, an amplification solution, A and B wash buffers, ligase, and 
polymerase (Table 6.22). Primary antibodies (Table 6.21), PBS, 4% paraformaldehyde, and 
a Blocking Solution I were prepared separately.  
24 h before the assay, HeLa cells were seeded onto collagen-coated coverslips and 
transduced with either WTVC or σ1R-V5 baculovirus as previously described in Chapter II, 
Section 2.4. Before fixation, cells were washed once with pre-warmed HBSS (37 °C) 
followed by 15 min treatment at 37°C in either HBSS (Basal) or Ca2+-free HBSS containing 
0.1 mM EGTA and 1µM thapsigargin (SOCE). Cells were fixed with 4% paraformaldehyde 
for 20 minutes at room temperature, followed by 3x washes in PBS. Blocking and 
permeabilization was performed by applying Blocking Solution I for 30 minutes. This was 
replaced with Blocking Solution II for another 20 min. Cells were incubated at 4°C overnight 
with Blocking Solution I containing primary antibodies directed against each of the two 
proteins of interest. For negative controls, only one or no primary antibody was included.  
Cells were washed 3x with Blocking Solution I before adding the PLA mix and incubating for 
30 min at 37°C. The PLA mix was prepared by diluting both 5x plus and minus PLA probes 
in antibody diluent and leaving for 10 min at room temperature prior to adding to cells. Cells 
were washed 2x with Wash Buffer A for 5 minutes under gentle agitation. The Ligase and 
Ligation solution were mixed according to the manufacturer’s instructions, vortexed, and 
applied to the cells for 30 minutes at 37˚C. Following 2x 5 min washes in Wash Buffer A the 
Amplification mix (polymerase plus amplification solution) was applied to cells and incubated 
for 2 hours at 37˚C. This was followed by 2x wash in Wash Buffer B for 10 minutes and a 
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final wash in 1x Wash Buffer B for 1 minute. The cells were mounted using 15 µl of 
Fluoroshield with DAPI and stored at 4˚C for <30 h before imaging. 
6.2.3 Confocal imaging of cells following IF and image processing  
Images were recorded sequentially using a Leica SP8 confocal microscope and oil-
immersion 63x objective. Z-stack image acquisition was performed to obtain focal middle 
and top plane of cells of interest. Photo excitation was achieved by the illumination of a) 
DAPI using 405 nm laser with emission collected between 450-480 nm, b) Alexa Fluor 488 
using Argon 488 nm laser with emission collected between 510-530 nm, and c) Alexa Fluor 
647 using 633 nm laser with emission collected between 660-690 nm. Images were 
processed applying ImageJ in-built background subtraction and Gaussian filter (1 px).  
6.2.4 Confocal imaging of cells following PLA and image processing 
Images were recorded sequentially using Leica SP8 confocal microscope and oil-
immersion 63x objective. Z-stack image acquisition was performed to obtain ~18-20 images 
through the cells. Photo excitation was achieved by the illumination of a) DAPI using 405 
nm laser with emission collected between 450-480 nm, and b) the fluorophore for the PLA 
Amplification Orange signal using 543 nm laser with emission wavelength of 570-590 nm. 
Each PLA dot represents a high concentration of fluorescence as a result of the probe 
proximity, which can be quantified independently of the intensity. “Z-projection" using the 
maximum intensity was applied to recorded stacks to quantify PLA interactions within the 
cells. DAPI and PLA Z-projections were processed using 3x3 mean filter (1 px) and analysed 
seperatelly using IMCF segmentation toolbar in ImageJ. The “Renyi Entropy-Threshold” 
command was used to isolate both nuclei and PLA signals, while "Analyse particles" 
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command was used to count their number in binary image. DAPI and PLA counts were 
recorded in GraphPad Prism where their ratio was calculated.  
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Table 6.2-1 List of antibodies and their respective dilutions as used in IF method and PLA assay 
 
  
Name Species Antigen Concentration Reference 
α-STIM1 rabbit 2-350aa of STIM1 1:100 Protein Tech 
α-STIM2 rabbit 
583-597 aa of human 
STIM2 
1:100 Alomone lab 
α-σ1R mouse 1-223 aa of human σ1R 1:100 
(F-5) Santa Cruz 
biotechnology 
α-Orai1 mouse 
synthetic peptide near the 
C-terminus of human Orai1 
1:100 Sigma  
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Duolink® In Situ Detection Reagents  Function a 
PLA probe anti-mouse minus 
A secondary antibody that binds to mouse primary 
antibodies.  
PLA probe anti-rabbit plus 
A secondary antibody that binds to primary rabbit 
antibodies. 
Blocking Solution II 
The blocking solution that prevents unspecific binding of 
the antibodies . 
Antibody diluent 
A mix of salts, detergents, and blocking solution 
provided to dilute antibodies. 
Ligation solution 
A solution that contains two different connector 
oligonucleotides which hybridize to the two PLA probe 
oligonucleotides. 
Ligase 
An enzyme that ligates the oligonucleotides together to 
form a closed circle which serves as a template for 
rolling circle amplification.  
Amplification solution 
A solution that contains nucleotides used to produce a 
single-stranded fluorophore during rolling circle 
amplification (ex/em = 554/579nm).  
Polymerase 
An enzyme that uses the ligated circle as a template for 
rolling circle amplification. 
Wash buffer A and B  
Wash buffer A was used after incubation with primary 
antibodies, PLA probes and ligation ligase solution. 
Wash buffer B was used after incubation with the 
amplification-polymerase solution 
Table 6.2-2 Reagents included in Duolink® In Situ Detection Reagents Orange kit. 
a The function of reagents in the PLA assay.  
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Figure 48 A schematic diagram of PLA assay analysis 
Fig6.21 A schematic diagram of PLA assay analysis. A) A PLA assay enables a fluorescent detection of 
protein-protein proximity ranging from 0-40 nm. A distance between antibody-targeted proteins that are 
further than 40 nm apart results in no signal. B) A positive PLA signal for STIM1-Orai1 interaction after 
prolonged thapsigargin (Tg) treatment of HeLa cells. Max projection images of brightfield, DAPI and PLA 
Z-stacks. A detected PLA signal co-localized with the area of HeLa cells. C) Following the verification that 
PLA fluorophores corresponding area of HeLa cells, DAPI and PLA images were segmented and analysed 
using in-built plugins in ImageJ. D) Protein-protein interaction is quantified and estimated using PLA 
“dots”/DAPI “Nuclei” ratio per analysed image.  
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6.3 Results 
6.3.1 Expression of endogenous STIM1, STIM2, Orai1, and σ1R in HeLa cells 
For the PLA assay, HeLa cells were chosen due to their large size and flat footprint 
which provides better resolution of the subcellular distribution of proteins in confocal images. 
The expression and distribution of endogenous STIM1, STIM2 and Orai1 in HeLa was 
examined by immunostaining using the primary antibodies listed in Table 6.21 and either 
the anti-mouse (Alex 488) or anti-rabbit (Alexa 647) secondary antibodies. The confocal 
images in Figs 6.31 and 6.32 show the distribution of endogenous STIM1 and STIM2, 
respectively. Both STIM isoforms exhibited an intracellular reticular-like distribution whereas 
Orai1 had a PM-like distribution, labelling the edges of cells in a cross-section through the 
middle.  Endogenous expression of STIM proteins and σ1R in HeLa cells was also analysed 
by Western blot analysis. Fig 6.33 shows bands identified at the expected molecular mass 
for STIM1, STIM2, and σ1R, after loading 20 µg of protein. Together with immunostaining 
data, this result confirms the endogenous expression of STIM1, STIM2, σ1R, and Orai1 in 
HeLa cells. Also, it confirmed the selectivity of the primary antibodies against STIM1 and 
STIM2, with no detection of STIM1 with a-STIM2 and vice versa, allowing us to proceed 
towards the PLA assay . 
  
199 
 
 
Figure 49 Subcellular localization of STIM1 and Orai1 in HeLa cells 
Fig6.31 Subcellular localization of STIM1 and Orai1 in HeLa cells. Confocal images of HeLa cells 
immunostained with -STIM1 (-647; red) and -Orai1 (-488; green) showing middle and surface 
cross-sections of the cell.  
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Figure 50 Subcellular localization of STIM2 and Orai1 in HeLa cells 
Fig6.32 Subcellular localization of STIM2 and Orai1 in HeLa cells. Confocal images of HeLa cells 
immunostained with -STIM2 (-647; red) and -Orai1 (-488; green) showing middle and surface 
cross-sections of the cell.  
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Figure 51 Western blot analysis of endogenous protein levels STIM2, STIM1, and σ1R in HeLa cells 
Fig6.33 Western blot analysis of endogenous protein levels STIM2, STIM1, and 1R in HeLa cells. HeLa 
cells express STIM2, STIM1, and 1R endogenously.  
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6.3.2 σ1R interacts with STIM1 in situ, but overexpression of  σ1R-V5 did not 
inhibit STIM1-Orai1 interaction 
Previous co-immunoprecipitation experiments with heterologously expressed 
STIM1-Myc, σ1R-V5 and Orai1-HA constructs suggested that there is an association 
between STIM1 and σ1R in unstimulated HEK293 cells, and that σ1R also associates with 
plasma membrane STIM1-Orai1 complexes following thapsigargin treatment34. To 
investigate interactions between the endogenous proteins in situ, the PLA assay was used 
with antibodies indicated in Table 6.21.  
Initially, negative controls were performed to ensure that detection of fluorescent 
puncta by the PLA was dependent upon inclusion of antibodies to both proteins of interest. 
Confocal images obtained from cells where either no primary antibody was added, or only 
one of α-STIM1, α-STIM2 or α-σ1R was included, are shown in Fig 6.34. In all four 
conditions, the fluorescent signal detected was negligible, ranging from 0.08 to 0.22 PLA-
puncta per cell. Detected range is marked as a ‘Background” on the graph summaries.  
Following these controls, antibodies against STIM1 and Orai1 were included to 
investigate the interaction of these two proteins under basal conditions and following Ca2+ 
store depletion, both with and without over-expression of σ1R (Fig 6.35). Upon seeding, 
HeLa cells were transduced with either WTVC or σ1R-V5 baculovirus and then analysed 24h 
later. Prior to fixation, HeLa cells were treated with either HBSS (Basal) or 1µM thapsigargin 
(Tg) in 0.1 mM EGTA nominal Ca2+-free HBSS for 15 min at 37oC. The prediction was that 
the STIM1-Orai1 interaction would increase following Ca2+ store depletion triggered by Tg 
treatment. Images of HeLa cells treated with HBSS revealed very few fluorescent puncta 
per cell (0.15 ± 0.06 for WTVC and 0.11 ± 0.04 for σ1R-V5) which resembled background 
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levels. Following treatment with Tg in Ca2+ free HBSS there was a dramatic, ~36-fold, 
increase in the number of fluorescent puncta per cell for the WTVC  HeLa cells (5.4± 0.6). 
Following statistical analysis with a one-way ANOVA with Tukey post-hoc test, this increase 
is highly significant (****, P < 0.0001). Similarly, in cells over-expressing σ1R-V5 the number 
of puncta increased ~42-fold following Tg treatment (4.6 ± 0.6; ***, p <0.001)). The frequency 
of the fluorescent puncta should provide a measure of STIM1-Orai1 interactions and its 
strong dependence upon Ca2+ store depletion is evidence towards the reliability of this 
assay. Although the increase in puncta frequency per cell was slightly less in cells 
expressing σ1R-V5, the difference between these cells and cells transduced with the WTVC 
type virus was not significant (n.s., P>0.05). These results suggest that σ1R does not exert 
a strong inhibitory effect on STIM1-Orai1 interactions. 
Fig 6.36 shows the PLA analysis of STIM1-σ1R interactions for both endogenous 
σ1R (WTVC) and following over-expression of σ1R-V5. In WTVC cells, puncta were detected 
under basal conditions (9.2 ± 0.8 per cell, n=3) and following Tg-induced store-depletion this 
increased ~2-fold (19.4± 1.6, n=3). This increase was statistically significant (***, P < 0.001). 
These results suggest that STIM1 and σ1R interact with one another and that depletion of 
the Ca2+ store promotes this interaction further. The overexpression of σ1R enhanced the 
interaction under basal conditions, but the lack of any further increase upon store depletion 
could be because the endogenous levels of STIM1 were limiting.  
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Figure 52 Negative controls for PLA assay 
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Figure 53 
Fig6.35 STIM1 interacts with Orai1 
after thapsigargin (Tg) treatment. A) 
Maximal Z-projections of confocal 
images of WTVC and 1R-V5 HeLa cells 
under basal and store-depleted (Tg) 
conditions. HeLa cells were stained 
with the nuclear marker DAPI (blue). 
The PLA signal, recognised as a 
fluorescent red dot, detects the 
proximity of STIM1 and Orai1 
antibodies. B) Box plots summarising 
results across three independent 
experiments (n=3) compared with 
one-way ANOVA. n.s., P>0.05, ****, 
P<0.0001. Scale bar = 10 m.  
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Figure 54 
Fig6.36 1R interacts with STIM1 
following store-depletion (Tg) and 
1R-V5 overexpression. A) Maximal Z-
projections of confocal images of WTVC 
and 1R-V5 HeLa cells under basal and 
store-depleted (Tg) conditions. HeLa 
cells were stained with the nuclear 
marker DAPI (blue). The PLA signal, 
recognised as a fluorescent red dot, 
detects the proximity of STIM1 and 1R 
antibodies. B) Box plots summarising 
results across three independent 
experiments (n=3) compared with one-
way ANOVA. n.s., P>0.05, ***, P<0.001. 
Scale bar = 10 m. 
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6.3.3 σ1R interacts with STIM2 in unstimulated cells and its upregulation 
promotes STIM2-Orai1 basal interaction. 
Similar experiments were carried out to determine the interaction of endogenous 
STIM2 with Orai1 and σ1R (Figs 6.37 and 6.38).  The number of STIM2-Orai1 fluorescent 
puncta under basal conditions was low (1.4 ± 0.16, n=3) and surprisingly it decreased ~5-
fold post-Tg treatment (0.19 ± 0.05, n = 3, *, P < 0.05) in contrast to what was observed for 
STIM1-Orai1. The overexpression of σ1R-V5 increased the number of puncta per cell by 
~4-fold under basal conditions (4.4 ± 0.41), suggesting it promotes STIM2-Orai1 association, 
but again there was a ~4.5-fold decrease post Tg treatment (1.3± 0.10,  n = 3 and,**** P < 
0.0001). PLA analysis of STIM2-σ1R interactions showed that for the endogenous proteins 
(cells expressing WTVC) the number of fluorescent puncta per cell also decreased ~3-fold 
following Tg-treatment from 3.3 ± 0.26 to 1.23 ± 0.14.  In cells expressing σ1R-V5 there was 
instead an increase in puncta post Tg treatment (3.6± 0.42 for basal and 5.9 ± 0.53 post-Tg, 
n = 3, ***, P < 0.001). The apparent reduction in STIM2 interaction with both Orai1 and σ1R 
post-Tg treatment could be related to the enhanced binding of STIM1 to both proteins under 
these conditions. Unlike STIM1, STIM2 is expected to show some translocation to ER-PM 
junctions and interaction with Orai1 under basal conditions. Upon Ca2+ store depletion, 
STIM1 will also translocates to these junctions and might therefore compete with STIM2 for 
binding Orai1. Similarly, enhanced STIM1-σ1R interactions could account for reduced 
STIM2- σ1R interactions. Under conditions of store depletion, the over-expression of σ1R 
increased the number of puncta seen using a combination of anti-STIM2 and anti-σ1R by 6-
fold, which supports the idea that the puncta frequency is providing a read-out of STIM2- 
σ1R interactions. 
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Figure 55 
Fig6.37 Overexpression of 1R-V5 
increases basal STIM2-Orai1 
interaction. A) Maximal Z-projections 
of confocal images of WTVC and 1R-V5 
HeLa cells under basal and store-
depleted (Tg) conditions. HeLa cells 
were stained with the nuclear marker 
DAPI (blue). The PLA signal, recognised 
as a fluorescent red dot, detects the 
proximity of STIM2 and Orai1 
antibodies. B) Box plots summarising 
results across three independent 
experiments (n=3) compared with one-
way ANOVA. *, P<0.05; ****, P<0.0001. 
Scale bar = 10 m.  
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Figure 56 
Fig6.38 1R interacts with STIM2 at 
the basal levels and following 
overexpression of 1R-V5. A) Maximal 
Z-projections of confocal images of 
WTVC and 1R-V5 HeLa cells under 
basal and store-depleted (Tg) 
conditions. HeLa cells were stained 
with the nuclear marker DAPI (blue). 
The PLA signal, recognised as a 
fluorescent red dot, detects the 
proximity of STIM2 and 1R antibodies. 
B) Box plots summarising results across 
three independent experiments (n=3) 
compared with one-way ANOVA. n.s., 
P>0.05; **, P<0.01,****, P<0.0001. 
Scale bar = 10 m. 
210 
 
6.3.4 σ1R and STIM2 co-localize in sub-PM puncta under basal conditions 
and post-thapsigargin treatment.    
Further investigation of a possible interaction between STIM2 and σ1R was carried 
out by analysing their subcellular distributions and co-localization under basal and store-
depleted conditions. STIM2.2-mCh and σ1R-EGFP were over-expressed in HeLa cells, and 
their expression in the vicinity of the plasma membrane was imaged using TIRFM. In the 
majority of cells, STIM2.2-mCh was already translocated to sub-PM puncta under basal 
conditions (normal HBSS) and was unresponsive to Tg-induced store-depletion. Within 
these puncta, STIM2.2-mCh clearly co-localized with σ1R-EGFP (Fig. 6.39). There were, 
however, some cells in which the translocation of both STIM2.2-mCh and σ1R-EGFP to the 
PM was enhanced by treating cells with 1 µM Tg for 6 min in Ca2+- free HBSS, and an 
example is shown in Fig 6.310.  
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Figure 57 
Fig6.39 1R-EGFP co-localizes with STIM2.2-mCh at sub-PM regions under basal conditions (HBSS). 
TIRFM images of HeLa cells co-transfected with STIM2.2-mCh (column 1) and 1R-EGFP (column 2). Two 
proteins co-localize at sub-PM regions in puncta-like structures. 
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Figure 58 
Fig6.310 1R-EGFP co-localizes with STIM2.2-mCh at sub-PM regions following store-depletion. 
TIRFM images of HeLa cells co-transfected with STIM2.2-mCh (column 1) and 1R-EGFP (column 2). 
As no puncta-like structures were observed in 0.1 mM EGTA, cells were treated with 1 M 
thapsigargin (Tg) for 6 min causing translocation of both proteins into the puncta-like structure at 
sub-PM regions. 
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6.4 Discussion 
6.4.1 σ1R interacts in situ with both STIM homologs  
Targeting σ1R and STIM proteins with primary antibodies (Table 6.21) allows for 
detection of their interaction in-situ using PLA method. If two proteins are sufficiently close 
(<40 nm), an in-situ PCR reaction is triggered upon binding of the secondaries resulting in 
the amplified signal that can be detected by confocal fluorescence microscopy. To test the 
specificity of detected PLA signals, I first took advantage of molecular mechanism of SOCE 
activation where STIM1 and Orai1 interaction occurs only after store-depletion. Following 
treatment of WTVC HeLa cells with Tg in Ca2+ free HBSS there was a dramatic, ~36-fold, 
increase in the number of fluorescent puncta per cell (Fig 6.35) while the signal in untreated 
cells remained at the level of background. Similar results were also observed σ1R-V5 HeLa 
cells showing strong dependence upon Ca2+ store depletion, and hence, supporting the 
reliability of this assay. Interestingly, the frequency of STIM1/Orai1 puncta between WTVC 
and σ1R-V5 HeLa cells was not significant (n.s., P>0.05), suggesting that σ1R does not 
exert a strong inhibitory effect on STIM1-Orai1 interactions as it was previously reported34. 
Using the approach, STIM1-σ1R interactions were tested in the presence of 
endogenous σ1R (WTVC HeLa cells) and following over-expression of σ1R-V5. In WTVC 
HeLa cells, puncta were detected under basal conditions suggesting that σ1R and STIM1 
can interact in unstimulated cells. Following Tg-induced store-depletion, the interaction 
between two proteins increased ~ 2 fold which is in agreement with earlier reports of σ1R’s 
“active mode” after dissociating from BiP, and attenuation of SOCE after associating with 
STIM122,34. Hence, these results suggest that STIM1 and σ1R interact with one another and 
that depletion of the Ca2+ store promotes this interaction further. The overexpression of σ1R 
enhanced this interaction already under basal conditions, suggesting it can occur 
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independently of store-depletion depending on the availability of both STIM1 and σ1R as 
interactive partners. 
Similar experiments were carried out to determine the interaction of endogenous 
STIM2 with Orai1 and σ1R (Figs 6.37 and 6.38). The number of STIM2-Orai1 fluorescent 
puncta under basal conditions was low (1.4 ± 0.16, n=3) and surprisingly it decreased after 
Tg treatment which is in contrast to what was observed for STIM1-Orai1 interaction. A 
possible explanation could be that, in comparison to STIM2, STIM1 possesses lower SAM 
stability and less robust EF-SAM interface. Hence, STIM1 exhibits increased kinetics of 
oligomerisation compared to STIM2 after thapsigargin treatment106,108. Also, the increased 
stability of STIM2 EF-SAM domain decreases protein’s propensity for oligomerisation, which 
attenuates STIM2-association kinetics and prevents hyperactivation of SOCE due to low 
drops in intraluminal Ca2+106. Thus, a decreased kinetics and propensity of oligomerisation 
may also result in less STIM2-Orai1 interaction after prolonged treatment with thapsigargin, 
especially when competing for Orai1-anchoring sites with stronger activator such as STIM1. 
Interestingly, the overexpression of σ1R-V5 increased the number of puncta per cell by ~4-
fold under basal conditions (4.4 ± 0.41), suggesting σ1R-V5 promotes or perhaps, stabilises 
STIM2-Orai1 association. Following thapsigargin treatment, there was again significant 
decrease in STIM2-Orai1 interactive puncta 1.3± 0.10,  n = 3 and,**** P < 0.0001). 
 PLA analysis of STIM2-σ1R interactions showed that for the endogenous proteins 
(WTVC HeLa cells) the number of fluorescent puncta per cell also decreased ~3-fold following 
thapsigargin treatment (from 3.3 ± 0.26 to 1.23 ± 0.14). On contrary, in cells expressing σ1R-
V5 there was instead an increase in puncta post thapsigargin treatment (3.6± 0.42 for basal 
and 5.9 ± 0.53 post-Tg; ***, P < 0.001) across three independent experiments (n=3).This 
suggests that the reduction in STIM2 interaction with endogenous σ1R under stress 
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conditions could be related to the enhanced binding of STIM1 to both proteins under these 
conditions.  
Unlike STIM1, STIM2 is expected to show some translocation to ER-PM junctions 
and interaction with Orai1 under basal conditions. Also, the polybasic tail of STIM proteins 
plays a crucial role in stabilising STIM proteins at contact sites between ER and PM allowing 
STIM proteins to interact with the proteins at the PM. In comparison to STIM1, STIM2 has a 
higher affinity of the polybasic tail for lipids that stabilises protein’s localisation at the PM 
even at the resting conditions111. However, upon Ca2+ store depletion, STIM1 also 
translocates to these junctions and might therefore compete with STIM2 for binding Orai1. 
Similarly, enhanced STIM1- σ1R interactions could account for reduced STIM2-σ1R 
interactions, where the interplay between σ1R and STIM homologs could play important role 
in the regulation of SOCE and consequently Ca2+ homeostasis. Under stress conditions, the 
over-expression of σ1R increased the number of puncta seen using a combination of anti-
STIM2 and anti-σ1R by 6-fold, which supports the idea that the puncta frequency is providing 
a read-out of STIM2- σ1R interactions and that the availability of  σ1R as interactive partner 
may be essential in regulation of different pathways. Additionally, TIRFM recordings of 
STIM2.2-mCh and σ1R-EGFP supported PLA data, indicating these two proteins can co-
localise at ER-PM junctions under both basal and store-depleted conditions. However, while 
our PLA results for STIM1-σ1R interaction are supported by current body of evidence, 
additional FRET or CoIP experiments are required for further characterisation of STIM2- 
σ1R interactions.  
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7 Chapter VII 
The functional role of σ1Rs in regulation of STIM2.2/Orai1 
mediated SOCE. 
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7.1 Introduction 
STIM1 is the most studied member of the STIM protein family and the main activator 
of SOCE in non-excitable cells. The exact role of its homolog, STIM2, has been a matter of 
debate98. STIM2 has been proposed to be the regulator of basal SOCE, and it has also 
emerged as more relevant STIM protein in the regulation of neuronal SOCE (nSOCE) due 
to its predominant expression within mouse spinal cord dorsal horn neurons, forebrain and 
hippocampus.  
Results presented in the previous chapter, provide evidence that σ1R, a 
neuroprotective ER chaperone, interacts with both STIM1 and STIM2 in situ. This interaction 
was dependent on (1) the levels of [Ca2+]ER, and (2) the level of σ1R expression. The STIM1- 
σ1R interaction was promoted by prolonged store depletion (stress conditions), whilst the 
highest PLA signal for σ1R-STIM2 was observed under basal conditions.   
In this chapter, the effect of σ1R on the function of STIM2 splice variants – STIM2.2 
and STIM2.1 – was examined in HEK293 cells. The aims were as follows: 
(1) To determine whether σ1R regulates STIM2.2-mediated SOCE in a population 
of HEK293 cells. 
(2) To investigate whether σ1R regulates STIM2.2-dependent Ca2+ influx within 
SOCE microdomains under basal conditions and following prolonged store-
depletion. 
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7.2 Methods 
7.2.1 Experimental timeline of Chapter VII 
 
  
Figure 59 Experimental timeline of TIRFM and Flexstation experiments in Chapter VII 
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7.3 Results 
7.3.1 σ1R-V5 inhibits STIM1 and STIM2.2-potentiated SOCE in HEK293 cells 
Having shown in Chapter VI that STIM2 interacts with σ1R in situ, I compared the 
inhibitory effects of σ1R-V5 on STIM1- and STIM2.2-mediated SOCE in HEK293 cells. For 
these experiments, in addition to using STIM2.2-mCh, the untagged STIM2.2 was also 
tested, whereas for the overexpression of STIM1, mCh-STIM1 and HA-STIM1 were used. 
Before transfection with STIM plasmids, HEK293 cells were transduced with either WTVC or 
σ1R-V5 baculovirus. 40-48 h after transfection (60-72h after transduction), SOCE was 
measured in a population of HEK293 cells using Flexstation III and GcAMP6f. 
The results of these experiments are shown in Fig 7.31. For each group, SOCE 
peaks from 18 biological replicates (N=18) across three independent experiments (n=3) 
were compared using one-way ANOVA with α=0.05. SOCE in σ1R-V5 HEK293 cells was 
significantly reduced in comparison to WTVC HEK293 cells (0.47 ± 0.018 for WTVC versus 
0.26 ± 0.021 for σ1R-V5, ****,P < 0.0001). Overexpression of HA-STIM1 and STIM2.2 in 
WTVC HEK293 cells significantly potentiated SOCE in comparison to WTVC HEK293 cells 
(0.75 ± 0.023 for WTVC + HA-STIM1 and 0.82 ± 0.032 for WTVC + STIM2.2, ****,P < 0.0001). 
Overexpression of HA-STIM1 and STIM2.2 in σ1R-V5 HEK293 cells restored SOCE to 
WTVC levels, but it was significantly lower in comparison to HA-STIM1- and STIM2.2-
potentiated SOCE in WTVC HEK293 cells (0.48 ± 0.023 for σ1R-V5 + HA-STIM1 and 0.46 ± 
0.031 for σ1R-V5 + STIM2.2, n.s, P > 0.05,****,P < 0.0001). This suggest  that σ1R-V5 
inhibits both HA-STIM1 and STIM2.2-potentiated SOCE in HEK293 cells. 
Results from similar experiments but using the mCherry-tagged STIM constructs are 
shown in Fig 7.31C and D. Again, they show that σ1R-V5 inhibits mCh-STIM1 and STIM2.2-
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mCh-potentiated SOCE in HEK293 cells. A comparison between these results suggests that 
STIM2.2-mCh behaves similarly to un-tagged STIM2.2.  
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Figure 60 σ1R-V5 inhibits STIM1 and STIM2.2-potentiated SOCE in HEK293 cells. 
Fig7.31 1R-V5 inhibits STIM1- and STIM2.2-potentiated SOCE in HEK293 cells. A) GcAMP6f traces during 
treatment by 1 M thapsigargin followed by restoration of 2 mM extracellular Ca2+ in HEK293 cells 
expressing WTVC (black), 1R-V5 (red), WTVC+HA-STIM1 (blue), 1R-V5+HA-STIM1 (orange), WTVC+STIM2.2 
(green), and 1R-V5 + STIM2.2 (pink). C) GcAMP6f traces under same treatment and conditions as above 
(A) where STIM2.2 is expressed using STIM2.2-mCH construct. B) and D) Summary results showing SOCE 
from 18 biological replicates (N=18) across three independent experiments (n=3). A population of HEK293 
cells within one well of 96W plate was used as a biological replicate (N) for statistical analysis. SOCE peaks 
were compared with one-way ANOVA, ****, P<0.0001.   
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7.3.2 STIM1 mediates the majority of Tg-evoked SOCE in HEK293 cells 
HEK293 cells have endogenous levels of both STIM1 and STIM2 proteins (Chapter 
III, Fig3.38). To further characterize thapsigargin-evoked SOCE in HEK293 cells, 
endogenous STIM1 levels were knocked-down using STIM1 specific siRNA (Fig7.32C). 
SOCE was measured in a population of HEK293 cells using a Flexstation III and the Ca2+ 
reporter GcAMP6f. 
Fig7.32 shows GcAMP6f responses from cells transfected with either siRNA for 
STIM1 or a control siRNA (siControlA). Cells were treated with 1 µM thapsigargin (Tg) in 
nominal Ca2+-free NES followed by restoration of 2 mM extracellular Ca2+ and the peak of 
the SOCE response was compared using 18 biological replicates (N=18) across three 
independent experiments (n=3) with a Student’ t-test using α of 0.05. Knockdown of STIM1 
significantly reduced the amplitude of the SOCE response (****, P<0.0001). This reduction 
in SOCE suggests that endogenous STIM1 mediates the majority of Tg-evoked SOCE in 
HEK293 cells.  
The knockdown of endogenous STIM1 was confirmed with Western blot analysis. 
Fig7.32C shows endogenous levels of STIM1 in (1) mock-transfected HEK293 cells, (2) cells 
transfected with siRNA control and (3) siSTIM1 transfected cells. 
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Figure 61 STIM1 mediates the majority of Tg-evoked SOCE in HEK293 cells 
Fig7.32 STIM1 mediates the majority of Tg-evoked SOCE in HEK293 cells. A) GcAMP6f traces during 
treatment by 1 M thapsigargin foll wed by r storation of 2 mM xtracellular Ca2+ in HEK293 cells 
expressing siControlA (black) and siSTIM1 (red). B) Summary results showing SOCE from 18 biological 
replicates (N=18) across three independent experiments (n=3). A population of HEK293 cells within one 
well of 96W plate was used as a biological replicate (N) for statistical analysis. SOCE peaks were 
compared with Student’s t-test. ****, P<0.0001. C) Western blot analysis of endogenous STIM1 in (1) 
wild-type (WT) HEK293 cells, and cells expressing (2) siControlA, and (3) siSTIM1.  
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7.3.3 Overexpression of STIM2.2-mCh rescues SOCE in siSTIM1 HEK293 cells  
After demonstrating that the majority of Tg-evoked SOCE in HEK293 cells is STIM1-
dependent, I tested whether overexpression of STIM2.2-mCh can rescue SOCE in siSTIM1 
HEK293 cells. To overexpress STIM2 proteins, STIM2.2-mCh and STIM2.1-mCh constructs 
were used. These constructs were provided by Barbara Niemeyer who characterized 
STIM2.2 and STIM2.1 variants as positive and negative regulators of SOCE, respectively116. 
Endogenous STIM1 levels were knocked down using STIM1 siRNA and SOCE was 
measured in the population of HEK293 cells using the Flexstation III and GCaMP6f. 
Responses are shown in Fig7.33 for cells expressing siControlA (black), siControlA 
+ STIM2.2-mCh (green), siControlA + STIM2.1-mCh (blue), siSTIM1(red), siSTIM1 + 
STIM2.2-mCh (pink) and siSTIM1 + STIM2.2-mCh (orange). HEK293 cells were treated with 
1 µM Thapsigargin in nominal Ca2+-free NES followed by restoration of 2 mM extracellular 
Ca2+ to measure SOCE. SOCE peaks from 18 biological replicates (N=18) across three 
independent experiments (n=3) were compared using one-way ANOVA with α of 0.05.  The 
knockdown of endogenous STIM1 inhibited SOCE (0.51 ± 0.018 for siControlA versus 0.21 
± 0.019 for siSTIM1, ****,P < 0.0001). Overexpression of STIM2.2-mCh significantly 
potentiated SOCE whilst overexpression of STIM2.1-mCh significantly reduced it (0.86 ± 
0.030 for siControlA + STIM2.2-mCh, ****,P < 0.0001 and 0.35 ± 0.025 for siControlA + 
STIM2.1-mCh, ****,P < 0.0001). Overexpression of STIM2.2-mCh combined with siSTIM1 
rescued SOCE to similar levels of control cells (0.58 ± 0.023), whereas overexpression of 
STIM2.1-mCh did not (0.20 ± 0.0061). 
  
225 
 
 
Figure 62 Overexpression of STIM2.2-mCh rescues SOCE in siSTIM1 HEK293 transients 
Fig7.33 Overexpression of STIM2.2-mCh rescues SOCE in siSTIM1 HEK293 transients. A) GcAMP6f 
traces during treatment by 1 M thapsigargin followed by restoration of 2 mM extracellular Ca2+ in 
HEK293 cells expressing siControlA (black), siSTIM1 (red), siControlA+STIM2.2-mCh (green), 
siSTIM1+STIM2.2-mCh (pink), siControlA+STIM2.1-mCh (blue) and siSTIM1+STIM2.1-mCh (orange). B) 
Summary results showing SOCE from 18 biological replicates (N=18) across three independent 
experiments (n=3). A population of HEK293 cells within one well of 96W plate was used as a biological 
replicate (N) for statistical analysis. SOCE peaks were compared with one-way ANOVA. ***,P<0.001; 
****, P<0.0001.  
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7.3.4 σ1R-V5 inhibits STIM2.2-mediated SOCE in siSTIM1 HEK293 cells 
Srivats et al. showed that σ1R inhibits SOCE by attenuating coupling of STIM1 to 
Orai134. As σ1R-V5 limited STIM2.2-potentiated SOCE in HEK293 cells, we tested whether 
σ1R-V5 reduces STIM2.2-mediated SOCE independently of STIM1. To simultaneously 
overexpress STIM2.2 and knockdown STIM1, cells were transfected with STIM2.2 
(untagged) and siSTIM1 RNA following transduction with either WTVC or σ1R-V5 
baculovirus. 40-48 h post transfection, SOCE was measured using the Flexstation III and 
GcAMP6f. Additionally, Western blot analysis was performed using lysates from cells treated 
in the same way as for the functional assay. 
SOCE responses are shown in Fig7.34 for HEK293 cells expressing σ1R-V5 (blue), 
WTVC + siSTIM1 (red), WTVC + STIM2.2 (green), σ1R-V5 + STIM2.2 (grey), WTVC + STIM2.2 
+ siSTIM1 (pink), and σ1R-V5 + STIM2.2 + siSTIM1 (orange). As in previous experiments, 
overexpression of σ1R-V5 and siSTIM1 significantly reduced SOCE. Overexpression of 
STIM2.2 in WTVC cells increased SOCE and it was significantly lower in σ1R-V5 + STIM2.2 
cells. Co-expression of siSTIM1 and STIM2.2 resulted in significantly lower SOCE in σ1R-
V5 HEK293 cells when compared to WTVC cells, indicating that σ1R-V5 inhibits STIM2.2-
mediated SOCE independently of endogenous STIM1. Statistical analysis for was 
performed using one-way ANOVA with α of 0.05. Number of biological replicates and the 
results are summarized in Table 7.31.  
Fig7.35 shows Western blot analysis of (1) WTVC + STIM2.2, (2) σ1R-V5 + STIM2.2, 
(3) WTVC + STIM2.2 + siSTIM1, (4) σ1R-V5 + STIM2.2 + siSTIM1, (5) WTVC + siSTIM1, and 
(6)  σ1R-V5 + siSTIM1 HEK293 lysates 40 hours after co-transfection with GcAMP6f to 
mimic the conditions of the FlexStation III experiments. Fig7.35B, C and D summarize 
normalized STIM2.2, STIM1, and σ1R-V5 intensity across three independent experiments 
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(n=3) analyzed with one-way ANOVA using α of 0.05. Overexpression of σ1R-V5 
significantly reduced STIM2.2 overexpression and endogenous STIM1 protein levels in 
comparison to the WTVC HEK293 cells, suggesting σ1R-V5 inhibits SOCE by reducing levels 
of both STIM proteins. However, there was no significant difference in overexpressed 
STIM2.2 and endogenous STIM1 protein levels following overexpression of siSTIM1 in 
WTVC and σ1R-V5 HEK293 cells. Considering that during Flexstation III experiments σ1R-
V5 +STIM2.2+siSTIM1 HEK293 cells had significantly lower Ca2+ influx in comparison to the 
WTVC+STIM2.2+siSTIM1 cells, similar protein levels between these two groups indicate  
σ1R-V5 also inhibits STIM2.2-mediated SOCE through additional mechanism.  
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Figure 63 σ1R-V5 inhibits STIM2.2-mediated SOCE in HEK293 cells 
Fig7.34 1R-V5 inhibits STIM2.2-mediated SOCE in HEK293 cells. A) GcAMP6f traces during treatment 
by 1 M thapsigargin followed by restoration of 2 mM extracellular Ca2+ in HEK293 cells expressing 1R-
V5 (blue), WTVC+siSTIM1 (red), WTVC+STIM2.2 (green), 1R-V5+STIM2.2 (grey), WTVC+STIM2.2+siSTIM1 
(pink), and 1R-V5+STIM2.2+siSTIM1 (orange). B) Summary results showing SOCE from 18 biological 
replicates (N=18) across three independent experiments (n=3). A population of HEK293 cells within one 
well of 96W plate was used as a biological replicate (N) for statistical analysis. SOCE peaks were 
compared with one-way ANOVA. n.s., P>0.05; ***,P<0.001; ****, P<0.0001.  
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Figure 64  Western blot analysis of STIM2.2 and siSTIM1 transients in  WTVC and σ1R-V5 HEK293 cells. 
Fig7.35 Western blot analysis of STIM2.2 and siSTIM1 
transients in WTVC and 1R-V5 HEK293 cells. A) 
Nitrocellulose membranes blotted with -STIM2, -
STIM1, -1R, and -actin showing protein levels of 
(Row 1) overexpressed (1-4) and endogenous (5,6) 
STIM2.2,  (Row 2) endogenous STIM1 before (1,2) and 
after (3-6) knockdown, (Row 3) overexpressed 1R-V5, 
and (Row 4) endogenous actin. Lanes 1-6 contain lysates 
of WTVC and 1R-V5 HEK293 cells 40 hours after co-
transfection with GcAMP6f to mimic conditions of 
Flexstation III experiments. kDa = molecular weight 
markers in kilodaltons. B), C) and D) show normalised 
STIM2.2, STIM1, and 1R-V5  intensities, respectively. 
Results are meanSEM across three independent 
experiments (n=3). n.s., P>0.05; *,P<0.05; ****, P<0.0001, 
relative to control. One-way ANOVA with Tukey’s posthoc 
analysis.  
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 Table 7.3-1 Summary of one-way ANOVA with Tukey posthoc analysis for the thapsigargin-evoked SOCE. 
SOCE measurements (Peaks, Fig 7.34) were taken across three independent experiments (n=3). A population 
of HEK293 cells within one well of 96W plate was used as a biological replicate (N) for statistical analysis. 
  
Group 
Mean± 
SEM 
N (1) (2) (3) (4) (5) (6) 
(1)  
σ1R-V5 
0.2118±
0.02616 
18  
n.s, P > 
0.5 
****, P < 
0.0001 
****, P < 
0.0001 
****, P < 
0.0001 
n.s, P > 
0.5 
(2) 
 WTVC+siSTIM1 
0.2266±
0.01651 
18   
****, P < 
0.0001 
****, P < 
0.0001 
****, P < 
0.0001 
n.s, P > 
0.5 
(3)  
WTVC+STIM2.2 
 
0.7816±
0.03935 
18    
***, P < 
0.001 
**, P < 
0.01 
****, P 
< 
0.0001 
(4)  
σ1R-V5+STIM2.2 
0.6000±
0.03201 
18     
n.s, P > 
0.5 
***, P < 
0.001 
(5) 
 WTVC+STIM2.2 
+siSTIM1 
0.5571±
0.04415 
18      
****, P 
< 
0.0001 
(6)  
σ1R-V5+STIM2.2 
+ siSTIM1 
0.3507±
0.04771 
18       
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7.3.5 STIM1 mediates the majority of Tg-evoked, G-GECO1.2-Orai1 measured 
SOCE in HEK293 cells 
Next I measured SOCE in single cells expressing G-GECO1.2-Orai1 using 
epifluorescence microscopy. Representative images are shown in Fig7.36 and the  
knockdown of STIM1 clearly inhibited the majority of the G-GECO1.2-Orai1-mediated Ca2+ 
response. G-GECO1.2-Orai1R91W expressing cells were used as a negative control (Fig7.36, 
row 3). A summary of the results is shown in Fig 7.37. SOCE peaks from 18 biological 
replicates (N=18) across the three independent experiments (n=3) were analyzed using the 
Kruskal-Wallis and Dunn’s multiple comparison tests with α of 0.05. Positionally-grouped 
ROIs were used as a one biological replicate. In cells transfected with siSTIM1 there was a 
>3-fold inhibition of the G-GECO1.2-Orai1-mediated SOCE. There was also a significant 
difference between the SOCE response for siSTIM1 expressing cells and the G-GECO1.2-
Orai1R91W response, indicating that siSTIM1 did not abolish G-GECO1.2-Orai1-mediated 
SOCE. Altogether these results demonstrate that  the majority of Tg-evoked SOCE in 
HEK293 cells is STIM1-mediated.   
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Table 7.3-2 STIM1 knockdown reduces the majority of G-GECO1.2-Orai1-mediated SOCE. 
Figure 65 STIM1 knockdown reduces the majority of G-GECO1.2-Orai1-mediated SOCE. 
Fig7.36 STIM1 knockdown reduced the majority of G-GECO1.2-Orai1-mediated SOCE. Epifluorescent 
images of G-GECO1.2-Orai1 and G-GECO1.2-Orai1R91W HEK293 transients in 0.1 mM EGTA (pre-
treatment; column 1), 2 mM Ca2+ (post-treatment with 1 M thapsigargin; column 2), and 2 mM Ca2+ 
with 5 M Ionomycin ( column 3) co-transfected with either siControlA (row 1) and siSTIM1 (row 2). 
Scale bar = 10 M.  
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Figure 66Quantification of G-GECO1.2-Orai1-mediated SOCE during STIM1 knockdown in HEK293 cells. 
Fig7.37 Quantification of G-GECO1.2-Orai1-mediated SOCE during STIM1 knockdown in HEK293 cells A) 
Representative meanSEM traces of  G-GECO1.2-Orai1+siControlA (black), G-GECO1.2-Orai1+siSTIM1 
(red),  and G-GECO1.2-Orai1R91W during SOCE. Grey traces show individual measurements within the 
recordings. Blue dashed line indicates the addition of 2 mM Ca2+ following store depletion. Scale bare = 
50% F/Fmax (y-axis) and 100 s (x-axis). B) Box and whiskers plot of SOCE (peaks) values from 18 biological 
replicates (N=18) across three independent experiments (n=3) compared with Kruskal-Wallis test. 
Positionally-grouped ROIs were used as one biological replicate. *, P<0.05; **<0.01;****,P< 0.0001.   
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7.3.6 σ1R-V5 inhibits Tg-evoked STIM2.2-mediated Ca2+ influx in SOCE 
microdomains 
Having investigated the effects of σ1R on STIM2.2 mediated SOCE using the 
Flexstation III, which measures global [Ca2+]cyt, I moved to testing the effects of σ1R on 
STIM2.2-enriched SOCE microdomains using G-GECO1.2-Orai1 and STIM2.2-mCh and 
TIRFM. The overexpression of STIM2.1-mCh was used as a negative control. Fig 7.38 
shows representative TIRFM images of HEK293 cells expressing (row 1) WTVC + G-
GECO1.2-Orai1 + STIM2.2-mCh, (row 2)  σ1R-V5 + G-GECO1.2-Orai1 + STIM2.2-mCh, 
and (row 3) WTVC + G-GECO1.2-Orai1 + STIM2.1-mCh. TIRFM images are shown at 
different time points throughout the experiment to show the baseline fluorescence (column 
1), the SOCE response after 6-min treatment with 1 µM Thapsigargin (column 2) and the 
maximal response obtained using 5 µM ionomycin (column 3). When comparing the three 
experimental groups, the Tg-induced SOCE in STIM2.2-mCh enriched microdomains is 
visibly lower in cells expressing σ1R-V5 (row 2) compared to WTVC cells (row 1). SOCE 
detected in WTVC cells  expressing STIM2.1-mCh was also significantly lower.  
Fig7.39 summarizes the results of the TIRFM experiments. Statistical analysis of 
SOCE peaks from 36 biological replicates from (N=36) across three independent 
experiments (n=3) was performed using Kruskal-Wallis and Dunn’s multiple comparison 
tests with α of 0.05. Tg-evoked SOCE within STIM2.2-mCh enriched microdomains of σ1R-
V5 HEK293 cells was significantly reduced in comparison to SOCE in WTVC HEK293 cell, 
but not significantly different when compared to STIM2.1-mCh enriched SOCE 
microdomains in WTVC HEK293 cells.  This result suggests that σ1R-V5 significantly reduces 
Ca2+ influx within STIM2.2-enriched SOCE microdomains. Results of statistical analysis 
have been summarized in Table 7.32. 
235 
 
 
Figure 67σ1R-V5 reduces Tg-evoked STIM2.2/Orai1-mediated SOCE in HEK293 cells 
Fig7.38 1R-V5 reduces Tg-evoked STIM2.2/Orai1-mediated SOCE in HEK293 cells. TIRFM images of G-
GECO1.2-Orai1-measured SOCE in HEK293 cells expressing (row 1 ) WTVC+STIM2.2-mCh, (row 2) 1R-
V5+STIM2.2-mCh, and (row 3) WTVC+STIM2.1-mCh in 0.1 mM EGTA (pre-treatment; column 1), 2 mM Ca2+ 
(post-treatment with 1 M thapsigargin; column 2), and 2 mM Ca2+ with 5 M Ionomycin (column 3). 
Scale bar = 10 M.  
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Figure 68 Quantification of Tg-evoked STIM2.2/Orai1-mediated SOCE in HEK293 cells in HEK293 cells. 
Fig7.39 Quantification of Tg-evoked 
STIM2.2/Orai1-mediated SOCE in HEK293 
cells A) Representative G-GECO1.2-Orai1 
meanSEM traces of HEK293 cells expressing 
WTVC+STIM2.2-mCh (black), 1R-V5+STIM2.2-
mCh (red), and WTVC+STIM2.1-mCh (green) 
during SOCE. Grey traces show individual 
measurements within the recordings. Blue 
dashed line indicates the addition of 2 mM Ca2+ 
following store depletion. Scale bare = 50% 
F/Fmax (y-axis) and 100 s (x-axis). B) Box and 
whiskers plot of SOCE (peaks) values from 36 
biological replicates (N=36) across three 
independent experiments (n=3) compared 
with Kruskal-Wallis test. One biological 
replicate consists of positionally grouped ROIs. 
n.s., P>0.05;**, P<0.01; **<0.01;***,P< 0.001.   
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Table 7.3-2 Summary of Kruskal-Wallis with Dunn’s multiple comparison analysis for Tg-evoked Ca2+ influx 
in STIM2-enriched SOCE microdomains. SOCE measurements (Peaks, Fig 7.39) were taken from 36 biological 
replicates (N=36) across three independent experiments (n=3). Positionally-grouped ROIs were used as a 
biological replicate (N) for statistical analysis. 
 
  
Group Median  Mean±SEM N 
Kruskal-Wallis 
summary 
σ1R-V5+G-
GECO1.2-
Orai1+STIM2.2-mCh 
Kruskal-Wallis 
summary 
WTVC+G-GECO1.2-
Orai1+STIM2.1-
mCh 
WTVC+G-
GECO1.2-
Orai1+STIM2.2-
mCh 
0.4592 0.5080±0.03842 36 ***, P < 0.001 **, P < 0.01 
σ1R-V5+G-
GECO1.2-
Orai1+STIM2.2-
mCh 
0.2669 0.2864±0.02659 36  n.s, P > 0.05 
WTVC+G-
GECO1.2-
Orai1+STIM2.1-
mCh 
 
0.2848 0.3356±0.03890 36   
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7.3.7  
7.3.8 σ1R-V5 fails to inhibit EGTA-evoked SOCE in STIM2.2-enriched 
microdomains of HEK293 cells  
STIM2 is proposed to regulate basal SOCE98 and the PLA results shown in the 
previous chapter provide evidence for a STIM2/σ1R interaction in situ under basal 
conditions.  Therefore, I tested whether σ1Rs functionally inhibits SOCE in STIM2.2-mCh 
enriched microdomains when ER Ca2+ stores are not severely depleted by thapsigargin (Tg) 
treatment but instead are incubated in a Ca2+ free HBSS containing 0.1 mM EGTA to 
produce a more modest reduction in ER [Ca2+].Fig7.310 shows representative TIRFM 
images of HEK293 cells expressing (row 1) WTVC + G-GECO1.2-Orai1 + STIM2.2-mCh, 
(row 2) σ1R-V5 + G-GECO1.2-Orai1 + STIM2.2-mCh, (row 3)  WTVC + G-GECO1.2-Orai1 + 
STIM2.1-mCh, and (row 4) WTVC + G-GECO1.2-Orai1R91W + STIM2.2-mCh. The G-
GECO1.2-Orai1R91W construct was included as a negative control to ensure that measured 
changes in fluorescence within the SOCE microdomains correspond to Ca2+ influx through 
the Orai1 channel.  
Statistical analysis of SOCE peaks from 24-54 biological replicates (N=24-54, Table 
7.33) across three independent experiments (n=3) was performed using Kruskal-Wallis and 
Dunn’s multiple comparison tests with α of 0.05. Following treatment with 0.1 mM EGTA, 
there was no significant difference in the SOCE response measured within STIM2.2-mCh-
enriched SOCE microdomains of WTVC and σ1R-V5 HEK293 cells. This result suggests that 
the inhibitory effect of σ1R on STIM2.2-mediated SOCE requires a large depletion of 
[Ca2+]ER. The significantly reduced SOCE response in WTVC HEK293 cells co-expressing 
either STIM2.1-mCh with G-GECO1.2-Orai1, or mutant G-GECO1.2-Orai1R91W with 
STIM2.2-mCh were as expected and provide evidence that the responses are mediated by 
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the G-GECO1.2-Orai1 channel. The results of the statistical analysis are summarized in Fig 
7.311 and Table 7.33. 
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Figure 69 σ1R-V5 fails to inhibit EGTA-evoked STIM2.2/Orai1-mediated SOCE in HEK293 cells 
Fig7.310 1R-V5 fails to inhibit EGTA-evoked STIM2.2/Orai1-mediated SOCE in HEK293 cells. TIRFM 
images of G-GECO1.2-Orai1-measured SOCE in HEK293 cells expressing (row 1 ) WTVC+STIM2.2-mCh, (row 
2) 1R-V5+STIM2.2-mCh, and (row 3) WTVC+STIM2.1-mCh, and G-GECO1.2-Orai1R91W-measured SOCE in 
HEK293 cells expressing (row 4) WTVC+STIM2.2-mCh. Images shows cells in 0.1 mM EGTA (pre-treatment; 
column 1), 2 mM Ca2+ (post-treatment with 1 M thapsigargin; column 2), and 2 mM Ca2+ with 5 M 
Ionomycin (column 3). Scale bar = 10 M.  
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Figure 70 Quantification of EGTA-evoked STIM2.2/Orai1-mediated SOCE in HEK293 cells in HEK293 cells 
Fig7.311 Quantification of EGTA-evoked STIM2.2/Orai1-
mediated SOCE in HEK293 cells A) Representative G-
GECO1.2-Orai1 meanSEM traces of HEK293 cells 
expressing WTVC+STIM2.2-mCh (black), 1R-V5+STIM2.2-
mCh (red), and WTVC+STIM2.1-mCh (green) during SOCE. 
G-GECO1.2-Orai1R91W meanSEM traces of HEK293 cells 
expressing WTVC+STIM2.2-mCh (pink).Grey traces show 
individual measurements within the recordings. Blue 
dashed line indicates the addition of 2 mM Ca2+ following 
store depletion. Scale bare = 50% F/Fmax (y-axis) and 100 
s (x-axis). B) Box and whiskers plot of SOCE (peaks) values 
from 24-54 biological replicates (N=24-54) across three 
independent experiments (n=3) compared with Kruskal-
Wallis test. One biological replicate consists of 
positionally grouped ROIs. n.s., P>0.05;**, P<0.01; 
**<0.01;***,P< 0.001.   
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Table 7.3-3 Summary of Kruskal-Wallis with Dunn’s multiple comparison tests for EGTA-evoked Ca2+ influx 
in STIM2-enriched SOCE microdomains. SOCE measurements (Peaks, Fig 7.311) were taken from 24-54 
biological replicates (N=24-54) across three independent experiments (n=3). Positionally-grouped ROIs were 
used as a biological replicate (N) for statistical analysis. 
 
  
Group Median  
Mean± 
SEM 
N 
Kruskal-
Wallis 
summary 
σ1R-V5+G-
GECO1.2-
Orai1+STIM2.
2-mCh 
Kruskal-Wallis 
summary 
WTVC+G-
GECO1.2-
Orai1+STIM2.1-
mCh 
 
Kruskal-Wallis 
summary 
WTVC+G-
GECO1.2-
Orai1R91W+STIM2.
2-mCh 
WTVC+G-
GECO1.2-
Orai1+STIM2.2-
mCh 
0.3264 
0.4047±
0.03204 
54 n.s, P > 0.5 ***, P < 0.001 ****, P < 0.0001 
σ1R-V5+G-
GECO1.2-
Orai1+STIM2.2-
mCh 
0.4289 
 
0.4493±
0.02969 
54  ****, P < 0.0001 ****, P < 0.0001 
WTVC+G-
GECO1.2-
Orai1+STIM2.1-
mCh 
 
0.1201 
 
0.1703±
0.02966 
24   n.s, P > 0.5 
WTVC+G-
GECO1.2-
Orai1R91W+STIM2.
2-mCh 
0.1163 
 
0.1413±
0.01947 
36    
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7.4 Discussion 
7.4.1 σ1R inhibits STIM2.2/Orai1 mediated SOCE after profound store-
depletion 
After demonstrating that σ1R can interact with both STIM homologs in Chapter VI, 
in Chapter VII I have demonstrated that enhanced expression of σ1R can also inhibit 
thapsigargin-evoked STIM2.2/Orai1-mediated SOCE. During measurements of [Ca2+]cyt in 
the population of HEK293 cells using GCaMP6f, σ1R inhibited (1) STIM2.2-potentiated 
SOCE, and (2) STIM2.2-potentiated SOCE during STIM1 knockdown. σ1R also inhibited 
STIM2.2-potentiated SOCE when measured by G-GECO1.2-Orai1 in STIM2.2 enriched 
microdomains (Fig 7.38-9). SOCE was also detected by G-GECO1.2-Orai1 in STIM2.2 
enriched microdomains during basal conditions (Fig. 7.310-11). To confirm that these 
measurements of Ca2+ influx truly correspond to the measurements of SOCE at ER-PM 
junctions, additional controls were run using negative regulator of SOCE, STIM2 splice 
variant STIM2.1, and dominant-negative mutant G-GECO1.2-Orai1R91W. Similar levels of 
Ca2+ influx were detected under both conditions, supporting initial hypothesis that small 
changes in ER [Ca2+] are sufficient to evoke STIM2.2/Orai1 mediated SOCE. However, 
enhanced expression of σ1R failed to inhibit STIM2.2-mediated SOCE during basal 
conditions (Fig. 7.310-11)  
The inhibition of STIM2.2-potentiated SOCE by σ1R in the population of HEK293 
cells can simply be explained as a result of reduced levels of STIM2.2 proteins that were 
detected by western blot analysis in the presence of σ1R ( Fig 7.35). However, potentiation  
of SOCE that occurs during STIM1 knockdown by overexpressing STIM2.2 (Fig 7.33)  
suggests that STIM2.2 can rescue Tg-evoked SOCE in the absence of STIM1 proteins, and 
σ1R exerted same inhibitory effect under those conditions (Fig. 7.34). In broader context, 
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during the overexpression of σ1R, thapsigargin treatment can also potentiate STIM2/ σ1R 
interaction, as observed in previous chapter. Altogether, these results suggest more than 
one underlying mechanism by which σ1R exerts its inhibitory effect on SOCE. Importantly, 
these results also demonstrate that σ1R can interact with STIM2.2 (Chapter VI) and 
modulate STIM2.2-mediated SOCE (Chapter VII). Recently, STIM2.2-mediated nSOCE 
came into focus during investigations of its role during pathologies of CNS. Several studies 
have shown that the downregulation of STIM2, but not STIM1, decreased apoptosis and 
improved neuronal survival, by reducing ER [Ca2+] release and Ca2+ overload205. Here, I 
have demonstrated that σ1R inhibits G-GECO1.2-Orai1-measured SOCE in STIM2.2 
enriched microdomains only during profound store-depletion using thapsigargin. During the 
basal activation of STIM2.2/Orai1-mediated SOCE using only 0.1 mM EGTA, similar results 
were observed in both presence and absence of σ1R. These results suggest that the 
modulation of STIM2.2-mediated SOCE by σ1R could also be part of its neuroprotective 
role.  
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8 Conclusion 
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Figure 8.1 The proposed mechanism of σ1R in SOCE microdomain as explained in Section 8.12 of this chapter. 
Figure 8.1 The proposed mechanism of σ1R in SOCE microdomain as explained in Section 8.12 of this chapter. 
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8.1.1 σ1R inhibits STIM1/Orai1- and STIM2.2/Orai1-mediated SOCE under ER 
stress conditions 
Tight and precise regulation of SOCE is crucial for numerous cellular processes, 
such as the replenishment of intracellular Ca2+ in non-excitable cells, or  the maintenance of 
Ca2+ homeostasis in excitable cells115,139. σ1R is a neuroprotective ER chaperone with 
established therapeutic potential that has been proposed as a functional regulator of Orai1-
mediated SOCE14,34. However, σ1R has been reported to inhibit, promote, and even 
potentiate SOCE in different cell lines requiring further investigation14,34,158,159  
In this doctoral work, the role of the σ1R in the regulation of SOCE has been 
investigated using measurements of changes in [Ca2+]cyt in the population of cells, but also 
at the point of Ca2+ entry – SOCE microdomains. In both experimental conditions, the 
enhanced expression of σ1R inhibited SOCE under ER stress conditions, as it was 
previously reported by Srivats et al34. However, the experimental evidence collected within 
this work suggests more subtle and organised inhibitory effect than previously reported.  
The comparison of SOCE frequencies at ER-PM junctions revealed that enhanced 
expression of σ1R in HEK293 cells results in a tighter control of G-GECO1.2-Orai1-
measured Ca2+influx when compared to WTVC HEK293 cells. This effect was confirmed by 
overexpression of mKate-tagged σ1R construct compared to the reported loss-of-function 
mKate-tagged mutant σ1RE102Q where expression of E102Q mutant resulted in increased 
number of highly potentiated G-GECO1.2-Orai1 puncta. These results suggest that σ1R 
possesses mechanism to reduce, rather than to completely diminish SOCE, and exerts it 
within SOCE microdomains during ER stress conditions. This underlying mechanism of 
SOCE modulation by σ1R is independent of σ1R’s interactive partner IP3R, and of efflux of 
intracellular K+, which was observed in colorectal and breast cancer cells14. 
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Under basal conditions, σ1R was shown to interact with both STIM1 and STIM2.2 
proteins. The frequency of STIM/σ1R interaction in situ has been promoted by enhanced 
expression of σ1R, suggesting that the effect of σ1R may depend on its availability as 
interactive partner. Recent reports suggest that the downregulation of STIM2, but not 
STIM1, decreased apoptosis and improved neuronal survival by reducing ER [Ca2+] release 
and Ca2+ overload205. PLA analysis of STIM1-σ1R and STIM2-σ1R interactions in HeLa cells 
showed that during limited expression σ1R, profound store-depletion increases STIM1--σ1R 
interaction while decreasing STIM2-σ1R, suggesting that the availability of  σ1R as 
interactive partner may be essential in the regulation of STIM1-mediated and STIM2-
mediated SOCE. Contrary to previously proposed model of STIM1-Orai1- σ1R, enhanced 
expression of σ1R increased STIM2/Orai1 interaction. The greatest increase was observed 
during basal conditions and it was reduced by profound store-depletion. These results 
suggest that the reduction in STIM2 interaction with endogenous σ1R post-thapsigargin 
treatment could be related to the enhanced binding of STIM1 to both proteins under these 
conditions. These results also show that in addition to STIM1, σ1R can also interact with 
STIM2. 
 σ1R is widely expressed in CNS where it exhibits neuroprotective properties12. σ1R 
confers a neuroprotective role in pre-clinical models of neurodegenerative disorders, but the 
mechanisms by which σ1R exhibits its neuroprotective role remain elusive. The results of 
this doctoral work show that σ1R can counter STIM2.2-mediated SOCE during profound ER 
[Ca2+] release (ER stress conditions), indicating that its ability to modulate STIM2.2/Orai1-
mediated SOCE could be part of the mechanism underlying its neuroprotective ability.  
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8.1.2 The proposed mechanism of σ1R in SOCE microdomain 
On the base of the previous studies14,22,34,116,139 and our findings, we propose a model 
(Fig8.1) where σ1R modulates Orai1 channel function in STIM-dependent manner: 
A) Basal conditions: 
1. At rest, σ1R is associated with well-characterized intraluminal chaperone 
BiP that binds luminal Ca2+.  
2. During same conditions, σ1R also interacts with STIM1 and STIM2.2. 
proteins. However, the STIM/σ1R interaction may be limited by the 
availability of σ1R as an interactive partner. 
B) Small drops in ER [Ca2+]: 
3. As the interactive partner of STIM proteins, σ1R has ability to translocate 
to ER-PM junctions in STIM-dependent manner. As the interactive 
partner of STIM2.2, σ1R can translocate to ER-PM junctions where it co-
localises with STIM2.2. The evidence suggests that enhanced expression 
of σ1R may promote STIM2.2/Orai1 interaction. However, no inhibitory 
effect of the σ1R was detected during STIM2.2/Orai1-mediated SOCE 
under these conditions.  
C) ER stress conditions: 
4. The switch from “inactive mode” (σ1R is bound to BiP) to “active mode” 
of σ1R (σ1R dissociates from BiP) is conditioned by the levels of luminal 
Ca2+. Following severe drop in ER [Ca2+], σ1R dissociates from BiP and 
it is available for interaction with other proteins, such as IP3Rs at MAMs 
or STIM proteins at ER-PM junctions. 
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5. As the interactive partner of STIM proteins, the σ1R has ability to 
translocate to ER-PM junctions in STIM-dependent manner. Hence, 
σ1R’s ability to modulate SOCE will be conditioned by the levels of 
luminal Ca2+, and the Ca2+ affinity of STIM homologs. As part of SOCE 
microdomain complex, σ1R inhibits Orai1-mediated Ca2+ influx.  
There are several additional mechanisms to explain how the σ1R inhibits Ca2+ influx 
as a part of SOCE microdomain complex. Based on our results, it is possible that, by binding 
to STIM proteins, σ1R restricts the stoichiometry of STIM/Orai interaction preventing 
maximum activation of SOCE. Current evidence suggests that Orai1 channel is a hexameric 
structure requiring two STIM proteins per Orai1 unit to achieve maximum activation and Ca2+ 
influx126. While binding to STIM proteins, σ1R possibly restricts their ability to form compact 
and sizable homo- or heterooligomers that would ensure the most efficient activation of 
Orai1 channel or perhaps, the most efficient crosslinking of Orai1 clusters. For example, 
inhibitory splice variant of STIM2, STIM2.1, inhibits Ca2+ influx by reducing STIM1’s ability 
to crosslink multiple Orai1 clusters once part of STIM1/STIM2.1 heterooligomer117.  
σ1R’s restriction of STIM/Orai stoichiometry would also explain no significant 
reduction of STIM2.2/Orai1-mediated SOCE induced by small changes in ER [Ca2+]. The 
comparison of STIM1 and STIM2 respective EF-SAM domains identified functionally 
relevant differences in the stability of two homologues. In comparison to STIM2, STIM1 
possesses lower SAM stability and less robust EF-SAM interface. Hence, STIM1 exhibits 
increased kinetics of oligomerisation compared to STIM2106,108. The increased stability of 
STIM2 EF-SAM domain decreases protein’s propensity for oligomerisation. Hence, during 
small changes in ER [Ca2+], STIM2.2 most likely activates basal SOCE at less efficient 
stoichiometry, diminishing the effect of σ1R as its interactive partner. 
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It is possible that σ1R modulates SOCE using similar mechanism as SARAF. 
Following SOCE activation, global increases in [Ca2+] activate SCDI that then occurs 
gradually in tens of seconds. SCDI is reported to be regulated by various proteins, including 
SARAF, caveolin, E-syt1, septin4, and PI(4,5)P2130,131. To regulate SCDI, SARAF has to 
interact with STIM1 interaction and STIM1-Orai1 complex has to form within microdomain206. 
Upon Ca2+ store depletion, SARAF replaces STIM1, as its interactive partner, for the C-
terminal region of Orai1. Following the raise in cytosolic Ca2+, SARAF dissociates from Orai1 
to re-interact with STIM1206. This re-association of SARAF and STIM1 possibly promotes 
inactivation of SOCE microdomain complex, aiding SCDI.  
8.1.3 Future directions 
In this doctoral work, we have shown that σ1R inhibits STIM1/Orai1- and 
STIM2.2/Orai1-mediated SOCE during ER stress conditions. The evidence that σ1R acts as 
a STIM interactive partner in situ was obtained mostly using PLA-approach that relies on the 
binding specificity of antibodies and oligonucleotides used in the process. Antibodies 
targeting Orai1, STIM1, STIM2 and σ1R were chosen based on the reported location of their 
epitopes and the specificity shown during Western blot and immunostaining analyses. Using 
manufacturer information, all epitopes were predicted to be cytosolic. Cytosolic epitope of 
σ1R was targeted based on the novel structure of σ1R that positions the majority of protein 
outside ER28.  
Undertaken PLA analysis verified earlier study that reported STIM1/Orai1 and 
STIM1/σ1R interactions using co-immunoprecipitation approach and targeting of HA-, myc- 
and FLAG-tagged proteins34. However, PLA results reporting STIM2/Orai1 and STIM2/ σ1R 
interactions within this thesis identify STIM2 as a new interactive partner of σ1R and require 
further investigation. The limitation of PLA approach lies in the specificity of the primary 
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antibody that influences proper data interpretation. Unspecific, off-target effects could yield 
false-positive interaction. Hence, the work performed in this thesis cannot fully exclude off-
target effects of α-STIM2, especially considering high sequence similarity of two STIM 
homologs. To verify STIM2/σ1R interaction, we propose creating recombinant STIM2 and 
σ1R proteins that will allow us to perform co-immunoprecipitation studies and more specific 
targeting using tag-antibodies. Additionally, this approach can be combined with introduction 
of different mutations to the sequence of STIM proteins, as well as C-terminal truncation of 
STIM proteins via PCR. This additional approach will allow us to identify domain(s) involved 
in STIM/ σ1R interactions. 
The measurements of SOCE via G-GECO1.2-Orai1 allows optical recording of 
changes in cytosolic  [Ca2+] 8nm below channel pore. This spatial restriction of optical 
recording, as well as the expression of dominant negative G-GECO1.2-Orai1R91W, can be 
advantage when studying neuronal SOCE using research models where voltage-gated Ca2+ 
channels and glutamate receptor channels dominate Ca2+ signalling. One such a model are 
cultured hippocampal neurons from WT and STIM2−/− mice where STIM2 (but not STIM1) 
was found essential for intracellular Ca2+ accumulation during cerebral ischemia114. In 
hippocampal neurons from STIM2-/- mice, the absence of STIM2 decreased Ca2+ overload 
during an ischemic challenge114. To investigate whether STIM2.2/ σ1R interaction underlies 
neuroprotective role of σ1R, we propose using the same model and translating the approach 
demonstrated throughout this thesis. This would allow us to test whether enhanced 
expression of σ1R counteracts STIM2.2-mediated Ca2+ overload during an ischemic 
challenge. Additionally, we could determine the contribution of Orai1-mediated Ca2+ influx 
to the development of cerebral ischemia.  
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